Nutraceuticals - Global Markets

NUTRACEUTICALS: GLOBAL MARKETS
FOD013F
March 2017
Natraj Pandal
Project Analyst
ISBN: 1-62296-448-9
BCC Research
49 Walnut Park, Building 2
Wellesley, MA 02481 USA
866-285-7215 (toll-free within the USA),
or (+1) 781-489-7301
www.bccresearch.com
info@bccresearch.com
FOD013F - Nutraceuticals: Global Markets
ABOUT BCC RESEARCH
BCC Research publishes market research reports that make organizations worldwide more
profitable with intelligence that drives smart business decisions. These reports cover
today's major industrial and technology sectors, including emerging markets. For more
than 40 years we've helped customers identify new market opportunities with accurate
and reliable data and insight, including market sizing, forecasting, industry overviews, and
identification of significant trends and key competitors. We partner with analysts who are
experts in specific areas of industry and technology, providing unbiased measurements
and assessments of global markets. Our clients include the top companies in industries
around the world as well as universities, business schools, start-ups, consulting firms and
investment companies. BCC Research is a unit of Eli Research LLC. Visit our website at
www.bccresearch.com. Contact us: (+1) 781-489-7301 (U.S. Eastern time), or email
info@bccresearch.com.
CONDITIONS OF PURCHASE
The purchase of the bound or electronic copy of this report constitutes a contractual
agreement between BCC Research and the purchaser. When purchased under a
single-user license, this report is intended for use solely by the person who made the
purchase. When purchased under a multiple-user license, this report is intended for
access by the maximum number of users specified by the license. For information, email
info@bccresearch.com or telephone (+1) 781-489-7301 (U.S. Eastern time). The report
and its contents are not to be made available to other persons, autonomous divisions,
foreign subsidiaries of the same company, or other companies, unless specified by
contract and/or license. It is here stipulated that terms in an authorized contract or license
will supercede any other conditions cited in any other location. Reproduction of any
material in this report is strictly forbidden without written permission of the publisher;
email editor@bccresearch.com.
REPORT SUBSCRIPTIONS
BCC Research offers cost-effective Report Subscription services that provide organizations
with access to reports in selected industry categories, including our back catalog of
reports and newly published reports.
CUSTOM ANALYSES
BCC Research provides custom research studies tailored to our clients’ needs in areas
related to the subject research material but perhaps not covered in detail in this report.
Please contact BCC Research to discuss such services: email info@bccresearch.com or
telephone (+1) 781-489-7301 (U.S. Eastern time).
Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com

DISCLAIMER
This publication provides informative material of a professional nature. It does not

constitute managerial, legal or accounting advice, nor should it serve as a corporate
policy guide, laboratory manual or an endorsement of any product. This information is
intended to be as accurate as possible at the time of publication, but BCC Research LLC
assumes no responsibility for any losses or damages that might result because of reliance
on this material.
©Copyright 2017 by BCC Research, Wellesley, MA 02481 USA
Reproduction of any material in this report is strictly forbidden without express permission
of the Publisher; email editor@bccresearch.com.
To receive a complete catalog of BCC Research studies, please visit our Web site at
www.bccresearch.com/product-catalog.
Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com

TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION .......................................................................................... 2

STUDY GOALS AND OBJECTIVES .................................................................................... 2
REASONS FOR DOING THE STUDY ................................................................................ 2
SCOPE OF REPORT ........................................................................................................ 2
INFORMATION SOURCES ............................................................................................... 3
INTENDED AUDIENCE .................................................................................................... 3
METHODOLOGY ............................................................................................................. 3
ANALYST'S CREDENTIALS .............................................................................................. 3
RELATED BCC RESEARCH REPORTS ............................................................................. 3
BCC RESEARCH WEBSITE .............................................................................................. 4
DISCLAIMER .................................................................................................................. 4
CHAPTER 2 SUMMARY ................................................................................................... 6
SUMMARY TABLE GLOBAL NUTRACEUTICAL MARKET, BY PRODUCT, THROUGH ........... 6
2021 ($ BILLIONS)
SUMMARY FIGURE GLOBAL NUTRACEUTICAL MARKET, BY PRODUCT, 2015-2021 ....... 6
($ BILLIONS)
CHAPTER 3 OVERVIEW .................................................................................................. 9
PREMIUM VERSUS MASS FUNCTIONAL PRODUCT MARKET POSITIONING ..................... 9
PREMIUM PRICING AND MARGIN EXPANSION ........................................................... 9
EVOLUTION OF FUNCTIONAL FBS ................................................................................ 10
REGULATIONS ............................................................................................................. 10
NORTH AMERICA .................................................................................................... 11
EUROPE .................................................................................................................. 11
ASIA-PACIFIC ........................................................................................................... 12
Japan .................................................................................................................. 12
China .................................................................................................................. 12
India ................................................................................................................... 13
TABLE 1 GLOBAL REGULATIONS ON NUTRACEUTICALS ................................ 13
VALUE CHAIN .............................................................................................................. 14
FIGURE 1 NUTRACEUTICAL VALUE CHAIN .............................................................. 14
CHAPTER 4 NUTRACEUTICAL MARKET BY TYPE ...................................................... 16
FUNCTIONAL FOOD ..................................................................................................... 16
TABLE 2 GLOBAL FUNCTIONAL FOOD MARKET, BY PRODUCT, THROUGH .............. 17
2021 ($ BILLIONS)
TABLE 3 GLOBAL FUNCTIONAL FOOD MARKET, BY REGION, THROUGH 2021 ........ 17
($ BILLIONS)
CONFECTIONERY .................................................................................................... 18
TABLE 4 GLOBAL NUTRACEUTICAL CONFECTIONERY MARKET, BY ..................... 18
REGION, THROUGH 2021 ($ BILLIONS)
TABLE 5 MAJOR CONFECTIONERY PRODUCTS ................................................... 19
BAKERY ................................................................................................................... 20
TABLE 6 GLOBAL NUTRACEUTICAL BAKERY MARKET, BY REGION, .................... 20
THROUGH 2021 ($ BILLIONS)
Bread ................................................................................................................. 20
SNACKS .................................................................................................................. 21
TABLE 7 GLOBAL NUTRACEUTICAL SNACKS MARKET, BY REGION, ................... 22
TABLE 8 TOP NUTRACEUTICAL SNACKS PRODUCTS .......................................... 23
Cookies and Crackers ........................................................................................ 23
DAIRY NONDRINKABLE ........................................................................................... 24
TABLE 9 GLOBAL NUTRACEUTICAL DAIRY NONDRINKABLE MARKET, BY ............ 24
TABLE 10 TOP NUTRACEUTICAL DAIRY PRODUCTS ........................................... 25
MEAT ...................................................................................................................... 25
TABLE 11 GLOBAL NUTRACEUTICAL MEAT MARKET, BY REGION, ..................... 26
GRAIN AND FLOUR .................................................................................................. 26
TABLE 12 GLOBAL NUTRACEUTICAL GRAIN AND FLOUR MARKET, BY ................ 27
FROZEN FRUITS AND VEGETABLES ........................................................................ 27
TABLE 13 GLOBAL NUTRACEUTICAL FROZEN FRUITS AND VEGETABLES ........... 28
MARKET, BY REGION, THROUGH 2021 ($ BILLIONS)
TABLE 14 TOP SUPERFRUITS BY CONTENT ........................................................ 29
FUNCTIONAL BEVERAGES ........................................................................................... 29
TABLE 15 GLOBAL FUNCTIONAL BEVERAGE MARKET, BY PRODUCT, ..................... 30
TABLE 16 GLOBAL FUNCTIONAL BEVERAGE MARKET, BY REGION, THROUGH ....... 31
2021 ($ BILLIONS)
NONCARBONATED DRINKS ..................................................................................... 31
TABLE 17 GLOBAL NONCARBONATED DRINKS MARKET, BY REGION, ............... 32
TABLE 18 TOP FUNCTIONAL NONCARBONATED DRINKS ................................... 33
DAIRY DRINKS ........................................................................................................ 33
TABLE 19 GLOBAL DAIRY DRINKS MARKET, BY REGION, THROUGH 2021 .......... 34
($ BILLIONS)
TABLE 20 TOP NONFERMENTED FUNCTIONAL DAIRY BEVERAGES .................... 35
FROZEN JUICES ....................................................................................................... 35
TABLE 21 GLOBAL FROZEN JUICES MARKET, BY REGION, THROUGH 2021 ........ 36
($ BILLIONS)
TABLE 22 TOP FUNCTIONAL JUICE PRODUCTS .................................................. 36
TEA AND COFFEE .................................................................................................... 37
TABLE 23 GLOBAL TEA AND COFFEE MARKET, BY REGION, THROUGH .............. 37
2021 ($ BILLIONS)
Green Tea .......................................................................................................... 38
Black Tea and Ice Tea ........................................................................................ 38
Functional Coffee ............................................................................................... 38
TABLE 24 TOP TEA AND COFFEE PRODUCTS ................................................ 39
DIETARY SUPPLEMENTS .............................................................................................. 39
TABLE 25 GLOBAL DIETARY SUPPLEMENTS MARKET, BY PRODUCT, ...................... 39
TABLE 26 GLOBAL DIETARY SUPPLEMENTS MARKET, BY REGION, THROUGH ........ 40
2021 ($ BILLIONS)
CHAPTER 5 NUTRACEUTICAL MARKET BY INGREDIENTS ....................................... 42
TABLE 27 GLOBAL NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, ...................... 42
TABLE 28 GLOBAL NUTRACEUTICAL FOOD MARKET, BY INGREDIENT, ....................... 43
TABLE 29 GLOBAL NUTRACEUTICAL BEVERAGE MARKET, BY INGREDIENT, ................ 43
TABLE 30 GLOBAL NUTRACEUTICAL SUPPLEMENT MARKET, BY INGREDIENT, ............ 44
VITAMINS AND MINERALS ........................................................................................... 44
TABLE 31 GLOBAL NUTRACEUTICAL VITAMIN AND MINERAL MARKET, BY .............. 45
PROBIOTICS ................................................................................................................ 45
TABLE 32 GLOBAL NUTRACEUTICAL PROBIOTICS MARKET, BY REGION, ............... 46
TABLE 33 GLOBAL NUTRACEUTICAL PROBIOTICS MARKET, BY PRODUCT .............. 47
TYPE, THROUGH 2021 ($ BILLIONS)
TABLE 34 GLOBAL NUTRACEUTICAL PROBIOTICS FOOD MARKET, BY ..................... 47
PRODUCT, THROUGH 2021 ($ BILLIONS)
TABLE 35 OTHER MAJOR PROBIOTIC PRODUCTS ................................................... 48
FIBER .......................................................................................................................... 48
TABLE 36 GLOBAL NUTRACEUTICAL FIBER MARKET, BY REGION, THROUGH ........ 49
2021 ($ BILLIONS)
TABLE 37 GLOBAL NUTRACEUTICAL FIBER MARKET, BY PRODUCT TYPE, .............. 49
TABLE 38 GLOBAL NUTRACEUTICAL FIBER FOOD MARKET, BY PRODUCT, ............ 50
WHOLE GRAINS ...................................................................................................... 50
TABLE 39 MAJOR WHOLE GRAINS PRODUCTS ................................................... 51
TABLE 40 SELECTED FIBER-BASED PRODUCTS ................................................. 51
HIGH-FIBER FOOD ................................................................................................... 51
BETA-GLUCAN ......................................................................................................... 52
OMEGA-3 ..................................................................................................................... 52
TABLE 41 GLOBAL NUTRACEUTICAL OMEGA-3 MARKET, BY REGION, .................... 52
TABLE 42 GLOBAL NUTRACEUTICAL OMEGA-3 MARKET, BY PRODUCT TYPE, ......... 53
TABLE 43 GLOBAL NUTRACEUTICAL OMEGA-3-BASED FOOD MARKET, BY ............. 54
TABLE 44 OTHER MAJOR OMEGA-3 PRODUCTS ..................................................... 55
PROTEIN AND PEPTIDES .............................................................................................. 55
TABLE 45 GLOBAL PROTEIN AND PEPTIDES MARKET, BY REGION, THROUGH ....... 56
2021 ($ BILLIONS)
TABLE 46 GLOBAL PROTEIN AND PEPTIDES MARKET, BY PRODUCT TYPE, ............ 56
TABLE 47 GLOBAL PROTEIN- AND PEPTIDE-BASED FOOD MARKET, BY .................. 57
PROTEIN TYPES ....................................................................................................... 57
Soy Protein ......................................................................................................... 57
Whey .................................................................................................................. 58
AMINO ACIDS .......................................................................................................... 59
TABLE 48 OTHER MAJOR PROTEIN PRODUCTS .................................................. 59
PHYTOCHEMICALS .................................................................................................. 61
TABLE 49 GLOBAL NUTRACEUTICAL PHYTOCHEMICAL MARKET, BY ................... 61
TABLE 50 GLOBAL NUTRACEUTICAL PHYTOCHEMICAL MARKET, BY ................... 62
PRODUCT TYPE, THROUGH 2021 ($ BILLIONS)
TABLE 51 GLOBAL NUTRACEUTICAL PHYTOCHEMICAL-BASED FOOD ................. 62
MARKET, BY PRODUCT, THROUGH 2021 ($ BILLIONS)
TABLE 52 GLOBAL NUTRACEUTICAL PHYTOCHEMICAL-BASED BEVERAGE ......... 63
PLANT STEROLS ...................................................................................................... 63
TABLE 53 MAJOR PLANT STEROLS PRODUCTS .................................................. 64
ANTIOXIDANTS ....................................................................................................... 64
TABLE 54 MAJOR ANTIOXIDANTS PRODUCTS .................................................... 65
TABLE 55 MAJOR NUTRACEUTICAL INGREDIENTS ............................................. 65
CHAPTER 6 NUTRACEUTICAL MARKET BY APPLICATIONS ..................................... 68
TABLE 56 GLOBAL NUTRACEUTICAL MARKET, BY APPLICATION, THROUGH 2021 ....... 68
($ BILLIONS)
SPORTS AND ENERGY ................................................................................................. 69
TABLE 57 GLOBAL SPORTS AND ENERGY MARKET, BY REGION, THROUGH ............ 70
2021 ($ BILLIONS)
TABLE 58 OTHER SPORTS AND ENERGY PRODUCTS AND INGREDIENTS ............... 71
GENERAL WELLNESS ................................................................................................... 71
TABLE 59 GLOBAL GENERAL WELLNESS MARKET, BY REGION, THROUGH ............. 71
2021 ($ BILLIONS)
WEIGHT MANAGEMENT ............................................................................................... 72
TABLE 60 GLOBAL WEIGHT MANAGEMENT APPLICATION MARKET, BY ................... 72
FUNCTIONAL BREAKFAST ....................................................................................... 73
SATIETY PRODUCTS ................................................................................................ 73
TABLE 61 MAJOR WEIGHT MANAGEMENT PRODUCTS ....................................... 74
TABLE 62 MAJOR WEIGHT MANAGEMENT FUNCTIONAL INGREDIENTS .............. 74
HEART HEALTH ........................................................................................................... 75
TABLE 63 GLOBAL HEART HEALTH APPLICATION MARKET, BY REGION, ................ 76
TABLE 64 MAJOR HEART HEALTH FUNCTIONAL PRODUCTS BY APPLICATION ........ 77
GI AND DIGESTIVE HEALTH ......................................................................................... 77
TABLE 65 GLOBAL GI AND DIGESTIVE HEALTH APPLICATION MARKET, BY ............. 78
TABLE 66 MAJOR GI PRODUCTS ............................................................................. 78
BEAUTY AND ANTI-AGING ........................................................................................... 79
TABLE 67 GLOBAL BEAUTY AND ANTI-AGING MARKET, BY REGION, ...................... 79
TABLE 68 ANTI-AGING AND BEAUTY INGREDIENTS AND APPLICATIONS ................ 80
TABLE 69 MAJOR ANTI-AGING AND BEAUTY PRODUCTS ........................................ 81
TYPE 2 DIABETES ........................................................................................................ 81
TABLE 70 GLOBAL TYPE 2 DIABETES MARKET, BY REGION, THROUGH 2021 .......... 82
($ BILLIONS)
MEMORY AND MENTAL HEALTH .................................................................................. 83
TABLE 71 GLOBAL MEMORY AND MENTAL HEALTH MARKET BY REGION, .............. 83
CHAPTER 7 NUTRACEUTICAL MARKET BY REGION ................................................. 85
GLOBAL NUTRACEUTICAL MARKET ............................................................................. 85
TABLE 72 GLOBAL NUTRACEUTICAL MARKET, BY REGION, THROUGH 2021 ........... 85
($ BILLIONS)
FIGURE 2 GLOBAL NUTRACEUTICAL MARKET BY REGION, 2015-2021 ($ ................ 85
BILLIONS)
NORTH AMERICA .................................................................................................... 86
TABLE 73 NORTH AMERICAN NUTRACEUTICAL MARKET, BY COUNTRY, ............ 86
TABLE 74 NORTH AMERICAN NUTRACEUTICAL MARKET, BY PRODUCT, ............ 87
TABLE 75 NORTH AMERICAN NUTRACEUTICAL FOOD MARKET, BY .................... 88
TABLE 76 NORTH AMERICAN NUTRACEUTICAL BEVERAGE MARKET, BY ............ 88
TABLE 77 NORTH AMERICAN NUTRACEUTICAL MARKET, BY APPLICATION, ........ 89
EUROPE .................................................................................................................. 89
TABLE 78 EUROPEAN NUTRACEUTICAL MARKET, BY COUNTRY, THROUGH ....... 90
2021 ($ BILLIONS)
TABLE 79 EUROPEAN NUTRACEUTICAL MARKET, BY PRODUCT, THROUGH ....... 91
2021 ($ BILLIONS)
TABLE 80 EUROPEAN NUTRACEUTICAL FOOD MARKET, BY PRODUCT, .............. 91
TABLE 81 EUROPEAN NUTRACEUTICAL BEVERAGE MARKET, BY PRODUCT, ...... 92
THROUGH 2021 ($ MILLIONS)
TABLE 82 EUROPEAN NUTRACEUTICAL MARKET, BY APPLICATION, .................. 93
ASIA-PACIFIC ........................................................................................................... 93
TABLE 83 ASIA-PACIFIC NUTRACEUTICAL MARKET, BY COUNTRY, .................... 94
TABLE 84 ASIA-PACIFIC NUTRACEUTICAL MARKET, BY PRODUCT, .................... 95
TABLE 85 ASIA-PACIFIC NUTRACEUTICAL MARKET, BY FOOD PRODUCT, .......... 96
TABLE 86 ASIA-PACIFIC NUTRACEUTICAL BEVERAGE MARKET, BY ..................... 96
TABLE 87 ASIA-PACIFIC NUTRACEUTICAL MARKET, BY APPLICATION, ............... 97
SOUTH AMERICA ..................................................................................................... 97
TABLE 88 SOUTH AMERICA NUTRACEUTICAL MARKET, BY COUNTRY, .............. 98
CHAPTER 8 PATENT EVALUATION ........................................................................... 100
NUTRACEUTICAL PATENTS BY COMPANY .................................................................. 100
TABLE 89 NUTRACEUTICAL PATENT ANALYSIS, BY COMPANY, 2011-2015 ........... 100
(NUMBER/%)
PATENTS BY COUNTRY/REGION ................................................................................ 101
FIGURE 3 NUTRACEUTICAL PATENT SHARES BY COUNTRY/REGION, .................... 101
2011-2015 (%)
U.S. NUTRACEUTICAL PATENTS ............................................................................ 102
TABLE 90 U.S. NUTRACEUTICAL PATENTS, 2011-2015 .................................... 102
EUROPEAN NUTRACEUTICAL PATENTS ................................................................. 115
TABLE 91 EUROPE NUTRACEUTICAL PATENTS, 2011-2015 ............................. 115
JAPANESE NUTRACEUTICAL PATENTS ................................................................... 131
TABLE 92 JAPANESE NUTRACEUTICAL PATENTS, 2011-2015 .......................... 131
CHAPTER 9 INDUSTRY STRUCTURE ......................................................................... 145
FACTORS INFLUENCING DEMAND ............................................................................. 145
TABLE 93 DRIVERS OF NUTRACEUTICAL MARKET, 2011-2020 ............................ 145
INCREASINGLY AGING POPULATIONS ................................................................... 145
RISING HEALTHCARE COSTS ................................................................................. 145
SHIFT TOWARD SELF-MEDICATION ....................................................................... 145
TECHNOLOGY DRIVING HIGHER EFFICACY ............................................................ 146
CHALLENGES IN THE NUTRACEUTICAL MARKET ........................................................ 146
HIGH NUTRACEUTICAL PRODUCT PRICES ............................................................. 146
LACK OF AWARENESS ABOUT NUTRACEUTICALS ................................................. 146
OPPORTUNITIES FOR NUTRACEUTICAL COMPANIES .................................................. 147
OPPORTUNITIES FOR ENTERING THE NUTRACEUTICALS MARKET ......................... 147
FEWER CONTRACT MANUFACTURERS .................................................................. 147
FOCUSED ON NEW PRODUCT DEVELOPMENT ....................................................... 147
MARKET STRATEGIES ................................................................................................ 147
STRATEGY BY TYPE ............................................................................................... 148
FIGURE 4 GLOBAL NUTRACEUTICALS MARKET GROWTH STRATEGIES, ............ 148
2011-2015 (%)
GROWTH STRATEGIES BY COMPANY .................................................................... 149
FIGURE 5 GLOBAL NUTRACEUTICALS GROWTH STRATEGY ACTIVITY BY .......... 149
COMPANY, 2011-2015 (%)
New Product Development .............................................................................. 150
TABLE 94 NEW NUTRACEUTICALS PRODUCT LAUNCHES, 2011-2015 ......... 150
Mergers and Acquisitions ................................................................................. 152
TABLE 95 MERGERS AND ACQUISITIONS, 2011-2015 ................................. 152
Partnerships, Collaborations, Expansion, Joint Ventures and Agreements ....... 154
TABLE 96 PARTNERSHIPS, COLLABORATIONS, EXPANSION, JOINT .............. 154
VENTURES AND AGREEMENTS, 2011-2015
CHAPTER 10 COMPETITIVE OUTLOOK AND COMPANY PROFILES ....................... 158
COMPETITIVE OUTLOOK ............................................................................................ 158
COMPANY PROFILES .................................................................................................. 159
ARISTA INDUSTRIES .............................................................................................. 159
Overview .......................................................................................................... 159
Financials ......................................................................................................... 159
Products and Services ...................................................................................... 159
Strategy ........................................................................................................... 159
BASF SE ................................................................................................................ 160
Overview .......................................................................................................... 160
Financials ......................................................................................................... 160
Strategy ........................................................................................................... 160
BENEO-ORAFTI S.A. .............................................................................................. 161
Overview .......................................................................................................... 161
Financials ......................................................................................................... 161
TABLE 97 BENEO'S NUTRACEUTICAL PRODUCTS ........................................ 161
Strategy ........................................................................................................... 161
CARGILL INC. ........................................................................................................ 162
Overview .......................................................................................................... 162
Financials ......................................................................................................... 162
TABLE 98 CARGILL'S PROBIOTIC PRODUCTS .............................................. 163
TABLE 99 CARGILL FEED NUTRITION PRODUCTS ........................................ 163
Strategy ........................................................................................................... 163
COSUCRA GROUPE WARCOING S.A. ..................................................................... 163
Overview .......................................................................................................... 163
Financials ......................................................................................................... 164
TABLE 100 COSUCRA: NUTRACEUTICAL PRODUCTS ................................... 164
Strategy ........................................................................................................... 164
CRODA INTERNATIONAL PLC ................................................................................ 165
Overview .......................................................................................................... 165
Financials ......................................................................................................... 165
TABLE 101 CRODA'S NUTRACEUTICAL PRODUCT INCROMEGA ................... 165
Strategy ........................................................................................................... 166
DANISCO A/S ........................................................................................................ 166
Overview .......................................................................................................... 166
Financials ......................................................................................................... 166
TABLE 102 DANISCO FOOD INGREDIENTS .................................................. 167
Strategy ........................................................................................................... 167
GROUPE DANONE S.A. .......................................................................................... 167
Overview .......................................................................................................... 167
Financials ......................................................................................................... 168
TABLE 103 DANONE'S NUTRACEUTICAL PRODUCTS ................................... 168
Strategy ........................................................................................................... 168
MARTEK BIOSCIENCES CORP. ............................................................................... 169
Overview ......................................................................................................... 169
Financials ......................................................................................................... 169
TABLE 104 MARTEK'S NUTRACEUTICAL PRODUCTS ................................... 170
Strategy ........................................................................................................... 170
NORDIC NATURALS ............................................................................................... 170
Overview .......................................................................................................... 170
Financials ......................................................................................................... 171
TABLE 105 NORDIC NATURALS' OMEGA-3 PRODUCTS ................................ 171
Strategy ........................................................................................................... 172
OCEAN NUTRITION CANADA LTD. ......................................................................... 172
Overview .......................................................................................................... 172
Financials ......................................................................................................... 172
Strategy ........................................................................................................... 173
OMEGA PROTEIN CORP. ........................................................................................ 173
Overview .......................................................................................................... 173
Financials ......................................................................................................... 173
TABLE 106 OMEGA PROTEIN'S NUTRITION PRODUCTS ............................... 174
Strategy ........................................................................................................... 174
PHARMA MARINE USA LLC .................................................................................... 175
Overview .......................................................................................................... 175
Financials ......................................................................................................... 175
TABLE 107 PHARMA MARINE'S CALAMARI PRODUCTS ................................ 175
Strategy ........................................................................................................... 176
ZYMES LLC ............................................................................................................ 176
Overview .......................................................................................................... 176
Financials ......................................................................................................... 176
TABLE 108 ZYMES' OMEGA-3 PRODUCTS ................................................... 176
Strategy ........................................................................................................... 177
CHAPTER 11 APPENDIX ............................................................................................ 179
LIST OF ACRONYMS ................................................................................................... 179
LIST OF TABLES
SUMMARY TABLE GLOBAL NUTRACEUTICAL MARKET, BY PRODUCT, THROUGH ........... 6

2021 ($ BILLIONS)
TABLE 1 GLOBAL REGULATIONS ON NUTRACEUTICALS ............................................. 13
TABLE 2 GLOBAL FUNCTIONAL FOOD MARKET, BY PRODUCT, THROUGH 2021 .......... 17
($ BILLIONS)
TABLE 3 GLOBAL FUNCTIONAL FOOD MARKET, BY REGION, THROUGH 2021 ($ ......... 17
BILLIONS)
TABLE 4 GLOBAL NUTRACEUTICAL CONFECTIONERY MARKET, BY REGION, ............... 18
TABLE 5 MAJOR CONFECTIONERY PRODUCTS ............................................................ 19
TABLE 6 GLOBAL NUTRACEUTICAL BAKERY MARKET, BY REGION, THROUGH ............ 20
2021 ($ BILLIONS)
TABLE 7 GLOBAL NUTRACEUTICAL SNACKS MARKET, BY REGION, THROUGH ........... 22
2021 ($ BILLIONS)
TABLE 8 TOP NUTRACEUTICAL SNACKS PRODUCTS ................................................... 23
TABLE 9 GLOBAL NUTRACEUTICAL DAIRY NONDRINKABLE MARKET, BY ..................... 24
TABLE 10 TOP NUTRACEUTICAL DAIRY PRODUCTS .................................................... 25
TABLE 11 GLOBAL NUTRACEUTICAL MEAT MARKET, BY REGION, THROUGH ............. 26
2021 ($ BILLIONS)
TABLE 12 GLOBAL NUTRACEUTICAL GRAIN AND FLOUR MARKET, BY REGION, ........... 27
TABLE 13 GLOBAL NUTRACEUTICAL FROZEN FRUITS AND VEGETABLES .................... 28
MARKET, BY REGION, THROUGH 2021 ($ BILLIONS)
TABLE 14 TOP SUPERFRUITS BY CONTENT ................................................................. 29
TABLE 15 GLOBAL FUNCTIONAL BEVERAGE MARKET, BY PRODUCT, THROUGH ........ 30
2021 ($ BILLIONS)
TABLE 16 GLOBAL FUNCTIONAL BEVERAGE MARKET, BY REGION, THROUGH ........... 31
2021 ($ BILLIONS)
TABLE 17 GLOBAL NONCARBONATED DRINKS MARKET, BY REGION, THROUGH ....... 32
2021 ($ BILLIONS)
TABLE 18 TOP FUNCTIONAL NONCARBONATED DRINKS ............................................ 33
TABLE 19 GLOBAL DAIRY DRINKS MARKET, BY REGION, THROUGH 2021 ($ ............... 34
BILLIONS)
TABLE 20 TOP NONFERMENTED FUNCTIONAL DAIRY BEVERAGES ............................. 35
TABLE 21 GLOBAL FROZEN JUICES MARKET, BY REGION, THROUGH 2021 ($ ............. 36
BILLIONS)
TABLE 22 TOP FUNCTIONAL JUICE PRODUCTS ........................................................... 36
TABLE 23 GLOBAL TEA AND COFFEE MARKET, BY REGION, THROUGH 2021 ($ .......... 37
BILLIONS)
TABLE 24 TOP TEA AND COFFEE PRODUCTS .............................................................. 39
TABLE 25 GLOBAL DIETARY SUPPLEMENTS MARKET, BY PRODUCT, THROUGH ......... 39
2021 ($ BILLIONS)
TABLE 26 GLOBAL DIETARY SUPPLEMENTS MARKET, BY REGION, THROUGH ............ 40
2021 ($ BILLIONS)
TABLE 27 GLOBAL NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, ...................... 42
TABLE 28 GLOBAL NUTRACEUTICAL FOOD MARKET, BY INGREDIENT, ....................... 43
TABLE 29 GLOBAL NUTRACEUTICAL BEVERAGE MARKET, BY INGREDIENT, ................ 43
TABLE 30 GLOBAL NUTRACEUTICAL SUPPLEMENT MARKET, BY INGREDIENT, ............ 44
TABLE 31 GLOBAL NUTRACEUTICAL VITAMIN AND MINERAL MARKET, BY .................. 45
TABLE 32 GLOBAL NUTRACEUTICAL PROBIOTICS MARKET, BY REGION, .................... 46
TABLE 33 GLOBAL NUTRACEUTICAL PROBIOTICS MARKET, BY PRODUCT TYPE, ......... 47
TABLE 34 GLOBAL NUTRACEUTICAL PROBIOTICS FOOD MARKET, BY PRODUCT, ........ 47
TABLE 35 OTHER MAJOR PROBIOTIC PRODUCTS ........................................................ 48
TABLE 36 GLOBAL NUTRACEUTICAL FIBER MARKET, BY REGION, THROUGH ............. 49
2021 ($ BILLIONS)
TABLE 37 GLOBAL NUTRACEUTICAL FIBER MARKET, BY PRODUCT TYPE, .................. 49
TABLE 38 GLOBAL NUTRACEUTICAL FIBER FOOD MARKET, BY PRODUCT, ................. 50
TABLE 39 MAJOR WHOLE GRAINS PRODUCTS ............................................................ 51
TABLE 40 SELECTED FIBER-BASED PRODUCTS .......................................................... 51
TABLE 41 GLOBAL NUTRACEUTICAL OMEGA-3 MARKET, BY REGION, THROUGH ....... 52
2021 ($ BILLIONS)
TABLE 42 GLOBAL NUTRACEUTICAL OMEGA-3 MARKET, BY PRODUCT TYPE, ............. 53
TABLE 43 GLOBAL NUTRACEUTICAL OMEGA-3-BASED FOOD MARKET, BY ................. 54
TABLE 44 OTHER MAJOR OMEGA-3 PRODUCTS .......................................................... 55
TABLE 45 GLOBAL PROTEIN AND PEPTIDES MARKET, BY REGION, THROUGH ............ 56
2021 ($ BILLIONS)
TABLE 46 GLOBAL PROTEIN AND PEPTIDES MARKET, BY PRODUCT TYPE, ................. 56
TABLE 47 GLOBAL PROTEIN- AND PEPTIDE-BASED FOOD MARKET, BY ....................... 57
TABLE 48 OTHER MAJOR PROTEIN PRODUCTS ........................................................... 59
TABLE 49 GLOBAL NUTRACEUTICAL PHYTOCHEMICAL MARKET, BY REGION, ............. 61
TABLE 50 GLOBAL NUTRACEUTICAL PHYTOCHEMICAL MARKET, BY PRODUCT ........... 62
TYPE, THROUGH 2021 ($ BILLIONS)
TABLE 51 GLOBAL NUTRACEUTICAL PHYTOCHEMICAL-BASED FOOD MARKET, .......... 62
BY PRODUCT, THROUGH 2021 ($ BILLIONS)
TABLE 52 GLOBAL NUTRACEUTICAL PHYTOCHEMICAL-BASED BEVERAGE .................. 63
TABLE 53 MAJOR PLANT STEROLS PRODUCTS ........................................................... 64
TABLE 54 MAJOR ANTIOXIDANTS PRODUCTS ............................................................. 65
TABLE 55 MAJOR NUTRACEUTICAL INGREDIENTS ...................................................... 65
TABLE 56 GLOBAL NUTRACEUTICAL MARKET, BY APPLICATION, THROUGH 2021 ....... 68
($ BILLIONS)
TABLE 57 GLOBAL SPORTS AND ENERGY MARKET, BY REGION, THROUGH 2021 ....... 70
($ BILLIONS)
TABLE 58 OTHER SPORTS AND ENERGY PRODUCTS AND INGREDIENTS .................... 71
TABLE 59 GLOBAL GENERAL WELLNESS MARKET, BY REGION, THROUGH 2021 ......... 71
($ BILLIONS)
TABLE 60 GLOBAL WEIGHT MANAGEMENT APPLICATION MARKET, BY REGION, ......... 72
TABLE 61 MAJOR WEIGHT MANAGEMENT PRODUCTS ................................................ 74
TABLE 62 MAJOR WEIGHT MANAGEMENT FUNCTIONAL INGREDIENTS ....................... 74
TABLE 63 GLOBAL HEART HEALTH APPLICATION MARKET, BY REGION, ..................... 76
TABLE 64 MAJOR HEART HEALTH FUNCTIONAL PRODUCTS BY APPLICATION ............. 77
TABLE 65 GLOBAL GI AND DIGESTIVE HEALTH APPLICATION MARKET, BY .................. 78
TABLE 66 MAJOR GI PRODUCTS ................................................................................. 78
TABLE 67 GLOBAL BEAUTY AND ANTI-AGING MARKET, BY REGION, THROUGH ......... 79
2021 ($ BILLIONS)
TABLE 68 ANTI-AGING AND BEAUTY INGREDIENTS AND APPLICATIONS .................... 80
TABLE 69 MAJOR ANTI-AGING AND BEAUTY PRODUCTS ............................................. 81
TABLE 70 GLOBAL TYPE 2 DIABETES MARKET, BY REGION, THROUGH 2021 ($ .......... 82
BILLIONS)
TABLE 71 GLOBAL MEMORY AND MENTAL HEALTH MARKET BY REGION, .................. 83
TABLE 72 GLOBAL NUTRACEUTICAL MARKET, BY REGION, THROUGH 2021 ($ ........... 85
BILLIONS)
TABLE 73 NORTH AMERICAN NUTRACEUTICAL MARKET, BY COUNTRY, ..................... 86
TABLE 74 NORTH AMERICAN NUTRACEUTICAL MARKET, BY PRODUCT, ..................... 87
TABLE 75 NORTH AMERICAN NUTRACEUTICAL FOOD MARKET, BY PRODUCT, ............ 88
TABLE 76 NORTH AMERICAN NUTRACEUTICAL BEVERAGE MARKET, BY ..................... 88
TABLE 77 NORTH AMERICAN NUTRACEUTICAL MARKET, BY APPLICATION, ................. 89
TABLE 78 EUROPEAN NUTRACEUTICAL MARKET, BY COUNTRY, THROUGH 2021 ....... 90
($ BILLIONS)
TABLE 79 EUROPEAN NUTRACEUTICAL MARKET, BY PRODUCT, THROUGH 2021 ....... 91
($ BILLIONS)
TABLE 80 EUROPEAN NUTRACEUTICAL FOOD MARKET, BY PRODUCT, ....................... 91
TABLE 81 EUROPEAN NUTRACEUTICAL BEVERAGE MARKET, BY PRODUCT, ............... 92
THROUGH 2021 ($ MILLIONS)
TABLE 82 EUROPEAN NUTRACEUTICAL MARKET, BY APPLICATION, THROUGH .......... 93
2021 ($ BILLIONS)
TABLE 83 ASIA-PACIFIC NUTRACEUTICAL MARKET, BY COUNTRY, THROUGH ............ 94
2021 ($ BILLIONS)
TABLE 84 ASIA-PACIFIC NUTRACEUTICAL MARKET, BY PRODUCT, THROUGH ............ 95
2021 ($ BILLIONS)
TABLE 85 ASIA-PACIFIC NUTRACEUTICAL MARKET, BY FOOD PRODUCT, ................... 96
TABLE 86 ASIA-PACIFIC NUTRACEUTICAL BEVERAGE MARKET, BY PRODUCT, ............ 96
TABLE 87 ASIA-PACIFIC NUTRACEUTICAL MARKET, BY APPLICATION, THROUGH ....... 97
2021 ($ BILLIONS)
TABLE 88 SOUTH AMERICA NUTRACEUTICAL MARKET, BY COUNTRY, THROUGH ...... 98
2021 ($ BILLIONS)
TABLE 89 NUTRACEUTICAL PATENT ANALYSIS, BY COMPANY, 2011-2015 ................ 100
(NUMBER/%)
TABLE 90 U.S. NUTRACEUTICAL PATENTS, 2011-2015 ............................................. 102
TABLE 91 EUROPE NUTRACEUTICAL PATENTS, 2011-2015 ...................................... 115
TABLE 92 JAPANESE NUTRACEUTICAL PATENTS, 2011-2015 ................................... 131
TABLE 93 DRIVERS OF NUTRACEUTICAL MARKET, 2011-2020 ................................. 145
TABLE 94 NEW NUTRACEUTICALS PRODUCT LAUNCHES, 2011-2015 ...................... 150
TABLE 95 MERGERS AND ACQUISITIONS, 2011-2015 .............................................. 152
TABLE 96 PARTNERSHIPS, COLLABORATIONS, EXPANSION, JOINT VENTURES .......... 154
AND AGREEMENTS, 2011-2015
TABLE 97 BENEO'S NUTRACEUTICAL PRODUCTS ..................................................... 161
TABLE 98 CARGILL'S PROBIOTIC PRODUCTS ............................................................ 163
TABLE 99 CARGILL FEED NUTRITION PRODUCTS ..................................................... 163
TABLE 100 COSUCRA: NUTRACEUTICAL PRODUCTS ................................................ 164
TABLE 101 CRODA'S NUTRACEUTICAL PRODUCT INCROMEGA ................................ 165
TABLE 102 DANISCO FOOD INGREDIENTS ............................................................... 167
TABLE 103 DANONE'S NUTRACEUTICAL PRODUCTS ................................................ 168
TABLE 104 MARTEK'S NUTRACEUTICAL PRODUCTS ................................................. 170
TABLE 105 NORDIC NATURALS' OMEGA-3 PRODUCTS ............................................. 171
TABLE 106 OMEGA PROTEIN'S NUTRITION PRODUCTS ............................................ 174
TABLE 107 PHARMA MARINE'S CALAMARI PRODUCTS ............................................. 175
TABLE 108 ZYMES' OMEGA-3 PRODUCTS ................................................................. 176
LIST OF FIGURES
SUMMARY FIGURE GLOBAL NUTRACEUTICAL MARKET, BY PRODUCT, 2015-2021 ....... 6

($ BILLIONS)
FIGURE 1 NUTRACEUTICAL VALUE CHAIN .................................................................. 14
FIGURE 2 GLOBAL NUTRACEUTICAL MARKET BY REGION, 2015-2021 ($ .................... 85
BILLIONS)
FIGURE 3 NUTRACEUTICAL PATENT SHARES BY COUNTRY/REGION, 2011-2015 ....... 101
(%)
FIGURE 4 GLOBAL NUTRACEUTICALS MARKET GROWTH STRATEGIES, ..................... 148
2011-2015 (%)
FIGURE 5 GLOBAL NUTRACEUTICALS GROWTH STRATEGY ACTIVITY BY ................... 149
COMPANY, 2011-2015 (%)
Chapter 1
INTRODUCTION
FOD013F
March 2017
Natraj Pandal
Project Analyst
ISBN: 1-62296-448-9
BCC Research
or (+1) 781-489-7301
www.bccresearch.com
CHAPTER 1
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This report provides a detailed analysis of the global nutraceutical market. It discusses
premium and mass functional products and the evolution of functional FBSs (foods,
beverages, supplements). This information will be useful for those involved in strategic
planning, marketing, sales and development of nutraceuticals.
The major objectives of this study are to:
● Analyze and forecast revenues of the global nutraceutical market.

● Identify driving and restraining factors for the global nutraceutical market.
● Analyze market trends and opportunities in the global nutraceutical market.
● Identify and analyze the global nutraceutical market based on key product segments
such as functional foods, functional beverages and dietary supplements.
● Provide comprehensive market sizing and revenue forecasts for various applications
and ingredients.
● Strategically profile and analyze major market players and their core competencies in
the nutraceutical market.
● Identify recent developments, alliances, joint ventures, and mergers and acquisitions
in the global nutraceutical market.
Projections for nutraceuticals will be made for geographical regions including North
America (U.S., Canada and Mexico), Europe (Germany, France, Spain, Italy and the, U.K.),
Asia-Pacific (China, India, Japan and Australia) and South America (Argentina, Brazil).
REASONS FOR DOING THE STUDY
Increasing health concerns among people, government support through various subsidies,
and increase in aging populations and growing per capita income in developing countries
are driving the demand for nutraceuticals.
Increasing consumer demand for nutraceutical products is also helping market players to
position themselves in the global market by launching a variety of new and innovative
products. Regulatory authorities in different countries are taking the initiative in setting
standards and regulations for the promotion of safe and healthy nutraceuticals. This report
is designed to cover aspects of nutraceutical types, demand trends and market
opportunities. It also examines the overall global nutraceutical market and the market
penetration of nutraceuticals in different regions and countries.
SCOPE OF REPORT
This market report organizes information from diverse sources into a cohesive unit that
includes a comparison of premium versus mass functional product as well as the
nutraceutical value chain and the evolution of functional FBS. Regulations are also covered
in the scope of this report.
Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com 2

BCC Research analyzed key categories and regions to determine the present and future
nutraceutical market status and forecasted market growth from 2015 to 2021. In this
report, we also discuss market strategies, patent evaluation and driving forces of the
market.
INFORMATION SOURCES
The data for this report was gathered from primary and secondary sources. Sources
include information obtained from industry analysts, manufacturer and company reports,
industry trade journals and industry associations. Additional information was obtained
from the U.S. Food and Drug Administration (FDA), Japan’s Foods for Specified Health Uses
(FOSHU), Mexico’s National Association of Food Supplements Industry (ANAISA), the
European Food and Safety Authority (EFSA), the World Health Organization (WHO), the U.S.
Department of Agriculture (USDA), the Food and Agriculture Organization of the United
Nations (FAO) and the China Health Care Association (CHCA).
INTENDED AUDIENCE
This report will be of particular interest to manufacturers of nutraceuticals, food

manufacturers, beverages manufacturers and supplements manufacturers as well as
traders, distributors and suppliers of nutraceuticals. It will also be of high interest to
professionals within governments and regulatory agencies and associations, as it will aid
understanding of the scope and pace of nutraceuticals as they continue to expand in the
market.
METHODOLOGY
A top-down approach was used to estimate the size of global nutraceutical markets. The
key players in the global nutraceutical markets were identified through secondary
research, and their market revenues were determined through primary and secondary
research. This included study of the annual reports of top market players and interviews
with key opinion leaders such as CEOs, directors and marketing professionals. The size of
the global nutraceutical market was derived from the aggregation of the market shares of
the major players. Forecasts are based on an analysis of market trends such as
nutraceutical production and consumption. The penetration of micro markets was
established through secondary sources and validated through primary sources.
ANALYST'S CREDENTIALS
Natraj Pandal is the BCC Research analyst for this report. Mr. Pandal has an MBA in
Marketing and Systems from Osmania University, India. Mr. Pandal has more than eight
years of experience in business research and market intelligence. He works as a
consultant for syndicated projects in different domains such as chemicals, materials, food
and beverage, automotive, aerospace, oil and gas, information technology and telecom,
healthcare and sporting goods.

RELATED BCC RESEARCH REPORTS
● FOD011HGlobal Markets and Technologies for Food Safety Testing.

● FOD027C Weight Loss Markets for Products and Services.
● FOD047AEnergy Foods and Drinks: Global Markets.
● FOD009EThe Global Market for Food Additives.
● FOD043BSports Nutrition and High Energy Supplements: The Global Market.
BCC RESEARCH WEBSITE
The BCC Research website, located at www.bccresearch.com, enables visitors to:
● Conduct keyword searches

● Examine the complete BCC Research catalog of market research reports and place
direct orders
● Read announcements of recently published reports
● View titles of near-term upcoming reports
● Sign up to receive email notifications when reports are published in selected
categories
● Contact BCC Research for additional information
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the

time of publication and is of a professional nature. This information does not constitute
managerial, legal or accounting advice, nor should it be considered as a corporate policy
guide, laboratory manual or an endorsement of any product, as much of the information is
speculative in nature. BCC Research and the author assume no responsibility for any loss
or damage that might result from reliance on the reported information or from its use.

Chapter 2
SUMMARY
FOD013F
March 2017
Natraj Pandal
Project Analyst
ISBN: 1-62296-448-9
BCC Research
or (+1) 781-489-7301
www.bccresearch.com
CHAPTER 2
SUMMARY
The global nutraceutical market has grown exponentially in the last few years, and growth
is expected to continue. The market is being driven by rising health concerns, an aging
population and growing per capita income in developing countries such as China, India and
Brazil. The global nutraceutical market is facing various challenges such as high prices for
nutraceutical products and a lack of awareness about nutraceuticals. Due to exponential
growth, there are potential opportunities to entering the global nutraceutical market.
There is opportunity for contract manufactures of nutraceutical products, which would
improve the product manufacturing and delivery time. Furthermore, increasing industry
regulation worldwide, new product launches and an upswing in acquisitions are enhancing
the global nutraceutical market growth.
SUMMARY TABLE
GLOBAL NUTRACEUTICAL MARKET, BY PRODUCT, THROUGH 2021

($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016-2021
Functional beverages 66.6 71.5 105.5 8.1
Functional food 60.1 64.6 92.3 7.4
Dietary supplements 58.3 62.6 87.2 6.9
Total 185.0 198.7 285.0 7.5
Source: BCC Research
Functional beverages dominated the global nutraceutical market with a 36.0% market
share in 2015. The global functional beverage market was $66.6 billion in 2015 and is
expected to reach $105.5 billion by 2021, growing at a CAGR of 8.1% from 2016 through
2021. The global dietary supplements market was $58.3 billion in 2015 and is expected to
reach $87.2 billion by 2021, growing at a CAGR of 6.9% from 2016 through 2021.
The global functional food market was $60.1 billion in 2015 and is expected to reach $92.3
billion by 2021, growing at a CAGR of 7.4% from 2016 through 2021. Producing foods with
added health benefits is the main development within the global functional food market.
New technology in the food industry such as the development of genetically modified (GM)
foods for specific functions requires nutrients, which will increase revenues within this
quickly expanding industry.

SUMMARY FIGURE
GLOBAL NUTRACEUTICAL MARKET, BY PRODUCT, 2015-2021

($ BILLIONS)
From a product point of view, functional beverages dominated the global nutraceutical
market in 2015 with a 36.0% share, followed by functional food with 32.5% and dietary
supplements with 31.5%. Noncarbonated drinks was the largest functional beverage type
in 2015, with a 54.1% share, followed by dairy drinks with a 33.9% share, frozen fruit and
vegetable juices with 6.5%, and tea and coffee with a 5.0% of share. In 2015,
confectionery was the largest functional food type with a 28.6% share, followed by bakery
with a 21.5% share, snacks with a 19.0% share, dairy nondrinkable products with 17.1%
and other with a 13.8% share.
In 2015, sports and energy were the largest nutraceutical market application with a 33.0%
share, followed by general wellness with 15.1% and weight management with a 14.2%
share. Vitamins and minerals dominated the global nutraceutical ingredients market in
2015 with a 45.0% share, followed by probiotics with 15.4% and fiber with 10.2% share.
The global nutraceutical market is dominated by various companies such as BASF SE

(U.S.), Croda International Plc (U.K.), Cargill Inc. (U.S.) and Omega Protein Corp. (U.S.). By
acquisitions, mergers and partnerships between nutraceutical manufacturers, food and
beverages and healthcare companies, industry leaders are trying to introduce new
nutraceutical products in the market. Introducing innovative nutraceutical products is
becoming one of the key trends in the market; this is expected to drive the growth of the
global nutraceutical market in next five years.

Chapter 3
OVERVIEW
FOD013F
March 2017
Natraj Pandal
Project Analyst
ISBN: 1-62296-448-9
BCC Research
or (+1) 781-489-7301
www.bccresearch.com
CHAPTER 3
OVERVIEW
The global functional food and supplement market is highly fragmented, driven primarily
by increasing consumer interest in more unique and personalized health solutions. Unlike
traditional pharmaceuticals, the functional foods market is not dominated by a blockbuster
model. Under pressure to compensate for rising commodity and energy costs that are
reducing margins, the food industry is moving toward one of two extremes:
premiumization or low pricing with high volume. The functional food, beverage and
supplements (FBS) market is looked upon as a market for premiumization with new
value-added products promising better health through better dietary choices. For suppliers,
functional FBSs can provide growth opportunities as well as wider profit margins not
available with traditional food products; moreover, consumers are able to benefit from
good health without sacrificing taste and convenience.
PREMIUM VERSUS MASS FUNCTIONAL PRODUCT MARKET POSITIONING
The functional FBS (food, beverage and supplements) market is broadly classified as:
● High-volume mass-market products.

● High-margin niche market products.
New market entrants will likely need to decide on a high volume versus a high margin
product strategy. Certain products, such as energy drinks and functional snacks, may
initially enjoy both benefits. Higher volumes, however, tend to create more power among
consumers and retailers, and erode manufacturer margins over time.
The more common current strategy in FBS companies is to provide more value-added food
products with significant health claims that are priced at a premium. With the increasing
materials and processing costs, this strategy can create margin pressure relief for major
food and beverage companies. It is also difficult for all but the largest companies to
effectively introduce and market new products to the mass market.
PREMIUM PRICING AND MARGIN EXPANSION
Nutraceutical products can enjoy even 100% to 1,500% price premiums over the nearest
ordinary competitive products. Consumers are willing to pay a significant premium for
fortified or high-nutrition products that will deliver desired specified benefits. Despite a
trend of reduced consumer spending in the wake of the economic downturn, consumers
are still willing to invest in their health. Such investments can be justified as a proactive
alternative to costly treatment of disease.
Premium pricing has become more acceptable to consumers as more of them become
educated on their health and take a more active role in health management. A premium
price is easier to justify when a consumer fully understands the proposed health benefit of
the product. Consumers are also more likely to pay a premium price if a key opinion leader
with a high media profile or recognition in the pertinent scientific community endorses the
product.

As consumers become more educated, they also have a desire to receive more
personalized benefits. Some companies are leveraging scientific developments to create
more advanced and convenient delivery systems, such as gel packs that deliver a serving
of whey protein.
Premiumization is based on a number of factors, including price, quality and packaging of

the product, efficacy of the health claims, product taste, branding of the product and
convenience of delivery. Among these factors, taste and price are the most important.
Many companies are increasing their spending on research and development to produce
more efficient and functional products that deliver unique claims. They are also spending
significant amounts on branding and advertising products despite the global economic
slowdown. This means that a successful nutraceutical launch will likely require a
significant investment with appreciable risk.
EVOLUTION OF FUNCTIONAL FBS
The functional food market has evolved over time to reflect advances in technology and
changing consumer wants and needs. The “less evil foods,” which are generally low-fat,
no-fat, low-cholesterol, low-calorie, or zero-calorie foods, are often misleadingly
categorized as functional food. They are actually a throwback to an earlier point in the
overall food evolution.
The less evil or “better-for-you” foods are generally not fortified with any of the bioactive
ingredients and are considered to be more natural but make no special health claims.
Functional food, which is fortified with one or more bioactive ingredients, provides
specified health benefits and disease prevention. Earlier versions of functional foods
lacked in taste, which deterred major market acceptance. Companies are now focusing
more heavily on the taste aspect of products. Although consumers value health benefits,
they are not willing to compromise on taste.
Functional food products are often packaged to provide added convenience to the
consumer. Controlled and efficient delivery of bioactive ingredients will also serve to boost
the market for functional products. Functional FBS products are now tapping the less evil
food market by fortifying the less evil foods with one or more bioactive ingredients,
providing extra health benefits and differentiated branding messages for producers.
REGULATIONS
The nutraceutical market is expected to be influenced by increased industry regulations

around the globe over the next 10 years due to growing concerns over product safety. This
will likely pose challenges for the business environment; however, it strengthens
consumer confidence in nutraceutical products. The nutraceutical regulatory environment
is developing and remains unclear, as the number of nutraceutical products continues to
expand internationally and local agencies, working with international trade associations,
struggle to comply with regulations across different jurisdictions to ensure consumer
safety.

Nutraceutical regulations are focused mainly on safety and proper labeling, giving less
importance to product claims as compared to pharmaceuticals. Moreover, nutraceuticals
do not face the same level of scrutiny as pharmaceuticals in regards to product claims and
intended use. Major companies are spending significant amounts to secure claims of
health benefits from regulatory agencies such as the U.S. Food and Drug Administration
(FDA), Foods for Specified Health Uses (FOSHU) in Japan, the European Food Safety
Authority (EFSA) in the European Union and other regulatory bodies. Such approvals
provide products with more credibility and make consumer buying decisions easier. The
Nutrition and Health Claims Regulation (NHCR) that was instituted in Europe in 2007 has
proven very restrictive, rejecting more than 90.0% of submitted claims thus far.
The Federal Institute for Risk Assessment in Germany has imposed restrictions on
marketing of energy drinks to certain sectors that could suffer adverse effects from the
products, including children and pregnant women. Consumption of energy drinks resulted
in cardiac dysrhythmia, seizures, kidney failure and fatalities. These restrictions will
reduce the potential target audience, and some companies may seek formulation changes
to target these groups with less potent product offerings.
NORTH AMERICA
The FDA is the principal U.S. regulatory body controlling the use of product safety. It works
through the Dietary Supplement Health and Education Act of 1994 (DSHEA). The
manufacturer of a dietary supplement or dietary ingredient is responsible for ensuring that
the product is safe before it goes to market. The FDA is responsible for taking action
against any unsafe food, beverage and supplement after its launch.
In Mexico, the National Association of Food Supplements Industry (ANAISA) was formed to
oversee companies committed exclusively to the manufacture or marketing of food and
dietary supplements. ANAISA also works with the Mexican regulatory body responsible for
food and food supplement regulation.
EUROPE
In the European Union, food regulation is largely coordinated under the European Food
and Safety Authority (EFSA). This regulatory entity focuses on food supplements—proteins,
vitamins, minerals and other substances that have a nutritional effect.
European Commission (EC) directive 2002/46 was established for the safety of food
supplements. The EC also maintains a list of permitted vitamin and mineral substances
that might be added to food supplements for specific nutritional purposes. Any new
products originating in Europe are required to pass these European regulatory and quality
requirements. These regulations are helpful for the European nutraceutical companies,
which are generally regarded as leaders in innovation and which enjoy a reputation for
creating products of the highest quality.
In 2015, EC launched a major partnership with the Bill & Melinda Gates Foundation and
announced new funding to tackle the global challenge of undernutrition to implement the
National Information Platforms on Nutrition (NIPN) in order to improve accountability and

governance on nutrition. The foundation will provide $500,000 for the initiative. The U.K.'s
Department for International Development will also support the initiative with $8 million to
support the EU's commitment in supporting partner countries to reduce the number
chronically undernourished children by at least 7 million by 2025. The EU is advancing
towards delivering on this commitment by announcing $25.6 million in funding for an
innovative new initiative: the National Information Platforms on Nutrition (NIPN).
ASIA-PACIFIC
The shift in raw material supply from the U.S. and Europe to China and India has
transformed the regulatory concept. In local markets, the nutraceutical industry operates
under a combination of national agencies with different standards and regulations.
However, global regulatory bodies are becoming more dominant within the nutraceutical
industry—including Codex Alimentarius, the World Health Organization (WHO) and the
Food and Agriculture Organization (FAO). The International Alliance of Dietary/Food
Supplement Associations (IADSA) works closely with both international and local bodies to
ensure that the standards of the food supplement industry are upheld in the development
of policy.
Japan
Japan has the most advanced regulatory environment for nutraceutical and functional
foods, which engenders higher consumer confidence in product offerings. It has developed
the leading formal regulatory framework for nutraceutical and functional foods, known as
the Foods for Specific Health Use (FOSHU) system. Only FOSHU oversees premarketing
approval of nutraceutical products in the Japanese market. However, the Food Safety
Commission affords an additional level of approval as it also examines the safety of the
proposed nutraceutical product.
For regulatory purposes, the nutraceutical industry in Japan is generally divided into two
groups.
● Foods with nutrient function claims must achieve the standards for the minimum and
maximum daily levels of 12 vitamins and five minerals; however, labels are not
greatly regulated.
● The FOSHU system contains dietary ingredients that have reported beneficial
physiological effects and promote health.
China
The China Health Care Association (CHCA), China’s State Food and Drug Administration
(SFDA) and the U.S.-China Health Products Association (USCHPA) are regulatory agencies
for the nutraceutical industry. There are three main entities involved in policing the
nutraceutical industry in China:
1. SFDA, which deals with dietary supplements and issues the “blue hat” registration.

2. The Ministry of Health (MOH), the main influence in the dietary supplements industry
for approval of new novel food ingredients.
3. The Administration of Quality Supervision Inspection and Quarantine (AQSIQ)

controls all of the imports and exports crossing China’s borders.
India
The Food Safety and Standards Act of India (FSSAI) is a regulatory body for the
manufacture, storage, distribution, sale and import of nutraceutical products in India.
FSSAI was established in 2006, guided by the consolidation of a collection of earlier laws
relating to food to form a single set of rules and oversight relating to food and
nutraceutical safety and standards. FSSAI in India poses several challenges for
nutraceutical manufacturers in regard to formulations of the correct combination of
ingredients on which to base their products.
Various regulations for nutraceuticals are shown in the following tables.
TABLE 1
GLOBAL REGULATIONS ON NUTRACEUTICALS
Country Label Definition Regulator

U.S. Dietary Any of the following that have a Food and Drug
Supplements beneficial nutritional effect: vitamins, Administration
minerals, botanicals and their extracts,
amino acids, concentrates and extracts.
European Food Concentrated sources of nutrients European Food
Union Supplements and other substances with a beneficial Safety Authority
nutritional effect.
India Food for special Plants or botanicals: Whole or extract Food Safety and
dietary use Minerals, vitamins, amino acids and Standards Act
enzymes Substances of animal origin
Japan Foods for Any food that can provide and/or Japan Health and
specific supple-ment any of the nutrition, Nutrition Food
health use sensory satisfaction and beneficial Association
physiological effect.
China Health Foods Any food that should be suitable for a State Food and
specific group people, able to adjust Drug Administration
body functions, and that should not aim
at curing diseases or cause acute, sub
acute or chronic harm to the body.

VALUE CHAIN
The major products making up nutraceuticals are fortified or functional foods, dietary or
functional supplements and functional beverages. Various raw materials are used for the
nutraceutical ingredients, such as trimethylhydroquinone and vegetable oil for the vitamin
E, ammonia or ammonium salts for amino acids and soybeans for soy proteins.
Trimethylhydroquinone is extracted from crude oil and it is available globally, although
vegetable oil extract is usually obtained from soy, and it is procured from India or Brazil.
Ammonia or ammonium salts are available globally and soybeans are usually procured
from India or Brazil to obtain non-GMO (genetically modified organism) raw materials. A
typical value chain of nutraceuticals is shown in the below figure.
FIGURE 1
NUTRACEUTICAL VALUE CHAIN

Chapter 4
NUTRACEUTICAL MARKET BY TYPE
FOD013F
March 2017
Natraj Pandal
Project Analyst
ISBN: 1-62296-448-9
BCC Research
or (+1) 781-489-7301
www.bccresearch.com
CHAPTER 4
NUTRACEUTICAL MARKET BY TYPE
The functional food, beverage and supplements (FBS) market, also known as the
nutraceutical market, is generally categorized as:
● Functional foods.
● Functional beverages.
● Dietary supplements.
This report defines the market as the aggregate sales of all the functional food, beverage
and supplement products that contain one or more of these ingredients: vitamins,
minerals, dietary fiber, probiotics, omega-3 fatty acids (omega-3), protein and peptides,
and phytochemicals. Supplements fortified with herbals are also considered part of the
market.
FUNCTIONAL FOOD
The functional food product market is defined as the aggregate sales value of
nondrinkable food products containing any of the previously mentioned bioactive
ingredients. This market is further divided into the categories of confectionery, snacks,
bakery, dairy nondrinkable food products, meat and poultry, grain and flour, and frozen
fruits and vegetables.
Most of the consumers in the food market are searching for foods that contain nutritious
value or provide a health benefit beyond the traditional nutrients. To cater to these
consumers in the food market, GM foods are being introduced in the market. Companies
are estimating high demand for functional foods due to consumers’ gaining information,
thus becoming more aware of the application of technology in foods. As well, research
bodies have begun to accept advanced-function food products as being safe for public
consumption and have publically released this information.
Snacks include all food bars, cereal bars and roasted nuts. There is a small amount of
overlap between the snacks and confectioneries markets, with certain companies
positioning snacks as confectionery items and vice versa. Dairy nondrinkable food
products include yogurts, cheese and margarine, regular ice cream and low fat/nonfat ice
cream. Bakery items include breads—commercial and retail—cookies and crackers, frozen
cakes, pies and pastries, and dry pasta.
The meat and poultry category includes meat products fortified with probiotics and any
other bioactive ingredients, meat replacements and enhancers. With the increasing cost of
eggs, certain bioactive ingredients are becoming a viable substitute for the protein in eggs.
Frozen fruits and vegetables predominantly consist of superfruits such as aronia,
buffaloberry, pichuberry, acai berry, avocados and blueberries.

TABLE 2
GLOBAL FUNCTIONAL FOOD MARKET, BY PRODUCT, THROUGH 2021

($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Confectionery 17.2 18.5 27.1 7.9
Bakery 12.9 13.8 19.9 7.6
Snacks 11.4 12.3 17.2 6.9
Dairy nondrinkable products 10.3 11.1 15.7 7.2
Meat 4.2 4.5 6.4 7.3
Grain and flour 1.5 1.6 2.6 10.2
Frozen fruits and vegetables 0.9 1 1.4 7.0
Other 1.7 1.8 2.0 2.1
Total 60.1 64.6 92.3 7.4
In 2015, the global functional food market was dominated by confectionery, bakery and
snacks with estimated 28.6%, 21.5% and 19.0% shares, respectively. The global
confectionery market was estimated to be worth $17.2 billion in 2015 and is expected to
reach $27.1 billion by 2021, growing at an estimated CAGR of 7.9% from 2016 to 2021.
The global bakery market was estimated to be worth $12.9 billion in 2015 and is expected
to reach $19.9 billion by 2021, growing at an estimated CAGR of 7.6% from 2016 to 2021.
The global snacks market was estimated to be worth $11.4 billion in 2015 and is expected
TABLE 3
GLOBAL FUNCTIONAL FOOD MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
North America 25.3 27.2 38.8 7.4
Europe 16.6 17.8 25.1 7.1
Asia-Pacific 15.9 17.1 25.1 8.0
South America 2.3 2.5 3.3 5.7
Total 60.1 64.6 92.3 7.4
In 2015, global functional food was dominated by North America and Europe, with
estimated 42.1% and 27.6% shares, respectively. The North American functional food
market was estimated to be $25.3 billion in 2015 and is expected to reach $38.8 billion by

2021, growing at a CAGR of 7.4% from 2016 to 2021. The European functional food market
was estimated to be $16.6 billion in 2015 and is expected to reach $25.1 billion by 2021,
growing at a CAGR of 7.1% from 2016 to 2021. The European functional food market is
dominated by probiotics due to a large dairy products market as compared with the U.S.
and Japan.
Asia-Pacific commanded the third largest market share with 26.5% of the overall
functional food market in 2015 at $15.9 billion and is expected to reach $25.1 billion in
2021, growing at a CAGR of 8.0% from 2016 to 2021. South America’s functional food
market is expected to grow from $2.3 billion in 2015 to $3.3 billion in 2021 at an
estimated CAGR of 5.7% from 2016 to 2021.
CONFECTIONERY
A prime target market for nutraceutical sugar confectionery will be children and
health-conscious parents. Children are often reluctant to eat foods that are not appealing
in taste and will choose nutraceutical products accordingly. Manufacturers need to focus
on new, innovative products with various health benefits paired with great taste.
TABLE 4
GLOBAL NUTRACEUTICAL CONFECTIONERY MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
North America 7.0 7.5 10.8 7.6
Europe 4.3 4.5 6.7 8.3
Asia-Pacific 5.2 5.6 8.5 8.7
Total 17.2 18.5 27.1 7.9
North America commanded the largest share of the overall nutraceutical confectionery
market in 2015 with a 40.7% of the market, valued at $7.0 billion and is expected to reach
nearly $10.8 billion by 2021, rising at a CAGR of 7.6% from 2016 to 2021. Asia-Pacific
commanded the second largest market share with 30.2% of the overall nutraceutical
confectionery market in 2015 at $5.2 billion and is expected to reach $8.5 billion in 2021,
growing at a CAGR of 8.7% from 2016 to 2021. The European nutraceutical confectionery
market is expected to grow from $4.3 billion in 2015 to $6.7 billion in 2021, growing at an
Confectionery products fortified with enriched calcium and ACE vitamins (A, C and E
vitamins) are a popular market offering. Manufacturers are also working on various fruit
flavors with fortified minerals and vitamins, and on confectionery products that
incorporate juices of superfruits such as pomegranate, cranberry and raspberry. These will

provide high levels of antioxidants. Danisco has introduced a new juice confectionery
demonstration kit that contains four confectionery prototypes incorporating fruit juices and
Danisco health-benefiting ingredients.
Dark chocolate has naturally high antioxidant content. It is also considered relatively
healthy since it contains high levels of polyphenols and flavonols that work to protect the
body from cell damage. Quaker Foods (U.S.), a leading breakfast cereal company, has
launched Life Chocolate Oat Crunch, which contains chocolate and oat pieces. It is a
low-fat, high-fiber product that contains 10 essential vitamins and minerals. It is estimated
that approximately 32.3% of global chocolate sales in 2015 come from dark chocolate
varieties of products.
Although vitamin- and mineral-based confectionery products are the largest nutraceuticals
market with $8.0 billion in 2015, the protein-fortified confectionery market is also doing
well with a market value of $3.5 billion, followed by the omega-3-based confectionery
market at $3.0 billion and probiotic-based confectionery market at around $2.7 billion.
The increasing demand for healthy sweeteners is encouraging ingredient manufacturers to

develop new offerings in the area. Some of the major confectionary products by company,
product and description are shown in the below table.
TABLE 5
MAJOR CONFECTIONERY PRODUCTS
Company Product Description

Kellogg Chocolate version of its Targeting women who want to lose weight. The
core diet brand, Special new chocolate Special K consists of rice cereal
K. flakes with pieces of chocolate.
Zile Bonbons Functional probiotic Added probiotics for better digestive health.
AG sweets.
Perfetti Van Fruitella. Comprises soft sweets with real fruit juice and
Melle enriched with vitamins B, C and E as well as
calcium.
Maramor Dark chocolates with Three chocolate squares provide 315 mg of
omega-3. omega-3.
Wrigley Orbit, Extra and Eclipse Wrigley’s Extra, Eclipse and Orbit brands are the
chewing gum brands. first sugar-free chewing gum brands to have the
Seal of Acceptance from the American Dental
Association.
Barry Acticoa, probiotic Products are manufactured with additive
Callebaut chocolates and probiotics, fiber and sweeteners with health
nutritional chocolates. benefits.

BAKERY
The specialty bakery market is characterized by the dominance of local bakery companies
over large established brands. As such, companies who seek to enter the bakery market in
the nutraceutical segment should focus on mainstream popular products such as whole
grain and brown bread products. Additives to bread such as honey and caraway and
sunflower seeds have found increased acceptance in recent years.
Bread is a staple food in the U.S. and Europe and serves as an ideal vehicle for delivering
functional benefits. Within bakery food products, bread is the biggest food category with
$9.1 billion in 2015 due to its popularity in the aforementioned regions. The cookies and
crackers market is also doing well, with a market value of $2.7 billion, followed by the
frozen cakes, pies and pastries market at $1.1 billion in 2015.
TABLE 6
GLOBAL NUTRACEUTICAL BAKERY MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016-2021
Europe 3.6 3.9 5.4 6.7
Asia-Pacific 3.1 3.3 4.8 7.8
Total 12.9 13.8 19.9 7.6
North America commanded the largest share of the overall nutraceutical bakery market in
2015 with a 39.5% share, worth $5.1 billion and is expected to reach $8.1 billion by 2021,
rising at a CAGR of 8.0% from 2016 to 2021. Europe commanded the second-largest
market share with 27.9% of the overall nutraceutical bakery market in 2015 at $3.6 billion
and is expected to reach $5.4 billion in 2021, growing at a CAGR of 6.7% from 2016 to
2021. The Asia-Pacific nutraceutical bakery market is expected to grow from $3.1 billion in
2015 to $4.8 billion in 2021, growing at an estimated CAGR of 7.8% from 2016 to 2021.
In developing functional bakery products, it is important to realize that achieving

functional food quality does not simply involve delivering physiological benefits.
Manufacturers must also ensure that they are supplying a product that meets consumers’
requirements in terms of appearance, taste and texture. This is especially important due
to the regular use of bakery items in Western diets.
Bakery products lend themselves easily to being enriched with fiber content. Fiber
commanded the largest share of the overall nutraceutical bakery market in 2015 with a
49.8% worth $6.4 billion, followed by protein and peptides with around $3.4 billion,
omega-3 with $1.9 billion and probiotics with around $900 million.

Bread
North America commanded the largest share of the overall nutraceutical bread market in
2015 with a 40.1% worth $3.6 billion, followed by Europe with $2.6 billion and Asia-Pacific
with around $2.4 billion. The bread market has witnessed several product launches that
incorporate whole grains and no preservatives. Bread is one of the oldest functional foods
because it has always been recognized as a good source of calcium and fiber in North
America and Europe. The bread market has recently witnessed several new whole-grain
based bread product introductions in Europe.
The growing focus on whole grain bread, the promotion of gluten-free breads and the
addition of fruits to breads to differentiate products and increase premium value are the
major trends for nutraceutical bread.
The key trends in the functional bread market can be summarized as greater use of whole
grains, lack of preservatives, vegetarian breads and nonallergenic breads. Allied Bakeries
is a leader in the functional bread sector in Europe, and its Kingsmill product is the
fastest-growing brand in the U.K.
Bread provides a common and widely used medium within which it is possible to
effectively regulate micronutrient consumption at a broad population level or to supply
functional ingredients to particular targeted groups.
SNACKS
Snacks manufacturers are moving toward healthier products since more and more
consumers are making the shift from high-fat products. Cereal bars are the
fastest-growing category in the nutraceutical snacks market. Demand has increased for
fiber-based snacks with digestive and weight reduction benefits. Nature Valley, Fiber One
and Kellogg are some of the leading companies for snack food in the world. Breakfast
cereal is also growing category in the nutraceutical snacks market due to increasing per
capita income in developing countries.
Snacks manufacturers are moving toward healthier products since more and more
consumers are making the shift from high-fat products. Cereal bars are the
fastest-growing category in the nutraceutical snacks market. Demand has increased for
fiber-based snacks with digestive and weight reduction benefits. Nature Valley, Fiber One
and Kellogg are some of the leading companies for snack food in the world. Breakfast
cereal is also a growing category in the nutraceutical snacks market due to increasing per
capita income in developing countries.

TABLE 7
GLOBAL NUTRACEUTICAL SNACKS MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 3.1 3.3 4.5 6.4
Asia-Pacific 2.7 3 4.3 7.5
Total 11.4 12.3 17.2 6.9
North America commanded the largest share of the overall nutraceutical snacks market in
2015 with a 43.9% worth $5.0 billion and is expected to reach nearly $7.6 billion by 2021,
market share with 27.2% of the overall nutraceutical snacks market in 2015 at $3.1 billion
2021. The sales for snacks in the European market have shown rapid growth, and have
expanded its healthy and fruit snack range. The Asia-Pacific nutraceutical snacks market is
expected to grow from $2.7 billion in 2015 to $4.3 billion in 2021, growing at an estimated
CAGR of 7.5% from 2016 to 2021. Leading breakfast cereal manufacturers are tapping
growing markets such as China and Russia, which now account for a fraction of the total
cereal market. There is high potential in these countries in terms of market volume and
revenue growth, with growth of 8.8% expected from 2016 to 2021. Fiber commanded the
largest share of the overall nutraceutical snacks market in 2015 with a 49.6% worth $5.7
billion, followed by protein and peptides with around $2.5 billion and omega-3 with $2.4
billion.
Cereal bars are a convenient snack choice and account for more than 71.5% of cereal
snack sales in the U.S., Japan, Australia and Europe’s five largest countries. The increasing
awareness and demand for healthy and organic foods has increased the sales of cereal
bars in the European Union (EU). Global snack bar sales will continue to take greater share
in the snack market in the future. Snack food manufacturers have increased their
revenues and profits due to strong snack or cereal bar sales. Whole grain and oat cereals
have proven successful in aiding cholesterol reduction, and they are performing well in
Europe. Many cereal manufacturers have launched new oat-based variants of their
traditional cereal lines such as Kellogg introduced Optivita, and Weetabix introduced
Oatibix.

TABLE 8
TOP NUTRACEUTICAL SNACKS PRODUCTS
Company Products Comments

Atkins Advantage bar, chocolate peanut butter Bars help in weight control; have
Nutritionals bar, S’mores bar, Double Chocolate reduced levels of carbohydrates
Inc. Crunch bar, Cookie Dough bar, and and sugars, and have a
Chocolate Peanut Nougat bar balanced level of protein, fiber,
fruits, vegetables and good fats.
Clif Bar Clif Bar, Clif Nectar, Clif Luna, Clif Shot, Low in fat and contain
Clif Mojo bar, Clif Builder’s bar ingredients
like whole oats, vitamins, fiber
and
minerals.
Kellogg All-Bran Special K High-fiber, reduced-calorie bars
with vitamins and minerals
formula.
General Mills Big G Cereals, Fiber One, Cascadian Fiber-rich bars that reduce risk
Farm, Lucky Charms, Cereal Partners of
Worldwide, Nature Valley, Cheerios, Trix, heart disease, diabetes, obesity
Chex and Wheaties and
certain types of cancer.
Herbalife High-protein bars and snacks Low-calorie bars for weight
management.
Jordan’s Organic muesli, organic granola, Bars high in fiber with vitamins
Cereals organic porridge, organic fruit and fiber and
and organic flakes, berries and Frusli microminerals.
Bars, Wheatgerm and Wheatbran.
Nestle Shredded Wheat, Shreddies, Cheerios, Whole grain cereal bars with
Fitness, Curiously Cinnamon, Clusters, high
Nesquik and Golden Nuggets fiber
PepsiCo Kretschmer wheat germ, Mother’s brand Bar is made of wheat germ and
cereals, Quaker Breakfast Bars and Bites, contains vitamin E and folic acid
and Frito-Lay for
healthy heart maintenance.
Cookies and Crackers
Cookies and crackers are gaining more acceptances by consumers as a healthy snack
option. The cookies and crackers segment includes filled and non-filled cookies, crackers,
biscuits, graham wafers and ice cream cones. The cookie enjoys a certain level of
popularity as a traditional snack; however, cookies, as well as crackers, are faced with
competition from other grain-based products, such as granola bars, which often provide
more nutrition and are viewed by consumers as a healthier option.
North America commanded the largest share of the overall nutraceutical cookies and
crackers market in 2015 with 39.0% worth $1.1 billion, followed by Europe with $1.0 billion

and Asia-Pacific with around $716.8 million. To capitalize on the healthy lifestyle trend,
cookie and cracker producers have introduced many whole grain, sugar-free and low-fat
alternatives, as well as small-portion, calorie-specific packaging to attract diet-conscious
consumers. Manufacturers have also reformulated some products to eliminate or reduce
the level of unhealthy trans fats. According to U.S. Dietary Guidelines, consumption of
trans fat should be as low as possible because, gram for gram, it is the most harmful fat of
all. Trans fat should be specifically listed on packaging.
Grain-based products with higher fiber levels and those fortified with vitamins and other
additives are in demand by older-aged segments of the population, while younger
consumers opt for more convenient ready-to-go items. Consumers of all ages are more
frequently choosing timesaving and convenient grain-based food items.
The cookies and crackers market is driven by major brands with household names in the
U.S., which is also the biggest market. Among cookies, the largest sales were by Kraft
Foods’ Oreo, Chips Ahoy and Newton’s Brands and by Kellogg’s Keebler products. Among
crackers, Ritz (Kraft Foods) and Cheez-It (Kellogg) are leading sellers.
DAIRY NONDRINKABLE
Probiotic products will add extra benefits to products in the dairy nondrinkable products
segment, which will help fuel future growth. The functional cheese market is a
comparatively small part of the functional dairy category. Its penetration rate is quite low
compared to the overall cheese market, which creates a significant market opportunity for
new product introductions. Over the last few years, various companies have introduced
probiotic cheese products in various countries. For example, a LAFTI probiotic cheese was
launched by Bustles Cheese in the U.K., Chr. Hansen introduced a probiotic cheese in Italy
and Europe’s second-largest dairy company, Arla Foods, launched in the U.S. a probiotic
cheese containing the Lactobacillus casei strain F19.
TABLE 9
GLOBAL NUTRACEUTICAL DAIRY NONDRINKABLE MARKET, BY REGION, THROUGH

2021
($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 2.9 3.2 4.3 6.1
Asia-Pacific 2.6 2.8 4.2 8.4
Total 10.3 11.1 15.7 7.2

The global nutraceutical dairy nondrinkable market was estimated to be $10.3 billion in
2015 and is expected to reach $15.7 billion by 2021, growing at a CAGR of 7.2% from
2016 to 2021. North America commanded the largest share of the overall nutraceutical
dairy nondrinkable market in 2015 with a 42.7% share, worth $4.4 billion and is expected
to reach $6.7 billion by 2021, rising at a CAGR of 7.3% from 2016 to 2021. Europe
commanded the second-largest market share with 28.2% of the overall nutraceutical dairy
nondrinkable market in 2015 at $2.9 billion and is expected to reach $4.3 billion in 2021,
growing at a CAGR of 6.1% from 2016 to 2021. Asia-Pacific’s nutraceutical dairy
nondrinkable market is expected to grow from $2.6 billion in 2015 to $4.2 billion in 2021,
growing at an estimated CAGR of 8.4% from 2016 to 2021.
Yogurts commanded the largest share of the overall nutraceutical dairy nondrinkable
market in 2015 with a 60.6% worth $6.2 billion, followed by cheese and margarines with
33.2%, regular ice cream with 5.3% and low-fat and nonfat ice cream with 0.9%. Low-fat
and nonfat ice cream is the fastest-growing market segment with a CAGR of 8.7% for 2016
to 2021. Low-fat and low-calorie has the consistency of jelly with the texture of ice cream.
More than 35 similar probiotic frozen desserts have been launched across the globe, with
many additional products expected.
Nondairy cheeses are available in major markets like the U.S., Europe and Australia. Some
of the key players in Europe are VBites Foods (formerly called The Redwood Wholefood Co.
(Cheezly), Bute Island Foods (vegan cheese) and Kallo Foods (soya, rice and other
nondairy ingredients). In Australia, the market leader is Simply Better Foods (omega-3 soy
cheese). The major U.S. companies are Galaxy Nutritional Foods (Veggie and Soyco Foods)
and Tofutti, which also has a presence in the U.K. and Australia.
TABLE 10
TOP NUTRACEUTICAL DAIRY PRODUCTS
Company Product Comment

Puleva Food S.A. Whole Puleva, Puleva A complete food with protein, lactose,
Omega-3 and Calcium Semi fat, minerals, vitamins and omega-3 oils.
Puleva
Dairy Crest Clover, Country Life, Utterly Product contains vitamins, minerals and
Butterly, Vitalite and Willow omega-3 oil for bone and joint
supplementation.
Valio Ltd. Oivariini, summer butter, Wide range of calcium-rich butter.
winter butter and extra hard
grating cheese
Sanitarium Sanitarium Peanut Butter, Yeast spreads and peanut butter with
Health Food Co. Marmite vitamins B1 and B2.
MEAT
Meat and poultry account for more than 26.0% of the total food market in North America
and Europe, but they are not yet a large part of the nutraceutical foods market. From

manufacturers’ point of view, it will only require a minor penetration in the nutraceutical
market to result in significant sales from the meat and poultry segments. (For purposes of
this report, both meat and poultry will be grouped into the “meat market.”)
TABLE 11
GLOBAL NUTRACEUTICAL MEAT MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 1.1 1.2 1.6 5.9
Asia-Pacific 1.0 1.0 1.5 8.4
Total 4.2 4.5 6.4 7.3
The global nutraceutical meat market was estimated to be $4.2 billion in 2015 and is
expected to reach $6.4 billion by 2021, growing at a CAGR of 7.3% from 2016 to 2021. The
increasing societal pressure for weight reduction properties and health benefits is
benefiting the market for meat replacements.
North America commanded the largest share of the overall nutraceutical meat market in
2015 with a 42.9% share, worth $1.8 billion and is expected to reach $2.8 billion by 2021,
market share with 26.2% of the overall nutraceutical meat market in 2015 at $1.1 billion
2021. Asia-Pacific’s nutraceutical meat market is expected to grow from $1.0 billion in
2015 to $1.5 billion in 2021, growing at an estimated CAGR of 8.4% from 2016 to 2021.
Noncommercial markets including schools, hospitals and airlines are early adopters of the
functional or nutraceutical meat market—in which single decisions can produce large sales.
In their daily lunches, schools are increasing the ratio of protein-enhanced meat or poultry,
soy ingredients in recipes and soy mixed into meat or poultry alternatives. The low market
penetration for functional meat or poultry or meat alternatives is a large opportunity for
functional meat companies. There is a large market for functional meat, especially if
products are trans fat-free and protein-fortified. Demand for some meat products is
increasing due to the continuing popularity of low-carbohydrate diets and the successful
marketing by manufacturers.
In recent years, the average price of whole eggs has increased as a response to higher
prices for fuel and commodity chicken feed. Advanced Food Systems introduced a range of
egg replacement “BakeRite” ingredients as a cost-effective alternative to whole eggs for
food manufacturers. This ingredient can replace up to 65.0% of whole egg solids while
maintaining texture and flavor. This modified egg product is used heavily in baked goods
such as pound cakes, muffins, cupcakes and cookies.

GRAIN AND FLOUR
Companies aim to fortify wheat flour with iron and folic acid in order to reduce a
problematic iron deficiency anemia in children and in women of reproductive age. The
incidence of neural tube defects in newborns is expected to be reduced by half as a result
of these dietary changes.
TABLE 12
GLOBAL NUTRACEUTICAL GRAIN AND FLOUR MARKET, BY REGION, THROUGH

2021
($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 0.4 0.4 0.8 14.9
Asia-Pacific 0.4 0.4 0.6 8.4
Total 1.5 1.6 2.6 10.2
The global nutraceutical grain and flour market was estimated to be $1.5 billion in 2015
and is expected to reach $2.6 billion by 2021, growing at a CAGR of 10.2% from 2016 to
2021. North America commanded the largest share of the overall nutraceutical grain and
flour market in 2015 with a 46.7% share, worth $700 million and is expected to reach $1.1
billion by 2021, rising at a CAGR of 9.5% from 2016 to 2021.
Europe commanded the second-largest market share with 26.7% of the overall
nutraceutical grain and flour market in 2015 at $400 million and is expected to reach more
than $800 million in 2021, growing at a CAGR of 14.9% from 2016 to 2021. Asia-Pacific’s
nutraceutical grain and flour market is expected to grow from $400 million in 2015 to
nearly $600 million in 2021, growing at an estimated CAGR of 8.4% from 2016 to 2021.
FROZEN FRUITS AND VEGETABLES
Government encouragement and heightened consumer awareness is increasing the

consumption of fruits worldwide. Demand for superfruits or functional fruit has increased
due to publicity of their role as a major source of antioxidants. Various exotic fruits like
pomegranate, acai berries, cranberries and blueberries belong to the superfruit category.
Demand is increasing every year for exotic superfruits such as acai berries, goji berries
and pomegranates. Superfruits with high levels of natural antioxidants are usually red
fruits. Companies are discovering the functionality of dietary fruits, vegetables and juices
(FVJs) based on their vitamin C and fiber content and serum ferritin and hemoglobin
concentrations. The high vitamin C content of dietary fruits helps in enhancing iron levels.

The demand for high-fiber based frozen fruits has increased due to their digestive health
benefits.
Functional fruit extracts in the form of fruit jellies or syrups are now mixed with foods or
beverages for added health benefits. Confectionery manufacturers are utilizing superfruit
extracts to increase antioxidant content in existing confectionery products. Wild, a
German ingredient manufacturer, introduced Fruit Up natural sweetener for fruit jelly
confectionery products and beverages.
TABLE 13
GLOBAL NUTRACEUTICAL FROZEN FRUITS AND VEGETABLES MARKET, BY REGION,

THROUGH 2021
($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 0.2 0.2 0.3 8.4
Asia-Pacific 0.2 0.2 0.3 8.4
Total 0.9 1.0 1.4 7.0
The global nutraceutical frozen fruits and vegetables market was estimated to be $900
million in 2015 and is expected to reach $1.4 billion by 2021, growing at a CAGR of 7.0%
from 2016 to 2021. North America commanded the largest share of the overall
nutraceutical frozen fruits and vegetables market in 2015 with a 33.3% worth $300 million
and is expected to reach $500 million by 2021, rising at a CAGR of 4.6% from 2016 to
2021. Asia-Pacific’s nutraceutical frozen fruits and vegetables market in 2015 at $200
million and is expected to reach more than $300 million in 2021, growing at a CAGR of
8.4% from 2016 to 2021. The European nutraceutical frozen fruits and vegetables market
is expected to grow from $200 million in 2015 to $300 million in 2021, growing at an
Fiber commanded the largest share of the overall nutraceutical frozen fruits and
vegetables market in 2015 with a 29.5% worth $265.5 million and followed by probiotics
at around $117.0 million. Capros, Utah-based Pure Fruit Technologies, RJA Foods, Ocean
Spray and Cargill are the major companies for the superfruit products and they offer
brand-name products such as Capros (Capros), Mango.xan (Utah-based Pure Fruit
Technologies), Pomegreat (RJA Foods) and Special FX (Cargill). Major superfruits with
respective “average grade” are shown in the below table.

TABLE 14
TOP SUPERFRUITS BY CONTENT
Major Superfruits Phenolics Carotenoids Vitamin C Dietary Fiber Average Grade

Goji High High High High High
Sea buckthorn High High High Medium High
Acai High Low Low High Medium
Blueberry High Low Low Medium Medium
Cranberry High Low Medium Medium Medium
Purple Grape High Low Medium Medium Medium
Mangosteen Low Low Low High Low
Noni Low Low High High Low
Pomegranate High Low Medium Low Low
FUNCTIONAL BEVERAGES
The total beverage market comprises alcoholic and nonalcoholic beverages. In

nonalcoholic beverages, carbonated soft drinks account for more than half of the total
market. The growth rate of carbonated soft drinks (CSDs) is decreasing due to consumer
health concerns, and the entire nonalcoholic beverage industry is shifting toward
functional or nutraceutical drinks.
The functional or nutraceutical beverage market is defined as the aggregate sales value of
drinkable food products containing any of the previously listed bioactive ingredients. This
mainly includes noncarbonated drinks, dairy drinks, fruit and vegetable juices, and tea and
coffee.
Noncarbonated drinks are dominated by sports and energy noncarbonated drinks such as
Red Bull, as well as functional water. Dairy drinks include functional beverages like
probiotic drinkable yogurts and fermented fluid milk fortified with omega-3 and probiotic
ingredients. Tea and coffee include green and black tea and coffee fortified with any one
of the bioactive ingredients mentioned in this report. Fruit and vegetable juices include
juices fortified with vitamins and minerals, proteins, probiotics and omega-3.

TABLE 15
GLOBAL FUNCTIONAL BEVERAGE MARKET, BY PRODUCT, THROUGH 2021

($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Noncarbonated drinks 36.0 38.6 57.7 8.4
Dairy drinks 22.6 24.3 35.7 8.0
Fruits and vegetable juice 4.3 4.6 6.5 7.2
Tea and coffee 3.3 3.6 5.0 6.8
Other 0.4 0.4 0.6 8.4
Total 66.6 71.5 105.5 8.1
In 2015, the global functional beverage market was dominated by noncarbonated drinks
and dairy drinks with estimated 54.1% and 33.9% shares, respectively. The global
noncarbonated drinks market was estimated to be worth $36.0 billion in 2015 and is
expected to reach $57.7 billion by 2021, growing at an estimated CAGR of 8.4% from 2016
to 2021.
The global dairy drinks market was estimated to be worth $22.6 billion in 2015 and is
expected to reach $35.7 billion by 2021, growing at an estimated CAGR of 8.0% from 2016
to 2021. The fruit and vegetable juices or frozen juices market is estimated to grow at
CAGR of 7.2% from 2016 to 2021 due to companies like Coca-Cola and Pepsi having
entered the market to tap the opportunities. Frozen juices have become one of the drivers
for the growing overall nutraceutical beverage market.
Major CSD companies like Coca-Cola and Pepsi have experienced a decrease in sales of
carbonated drink products and now are focusing on the faster-growing functional beverage
market as a means to grow sales and retain market share. The major trend in beverages is
fortification, functionality and a shift toward premium, “green” and organic products. Tea,
which was not historically widely accepted in the U.S., is now seeing a larger market
penetration with the help of surging green tea demand. Waters fortified with healthy
ingredients (“enhanced waters”) hold the biggest potential, and beverage giants are
cashing in on this opportunity. Of Coca-Cola’s net sales, enhanced water and sports drinks
are showing the largest growth. The top three companies in this market are now Coca-Cola,
PepsiCo and Energy Brands, accounting for more than 89.0% of the market in 2015.

TABLE 16
GLOBAL FUNCTIONAL BEVERAGE MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
North America 21.0 22.6 32.7 7.7
Europe 22.1 23.8 36.0 8.6
Asia-Pacific 17.0 18.2 27.0 8.2
Total 66.6 71.5 105.5 8.1
Europe commanded the largest share with 33.2% of the overall functional beverage
market in 2015 at $22.1 billion. The market is expected to reach $36.0 billion in 2021,
rising at a CAGR of 8.6% for 2016 to 2021 due to increasing demand for dairy drinks and
sports and energy drinks in Europe and also to huge growth from developing Eastern
European countries. North America commanded the second- largest market share with
31.5% of the overall functional beverage market in 2015 at $21.0 billion and is expected
to reach $32.7 billion in 2021, growing at a CAGR of 7.7% from 2016 to 2021.
Asia-Pacific commanded the third largest market share with 25.5% of the overall
functional beverage market in 2015 at $17.0 billion and is expected to reach $27.0 billion
in 2021, growing at a CAGR of 8.2% from 2016 to 2021. South America’s functional
beverage market is expected to grow from $6.5 billion in 2015 to $9.8 billion in 2021 at an
NONCARBONATED DRINKS
This segment is defined as noncarbonated, nondairy products. It includes all functional

beverages such as energy drinks, sports drinks and functional water. Major innovation is
taking place within this segment, which largely caters to the sports and energy market.
Red Bull is one of the leading energy products in the energy and sports drink category and
accounts for 43.4% of the global energy drink market in 2015. Pepsi and Coca-Cola are
leaders in the carbonated drink market with 69.1% of share in 2015, and are now
establishing strong positions in the noncarbonated drinks market as well. They have
adopted inorganic and organic growth strategies to expand their market presence in the
sector. The companies have actively acquired beverage companies in North America and
Europe, which are the biggest markets for functional beverages.

TABLE 17
GLOBAL NONCARBONATED DRINKS MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
North America 14.1 15.2 22.2 7.9
Europe 10.9 11.7 18.0 9.0
Asia-Pacific 7.4 8.0 12.0 8.4
Total 36.0 38.6 57.7 8.4
North America commanded the largest share of the overall nutraceutical noncarbonated
drinks market in 2015 with a 39.2% share, worth $14.1 billion, and is expected to reach
$22.2 billion by 2021, rising at a CAGR of 7.9% from 2016 to 2021. Europe commanded
the second-largest market share with 30.3% of the overall nutraceutical noncarbonated
drinks market in 2015 at $10.9 billion and is expected to reach $18.0 billion in 2021,
growing at a CAGR of 9.0% from 2016 to 2021. Asia-Pacific’s nutraceutical noncarbonated
drinks market is expected to grow from $7.4 billion in 2015 to $12.0 billion in 2021,
growing at an estimated CAGR of 8.4% from 2016 to 2021.
In Europe, there were issues with functional water products. They were initially rejected in
France and the U.K. due to their unpleasant taste. The Dannon functional water brand was
withdrawn from the U.K. and French markets. Despite these issues, the market potential is
immense and companies will continue to introduce new products to capture market share.
The CSD drinks market is decreasing year by year as consumers shift to healthier
alternatives such as energy drinks, functional waters and juices. The cola market has been
shrinking in many Western markets, including the U.S., as consumers shift their
preferences to options like juices, waters, teas, functional waters and other carbonated
energy drink options. The category still represents almost half of the U.S. market,
providing significant opportunities for further functional beverage gains. Sports and energy
drinks offer overall wellness benefits and are now widely available through mass
distribution channels like supermarkets. Pepsi and Coca-Cola are investing heavily to enter
and expand in the energy market. For instance, Coca-Cola has expanded its presence in
Africa with the acquisition of a minority stake in Chi Limited, Nigeria’s leading dairy, juice,
and snacks company in 2016. Coca-Cola Bottling Co. Consolidated also signed agreements
to expand the distribution area to territories located in parts of Kentucky, Indiana, Ohio,
Illinois and West Virginia in 2016, and to purchase manufacturing facilities in Indiana and
Ohio.
Functional waters are one of the fastest-growing product categories in the functional
beverage sector. The global functional/fortified bottled water market doubled between
2005 and 2015, but growth has started to level off. This category has attracted many
players including manufacturers of carbonated soft drinks (CSD) and general beverages
due to its high growth and profit potential.

Pepsi markets many brands under the fortified water category as well, such as SoBec Life
Water and certain Gatorade products. Tata Tea Ltd., the world’s second largest
manufacturer and distributor of tea, has launched a fortified version of the Himalayan
mineral water brand in Western Europe, North America, West Asia and the Far East. Major
functional noncarbonated drinks and their manufacturers are shown in the following table.
TABLE 18
TOP FUNCTIONAL NONCARBONATED DRINKS
Company Product Comments

Red Bull Red Bull This is the pioneer drink in this
category and it is leading the
market.
Coca-Cola Powerade, Full Throttle, Tab Drinks containing ginseng extract,
and Energy Brands/Glaceau guarana extract, caffeine and B
energy drinks vitamins.
Nutraceutical Ultimate Nutrition, Natural Provides quick energy from
International Corp. Sport, Supplement Training carbohydrate breakdown.
Systems
Kellogg Special K2O Protein Digestive protein-based beverages.
General Nutrition FRS, GNC X-12 Nutritional drinks contain a range of
Center vitamin B and proteins.
GlaxoSmithKline Horlicks, Maltova, Boost, Horlicks, Boost and Maltova have
Lucozade and Viva acquired major shares of the healthy
drinks market.
PepsiCo. Gatorade and G2, Recovery Noncarbonated energy drinks with
shakes, Edge, energy drinks, carbohydrates and electrolytes.
Endurance Formula drinks,
nutrition bars, nutrition shakes
and Power.
DAIRY DRINKS
Currently there is increasing demand for soy derivatives products. Soy products contain
many ingredients that are beneficial to consumers’ health. The functional milk market’s
two major categories: functional dairy beverages and functional dairy alternative drinks.
Probiotics commanded the largest share of the overall nutraceutical noncarbonated drinks
market in 2015 with a 49.9% worth $17.9 billion and followed by omega-3 with 28.3%,
protein and peptides with 4.7% and fiber with 4.6%. Faced by the rising cost of energy and
raw material and facing fierce competition, dairy market companies are continuously
introducing innovative product extensions to safeguard their market share. Most dairy
companies are now concentrating on functional dairy products to increase their profits and
market share in the overall dairy market. The companies are increasingly adopting
strategies such as partnerships, mergers or acquisitions to introduce new products to new
and existing markets. They are also undertaking considerable investment in R&D to

increase the functional product line. Dutch dairy group Campina DMV collaborated with
Wageningen University for research into ingredients for the fortification of dairy products.
Danisco has launched functional dairy products in the U.S. probiotic market to respond to
competition.
TABLE 19
GLOBAL DAIRY DRINKS MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 9.1 9.7 14.8 8.8
Asia-Pacific 7.6 8.1 12.1 8.4
Total 22.6 24.3 35.7 8.0
Europe commanded the largest share of the overall nutraceutical dairy drinks market in
2015 with a 40.3% share, worth $9.1 billion, and is expected to reach $14.8 billion by
2021, rising at a CAGR of 8.8% from 2016 to 2021. Asia-Pacific commanded the
second-largest market share with 33.6% of the overall nutraceutical dairy drinks market in
2015 at $7.6 billion and is expected to reach $12.1 billion in 2021, growing at a CAGR of
8.4% from 2016 to 2021. The North American nutraceutical dairy drinks market is
expected to grow from $4.0 billion in 2015 to $6.5 billion in 2021, growing at an estimated
CAGR of 8.6% from 2016 to 2021.
Soy milk, an alternative to dairy products, has a large market due to greater media
attention and consumer awareness of its health benefits. Soy reduces blood cholesterol,
protects against prostate and breast cancer and helps heal bone fractures. Other major
nondairy alternative beverages are rice-, oat- and almond-based milk. Dean Foods is one
of the largest producers of soy milk in the U.S., and its Silk brand is a major market name.
The Australian market has a higher penetration for soy milk with more than 11.0% of the
total milk sales in terms of value coming from soy in 2015. Fresh soymilk offerings account
for a high share of the U.S. market, proving to be more popular than shelf-stable,
ultra-high-temperature (UHT) packaged offerings. The soy milk market in the U.S. has
started to lose some ground due to higher prices, soy allergies and general soy burnout
within the consumer population.

TABLE 20
TOP NONFERMENTED FUNCTIONAL DAIRY BEVERAGES

Nestle Omega Plus and Carnation Low-fat milk with omega-3.
product High-protein-content Carnation milk.
Dannon (U.S.) Zen Fermented milk fortified with magnesium.
Yakult Honsha Yakult (L. casei) Probiotic fermented milk.
Co.,
Unilever, Flora proactive Low-fat milk, margarines and yoghurt
Germany fortified with phytosterol to reduce
cholesterol.
Meiji, Dairies Meiji Love and Snow Milk fortified with calcium and iron. Low in
Corp., Japan Brand Milk fat, with a small amount of sweetener
added.
Lactantia, Lactantia Omega-3 Low-fat milk with omega-3-rich flaxseed oil
Canada
Cricketer Farm, Night Time Milk Milk fortified with melatonin, promoted as
U.K. providing a good night’s sleep.
Stolle Milk Stolle Milk alpha, beta Distributed as powder, fortified with
Biologics, U.S. and gamma peptide (casein).
Coca-Cola Co. Fanta Lactic Drink Added value of milk protein and available in
various flavors.
Johnson & LACTAID dietary Low-fat milk drinks.
Johnson supplements, LACTAID
Fast Act and LACTAID milk
Valio Oy, Finland Valio lactose-free milk Milk free of lactose and fat and low in
drinks, Gefilus milk, 1%, caloric value.
Valio Benecol fat-free milk
drink and Valio ProFeel
low-energy milk drink
FROZEN JUICES
The increasing media attention paid to the adverse effects on health from
sugar-sweetened beverages and carbonated soft drinks has shifted consumer demand to
healthy fruit and vegetable juices and drinks. This level of awareness paired with the
exploding obesity and diabetes epidemics are the main drivers for the growth of fruit and
vegetable drinks. Beverage companies like Coca-Cola, Pepsi and Dr. Pepper are increasing
the fruit juice selections in their product portfolios in answer to increasing customer
demand.
Germany has a long-established tradition of ACE-fortified (vitamins A, B, C) and

multivitamin juices, and it is an important European market for functional juices.
Calcium-enriched juices have gained a strong market share in the U.S. and Europe. These
drinks are not priced at a premium rate as compared with other fruit juice alternatives,

and consumers have the choice of a wide range of products within the category.
Innovative fruit juices have recently been launched, such as Minute Maid’s Heart Wise
juices, which incorporate plant sterols to help lower blood cholesterol levels. In Germany,
ACE juices, which contain folic acid, have shown strong growth.
TABLE 21
GLOBAL FROZEN JUICES MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 1.2 1.3 1.8 6.7
Asia-Pacific 1.3 1.4 1.9 6.3
Total 4.3 4.6 6.5 7.2
The global nutraceutical frozen juices market was estimated to be worth $4.3 billion in
2015 and is expected to reach $6.5 billion by 2021, growing at an estimated CAGR of 7.2%
from 2016 to 2021. Asia-Pacific commanded the largest share of the overall nutraceutical
frozen juices market in 2015 with a 30.2% share, worth $1.3 billion, and is expected to
reach $1.9 billion by 2021, rising at a CAGR of 6.3% from 2016 to 2021. The North
American nutraceutical frozen juices market is expected to grow from $1.1 billion in 2015
to $1.7 billion in 2021, growing at an estimated CAGR of 7.2% from 2016 to 2021.
TABLE 22
TOP FUNCTIONAL JUICE PRODUCTS
Company Product/Brand Comments

IFF Generessence line of The product is global, natural, GRAS and
flavors kosher.
Xango (U.S.) XALO Ageless The juice is seen as a premium product and
will wholesale at $25 (€18). The group claims
to have secured 80.0% of the global market
share of mangosteen juice since it introduced
its product in 2003. Application- contains
mangosteen, aloe vera, grape seed and green
tea extracts
Amazon and Acai berry juice Antioxidant with high level of anthocyanins.
JO Sims Application: sourced-acai berry
PepsiCo Naked Juice, Ocean Spray Juices are rich in vitamins and fortified with
Light Cranberry various additives to provide specific health
Pomegranate Juice Drink benefits. Application: natural and sugar free

Coca-Cola Hi-C Drink Box, Hi-C Blast Juices are rich in vitamin C and fortified with
and Hi-C Sour Blast; Minute calcium and glucosamine
Maid, Odwalla
TEA AND COFFEE
The global tea market (both nonfunctional and functional) includes instant, leaf, liquid
concentrate and ready-to-drink tea. Phytochemical and antioxidants commanded the
largest share of the overall nutraceutical tea and coffee market in 2015 with a 56.7%
worth $0.3 billion, followed by omega-3 with 18.5%, protein and peptides with 16.5% and
fiber with 8.3%.
The increasing popularity of green tea in the U.S., Europe and Australia is one the main
growth drivers for the green tea market. Consumption of green and black tea in the U.S.
has rapidly grown over the last five years. Convenient ready-to-drink (RTD) tea and coffee
are consumed and marketed as an alternative to CSD (carbonated soft drinks). Green and
black teas are more natural and contain antioxidants and polyphenols.
Functional teas with flavors are used by tea companies to cater to different tastes in
markets worldwide. The U.S., China and Singapore are important markets for flavored tea.
In Asia, consumers prefer tea with less astringency and more floral flavors, while less floral
flavors are favored in U.S. markets. Green, black and oolong teas are most popular in the
U.S.
The leading companies in the tea market have entered the functional teas market.
Unilever is the world’s largest tea company, while Tetley is the second largest tea bag
brand worldwide and a top producer in the U.K. and Canadian markets. Twinings is one of
the oldest tea companies and a leader in the specialty teas market.
TABLE 23
GLOBAL TEA AND COFFEE MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 0.9 0.9 1.2 5.9
Asia-Pacific 0.6 0.6 0.9 8.4
Total 3.3 3.6 5.0 6.8
The global nutraceutical tea and coffee market was estimated to be worth $3.3 billion in
2015 and is expected to reach $5.0 billion by 2021, growing at an estimated CAGR of 6.8%

from 2016 to 2021. North America commanded the largest share of the overall
nutraceutical tea and coffee market in 2015 with a 30.3% share, worth $1.0 billion, and is
expected to reach $1.4 billion by 2021, rising at a CAGR of 4.9% from 2016 to 2021. There
is increasing awareness of the health benefits that can be gained through consumption of
green and black tea, and the U.S. market is responding accordingly. Tea, especially in iced
tea form, is now becoming a daily drink in the U.S. with other forms also gaining market
traction.
Europe commanded the second-largest market share with 27.3% of the overall
nutraceutical tea and coffee market in 2015 at $900 million and is expected to reach $1.2
billion in 2021, growing at a CAGR of 5.9% from 2016 to 2021. Asia-Pacific’s nutraceutical
tea and coffee market is expected to grow from $600 million in 2015 to $900 million in
2021, growing at an estimated CAGR of 8.4% from 2016 to 2021.
Green Tea
The market for green tea is increasing due to its use in a wide variety of product
categories including beverages, cosmetics, nutraceutical, medicinal and flavors and
fragrances. The major health benefit of green tea is the potential for disease cures and
prevention. More specifically, defense against bacterial and viral infections and treatment
of certain types of cancer are the main benefits of green tea. There is an increasing trend
toward the production of green tea extracts, which are used in tablets, capsules and
health drinks. Ready to drink (RTD) green tea is gaining more popularity in the North
America and Europe, where convenience is a major selling point. China and Japan are the
dominant producers of green tea extracts, accounting for approximately 85.0% of the total
world crop and 90.0% of world exports.
Black Tea and Ice Tea
Black tea extract induces the precipitation of mixed bile salt micelles, lowers blood
cholesterol levels and helps in body weight loss. In this regard, further investigation of the
effects of black tea extracts on body weight loss is warranted. However, the product
category is promising in that it can address the growing world obesity epidemic. RTD teas
and coffee are consumed as alternatives to carbonated soft drinks, which are now
recognized as containing unhealthy levels of sugar and for promoting weight gain and
obesity from calorie intake. Flavored iced teas with additional herbal extracts are growing
in popularity. There is an increase in the number of product launches with full or partial
sugar replacement, and this trend will continue into the future.
Functional Coffee
After tea, coffee is the most consumed beverage worldwide. International Coffee
Organization (ICO) estimated that North America, Europe and Japan account for almost
53.0% of world coffee consumption. Functional coffee typically contains extra antioxidants
(vitamins A, C and E) and carotenoids like beta-carotene, which help to protect cells.
Consumption of three or more cups of coffee per day has been linked to prevention of
ovarian cancer. Unroasted green coffee bean extracts have been tied to weight reduction.

TABLE 24
TOP TEA AND COFFEE PRODUCTS

Unilever Lipton tea bag Unilever is the world’s largest tea company.
Tetley Redbush Second largest tea bag brand.
Twinings Specialty teas One of the oldest tea companies.
Coca-Cola Diet Nestea, These are green tea brands with
Enviga calorie-burning benefits.
DSM Nutritional Teavigo Green tea extract helps in detoxification,
Products improvement of blood flow and overall
improvement of resistance to disease.
Plethico Natrol Green Tea Green tea is an energy drink with 50%
Pharmaceuticals Ltd. polyphenol content, providing 25.0% total
catechins.
Lipton Lipton tea bags, Widely available at retail.
Jasmine Green
DIETARY SUPPLEMENTS
The dietary supplements market is defined as the aggregate sales value of supplements
containing any of the bioactive ingredients. This mainly includes vitamins and multivitamin
supplements, mineral supplements such as calcium and herbal and nonherbal
supplements. This market is often wrongly defined in other reports as the total
nutraceutical market. For the purposes of this report, dietary supplements are considered
to be a part of the total nutraceutical market.
TABLE 25
GLOBAL DIETARY SUPPLEMENTS MARKET, BY PRODUCT, THROUGH 2021

($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Vitamin and multivitamins 21.0 22.5 31.0 6.6
Mineral 12.8 13.8 19.3 6.9
Herbal 9.9 10.6 15.6 8.0
Other 14.6 15.7 21.3 6.3
Total 58.3 62.6 87.2 6.9

In 2015, the global dietary supplements market was dominated by vitamins multivitamins,
and minerals, with estimated 36.0% and 22.0% shares, respectively. The global vitamin
and multivitamin market was estimated to be worth $21.0 billion in 2015 and is expected
The global mineral market was estimated to be worth $12.8 billion in 2015 and is expected
TABLE 26
GLOBAL DIETARY SUPPLEMENTS MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
North America 27.7 29.7 42.2 7.3
Europe 9.4 10.1 11.5 2.6
Asia-Pacific 21.0 22.5 32.8 7.8
Total 58.3 62.6 87.2 6.9
North America commanded the largest share with 47.5% of the overall global dietary
supplements market in 2015 at $27.7 billion. The market is expected to reach $42.2 billion
in 2021, rising at a CAGR of 7.3% for 2016 to 2021. Asia-Pacific commanded the
second-largest market share with 36.0% of the overall dietary supplements market in
2015 at $21.0 billion and is expected to reach $32.8 billion in 2021, growing at a CAGR of
7.8% from 2016 to 2021. Europe commanded the third-largest market share with 16.1% of
the overall dietary supplements market in 2015 at $9.4 billion and is expected to reach
$11.5 billion in 2021, growing at a CAGR of 2.6% from 2016 to 2021. South America’s
dietary supplements market is expected to grow from $200 million in 2015 to $700 million
in 2021 at an estimated CAGR of 18.5% from 2016 to 2021.

Chapter 5
NUTRACEUTICAL MARKET BY
INGREDIENTS
FOD013F
March 2017
Natraj Pandal
Project Analyst
ISBN: 1-62296-448-9
BCC Research
or (+1) 781-489-7301
www.bccresearch.com
CHAPTER 5
NUTRACEUTICAL MARKET BY INGREDIENTS
Nutraceutical products are in great demand globally, though the relative popularity of
products varies by geographic region based on the basic ingredients used. While
probiotic-based nutraceutical products are most popular in Europe and Japan, U.S.
consumers prefer vitamin- and mineral-based products. There is also a great demand for
specific proteins in Japan. Different techniques, such as nanotechnology,
microencapsulation and fortification, are used to manufacture these products according to
the kind of ingredients used.
Both consumption and production of nutraceutical ingredients in developing regions is

much faster than developed regions. Increasing economic wealth will enable the
developing countries such as Brazil, Russia, India and China, as well as Mexico, Poland and
South Korea, to expand their food and beverage, processing and pharmaceutical industries.
TABLE 27
GLOBAL NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, THROUGH 2021

($ BILLIONS)
CAGR%
Ingredients 2015 2016 2021 2016–2021
Vitamin and minerals 83.3 89.4 128.3 7.5
Probiotics 28.5 30.6 49.0 9.9
Phytochemicals 21.2 22.8 27.4 3.7
Fiber 18.9 20.3 29.9 8.1
Omega-3 17.4 18.7 26.5 7.2
Protein and peptides 15.7 16.9 23.9 7.2
Total 185.0 198.7 285.0 7.5
The global nutraceutical ingredients market is dominated by vitamins and minerals, which
accounted for 45.0% of the overall market in 2015. The global vitamins and minerals
market was estimated to be $83.3 billion in 2015 and is expected to reach $128.3 billion
by 2021, growing at a CAGR of 7.5% from 2016 to 2021.
Probiotics commanded the second-largest market share with 15.4% of the overall
nutraceutical ingredients market in 2015 at $28.5 billion and is expected to reach $49.0
billion in 2021, growing at a CAGR of 9.9% from 2016 to 2021 due to increasing consumer
awareness and application in new areas such as smoothies to salad dressings. The global
fiber market was estimated to be $18.9 billion in 2015 and is expected to reach $29.9
billion by 2021, growing at a CAGR of 8.1% from 2016 to 2021.

TABLE 28
GLOBAL NUTRACEUTICAL FOOD MARKET, BY INGREDIENT, THROUGH 2021

($ BILLIONS)
CAGR%
Ingredients 2015 2016 2021 2016–2021
Fiber 15.5 16.6 25.6 9.1
Soy 13.5 14.5 20.9 7.6
Probiotics 10.2 11.0 17.1 9.2
Omega-3 8.7 9.4 12.8 6.4
Other 12.2 13.1 15.9 4.0
Total 60.1 64.6 92.3 7.4
The global nutraceutical food market is dominated by the ingredient fiber, which
accounted for 25.8% of the overall market in 2015. The fiber-based nutraceutical food
2021, growing at a CAGR of 9.1% from 2016 to 2021. Soy commanded the second-largest
market share with 22.5% of the overall nutraceutical food ingredient market in 2015 at
$13.5 billion and is expected to reach nearly $20.9 billion in 2021, growing at a CAGR of
7.6% from 2016 to 2021. The global omega-3 based nutraceutical food market was
estimated to be $8.7 billion in 2015 and is expected to reach $12.8 billion by 2021,
growing at a CAGR of 6.4% from 2016 to 2021.
TABLE 29
GLOBAL NUTRACEUTICAL BEVERAGE MARKET, BY INGREDIENT, THROUGH 2021

($ BILLIONS)
CAGR%
Ingredient 2015 2016 2021 2016–2021
Vitamins and minerals 38.0 40.8 60.8 8.3
Probiotics 12.8 13.7 20.1 8.0
Omega-3 8.1 8.7 12.7 7.9
Fiber 3.3 3.6 5.2 7.6
Soy 2.0 2.1 3.1 8.1
Other 2.4 2.6 3.6 6.7
Total 66.6 71.5 105.5 8.1
The ingredients of the global nutraceutical beverage market are dominated by vitamins
and minerals, which accounted for 57.1% of the overall market in 2015. The vitamin- and
mineral-based nutraceutical beverage market was estimated to be $38.0 billion in 2015
2021.

The probiotics-based nutraceutical beverage market was estimated to be $12.8 billion in

2015 and is expected to reach $20.1 billion in 2021, growing at a CAGR of 8.0% from 2016
to 2021. The omega-3 based nutraceutical beverage market was estimated to be $8.1
billion in 2015 and is expected to reach $12.7 billion by 2021, growing at a CAGR of 7.9%
from 2016 to 2021.
TABLE 30
GLOBAL NUTRACEUTICAL SUPPLEMENT MARKET, BY INGREDIENT, THROUGH

2021
($ BILLIONS)
CAGR%
Ingredients 2015 2016 2021 2016–2021
Vitamins and minerals 45.3 48.6 67.5 6.8
Other 13.0 14.0 19.7 7.1
Total 58.3 62.6 87.2 6.9
The global nutraceutical supplement market is dominated by the vitamin and mineral
ingredients, which accounted for 77.7% of the overall market in 2015. The global vitamin-
and mineral-based nutraceutical supplement market was estimated to be $45.3 billion in
2016 to 2021.
VITAMINS AND MINERALS
The mandatory inclusion on food labels of the commonest food allergen ingredients and
their derivatives covers cereals containing gluten, fish, crustaceans, egg, peanuts,
soybeans, milk and dairy products, lactose, nuts, celery, mustard, sesame seeds and
sulfites. According to the World Allergy Organization, 220 to 250 million people in the
world suffered from food allergies in 2015. According to the Food Standards Agency, more
than 15 million people in the U.S. suffered from food allergies in 2015. There is also a
general backlash against genetically modified (GM) products, which many consumers view
as artificial and unsafe. To capitalize on these market trends, companies are looking to
manufacture products that avoid the GM label and are allergen-free.
DSM Nutritional Products has introduced a new oily form of vitamin A that is both GM- and
allergen-free. This vitamin A form uses medium chain triglycerides (MCTs) as a carrier,
which guarantees ingredients free of genetically modified organisms and eliminates
potential allergic reactions related to peanut oil. BASF has introduced allergen-free
vegetarian variants of vitamin E and beta-carotene for its supplements, and Cognis is
manufacturing a GM-free vitamin E for consumers wary of GM ingredients.Vitamins are
major ingredients in foods, pharmaceuticals, cosmetics and feed additives.

TABLE 31
GLOBAL NUTRACEUTICAL VITAMIN AND MINERAL MARKET, BY REGION, THROUGH

2021
($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
North America 30.2 32.5 46.4 7.4
Europe 19.1 20.5 28.7 7.0
Asia-Pacific 27.1 29.1 43.6 8.4
Total 83.3 89.4 128.3 7.5
In 2015, the global vitamins and mineral market was dominated by North America and
Asia-Pacific, with estimated 36.3% and 32.5% shares, respectively. The North American
vitamin and mineral market was estimated to be $30.2 billion in 2015 and is expected to
reach $46.4 billion by 2021, growing at a CAGR of 7.4% from 2016 to 2021. This is due
mainly to the willingness with which consumers in North America are seeking to maintain
vitality and wellness by increased consumption of nutraceutical supplements. ADM
(Archer-Daniels-Midland Co., U.S.) and Cargill Inc. (U.S.) are the major players in regard to
minerals in the North American market. DSM (Netherlands) is the major player in the North
American vitamin market with a 13.0% share in 2015, followed by BASF (Germany) with a
7.7% share in 2015.
Asia-Pacific’s vitamins and minerals market were estimated to be $27.1 billion in 2015 and
are expected to reach $43.6 billion by 2021, growing at a CAGR of 8.4% from 2016 to
2021. The European vitamin and mineral market was estimated to be $19.1 billion in 2015
and is expected to reach nearly $28.7 billion by 2021, growing at a CAGR of 7.0% from
2016 to 2021 due to the rise in the consumption of dietary supplements in order for
consumers to improve their overall health and wellness. Consumers in Europe are willing
to spend premium amounts on higher quality nutraceuticals, which drives the demand for
vitamin and mineral ingredients. BASF (Germany), ADM (U.S.), Cargill (U.S.) and Ingredion
(U.S.) are the major players for vitamins and minerals in the European market.
PROBIOTICS
Oral probiotics are living microorganisms that deliver digestive tract health benefits
beyond basic nutrition. Common probiotic bacteria include Lactobacillus and “bifido,” the
Bifidobacterium species—a carbohydrate not digested by humans that reaches the large
intestine and serves as a substrate for growth of certain beneficial intestinal microbes.
Examples include fructooligosaccharides and inulin, a soluble dietary fiber. Probiotic health
claims are natural defenses, immune function, digestive health, intestinal transit, gut
integrity and balanced micro biota during antibiotic treatment.

The addition of probiotics to their diet may reduce the occurrence of low-level
inflammatory processes in an older population. Prebiotic products are currently being
added to finished products such as bread, chocolate, yogurt and dietary supplements.
Probiotics have proven successful in combating lifestyle-related disorders and
degenerative diseases such as stress, food intolerance, type 2 diabetes, obesity, kidney
failure, and oral and skin health disorders.
TABLE 32
GLOBAL NUTRACEUTICAL PROBIOTICS MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 10.3 11.1 17.9 10.0
Asia-Pacific 8.3 8.9 14.2 9.8
Total 28.5 30.6 49.0 9.9
In 2015, the global probiotics market was dominated by Europe and Asia-Pacific, with
estimated 36.1% and 29.1% shares, respectively. The European probiotics market was
growing at a CAGR of 10.0% from 2016 to 2021 due to rising concern regarding fitness
and resultant high awareness of nutraceuticals, which makes for wide acceptance of
probiotic products among European consumers. An appreciable amount of probiotic
products and product extensions are currently being introduced in Europe.
Asia-Pacific’s probiotics market was estimated to be $8.3 billion in 2015 and is expected to
reach $14.2 billion by 2021, growing at a CAGR of 9.8% from 2016 to 2021. The North
American probiotics market was estimated to be $6.7 billion in 2015 and is expected to
reach $11.5 billion by 2021. North America is the third- largest market for probiotics but is
expected to grow closely in line with Europe at a CAGR of 9.8% due to the fact that more
than 70 million North American adults suffer from digestive problems caused by poor
consumption habits, high usage of additives for processing food and a high rate of
antibiotic intake.

TABLE 33
GLOBAL NUTRACEUTICAL PROBIOTICS MARKET, BY PRODUCT TYPE, THROUGH

2021
($ BILLIONS)
CAGR%
Product Type 2015 2016 2021 2016–2021
Beverages and supplements 18.3 19.6 31.9 10.2
Food 10.2 11.0 17.1 9.2
Total 28.5 30.6 49.0 9.9
Beverages and supplements dominate the global nutraceutical probiotics market with a
share of 64.2% in 2015. The probiotics-based nutraceutical beverages and supplements
2021, growing at a CAGR of 10.2% from 2016 to 2021. Availability of probiotics in both
supplements and functional foods such as yogurts and other dairy products has increased.
TABLE 34
GLOBAL NUTRACEUTICAL PROBIOTICS FOOD MARKET, BY PRODUCT, THROUGH

2021
($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Frozen desserts 4.4 4.8 7.5 9.3
Bakery 0.8 0.9 1.3 7.6
Cheese 0.8 0.9 1.3 7.6
Meat 0.4 0.4 0.6 8.4
Frozen fruits and vegetables 0.3 0.3 0.4 5.9
Total 10.2 11.0 17.1 9.2
Frozen desserts accounted for the largest share of the overall nutraceutical probiotics food
market with a 43.1% share, worth $4.4 billion in 2015, and is expected to reach $7.5
billion in 2021, growing at a CAGR of 9.3% from 2016 to 2021. Confectionery commanded
the second-largest market share with 34.3% of the overall nutraceutical probiotics food
market in 2015 at $3.5 billion, which is expected to reach $6.0 billion in 2021, growing at a
CAGR of 10.2% from 2016 to 2021.
Companies are marketing probiotic microorganisms as an ingredient in sports drinks,

claiming relief of stress caused by heavy exercise. The probiotic bacterium can also be
found in dental applications like sugar free chewing gum. Use of probiotics can be

challenging due to the inability of probiotic strains to survive under difficult technological
and gastrointestinal conditions. Once the ability to alleviate this is achieved, probiotic
applications can be extended into nondairy products.
Drinkable probiotic yogurts are a key product for the probiotic market. Fermented dairy
products fortified with probiotics are very popular in Europe. Probiotic food applications
are also gradually finding uses in other food categories, such as fruit juices, soups,
chocolate and soy- and cereal-based products. Probiotic juices are expected to gain
popularity as a beverage alternative for the health conscious. Kraft introduced the first
cheese products with probiotics, Kraft LiveActive, in the Canadian market. Other
companies’ probiotics are shown in the below table.
TABLE 35
OTHER MAJOR PROBIOTIC PRODUCTS

Barry Chocolate A chocolate enriched with probiotics to restore the balance of
Callebaut enriched intestinal flora. Its Probiocap technology involves applying a
protective shield around the probiotic bacteria, ensuring
survival in the digestive tract and enabling optimal activity in
the gut.
Yakult Probiotic The probiotic drink is consumed daily by more than 25 million
drink people in 30 countries around the world.
Dannon Actimel Over 6 million bottles of the drink are consumed daily in 26
countries across the world.
Valio Gefilus Finland’s top probiotic juice brand with more than 33.2%
market share — more than twice that of PepsiCo’s Tropicana
brand.
Nestle LC1 The first probiotic culture to produce its effect in a yogurt.
FIBER
Fiber is edible matter obtained from plants. The small intestine does not absorb fiber and
allows it to pass through to the large intestine. Once there, soluble fiber such as
beta-glucan from oats and barley, inulin and polysaccharides is fermented. This
fermentation helps to slow blood glucose absorption and has a prebiotic effect (stimulates
probiotic bacteria in the gut). Insoluble fiber is excreted intact, providing fecal bulking and
helping to regulate bowel function and prevent constipation. In addition to soluble and
insoluble fibers, a third type of fiber is resistant starch.
Several major food and beverage companies have incorporated fiber into their products.
PepsiCo added a fiber product to its Tropicana Pure Premium Essentials orange juice,
becoming the first U.S. brand to do so. ADM’s FibreSol-2, a fiber product, is used in
Dannon’s prebiotic yogurt. Cargill manufactures Barliv from barley beta-glucan that can be
added to beverages, snacks and cereals.

Nutraceutical recommendations by government bodies, increasing awareness of healthy

diet benefits, the rising popularity of weight control programs and the FDA’s authorization
of oat and barley beta-glucan heart health claims has resulted in several dietary products
entering and succeeding in the market. Fibers are also finding an increasing market as a
sugar and fat replacement.
TABLE 36
GLOBAL NUTRACEUTICAL FIBER MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 5.6 6.0 8.4 7.0
Asia-Pacific 5.1 5.5 8.2 8.3
Total 18.9 20.3 29.9 8.1
In 2015, the global fiber market was dominated by North America and Europe, with
estimated 36.5% and 29.6% shares, respectively. The North American fiber market was
growing at a CAGR of 9.0% from 2016 to 2021 due to increased consumption of dietary
supplements by consumers in an effort to avoid health issues such as obesity, diabetes
and cardiac disorders.
The European fiber market was estimated to be $5.6 billion in 2015 and is expected to
reach $8.4 billion by 2021, growing at a CAGR of 7.0% from 2016 to 2021. Asia-Pacific’s
fiber market was estimated to be $5.1 billion in 2015 and is expected to reach $8.2 billion
by 2021, growing at a CAGR of 8.3% from 2016 to 2021. Asia-Pacific has plenty of raw
material and resources for dietary fiber production, especially in India, China and Australia.
These countries have tremendous amounts of agricultural production of high-fiber-content
plants and oilseeds that are a primary source of raw material for fiber ingredients.
TABLE 37
GLOBAL NUTRACEUTICAL FIBER MARKET, BY PRODUCT TYPE, THROUGH 2021

($ BILLIONS)
CAGR%
Type 2015 2016 2021 2016–2021
Food 15.5 16.6 25.6 9.1
Total 18.9 20.3 29.9 8.1

Foods dominate the global nutraceutical fiber market with 82.0% of share in 2015. The
fiber-based nutraceutical food market was estimated to be $15.5 billion in 2015 and is
expected to reach $25.6 billion by 2021, growing at a CAGR of 9.1% from 2016 to 2021.
TABLE 38
GLOBAL NUTRACEUTICAL FIBER FOOD MARKET, BY PRODUCT, THROUGH 2021

($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Bakery 6.3 6.8 10.5 9.1
Snacks 5.6 6.0 9.2 8.9
Meat 0.5 0.5 0.8 9.9
Cheese 0.3 0.3 0.4 5.9
Total 15.5 16.6 25.6 9.1
Bakery accounted for the largest share of the overall nutraceutical fiber food market with
a 40.6% share, worth $6.3 billion in 2015, and is expected to reach nearly $10.5 billion in
2021, growing at a CAGR of 9.1% from 2016 to 2021. Snacks commanded the
second-largest market share with 36.1% of the overall nutraceutical fiber food market in
2015 at $5.6 billion, and the market is expected to reach $9.2 billion in 2021, growing at a
CAGR of 8.9% from 2016 to 2021.
WHOLE GRAINS
Whole grains are found in whole wheat, oatmeal, popcorn and brown rice and consist of
starchy endosperm, fiber-rich bran and inner micronutrient-rich germ. Whole grains have
high levels of fiber and also provide vitamins, minerals and antioxidants. The U.S.
government recommended increased whole grain consumption in 2005, providing a boost
to whole grain products. This development prompted major food manufacturers like
General Mills, Nestle, Sara Lee and Kellogg to include whole grains in various product
offerings. The European Commission also recommended an increase in whole grain
consumption, giving a boost to the whole grain market in Europe.
The multifaceted health benefits of whole grains, such as digestive health, weight loss,
heart health and cancer prevention, are gaining recognition, according to the Natural
Marketing Institute (NMI). The following is a selected list of products from some of the
major companies that are active in this segment.

TABLE 39
MAJOR WHOLE GRAINS PRODUCTS
Company Ingredient Technology Application

ConAgra Ultragrain Platte Patent-pending grinding technology General food
wheat maintains the flour’s milder taste and applications.
develops the smooth texture while
preserving the fiber, antioxidants,
phytonutrients and other essential
nutrients found in whole wheat bran
and germ.
NutriTech Activated Barley Beta-glucans used in Activated Barley Energy-generating
have been captured at the point of foods
sprouting in a nondegraded form.
Cargill Wheat Select Wheat Select flour was developed Finely ground flour
brand—white through an alliance with breeding suited for baking.
spring whole company WestBred.
wheat flour
Some of fiber-based products are shown in the following table.
TABLE 40
SELECTED FIBER-BASED PRODUCTS
Company Products Comments

Cargill Barliv Patented.
Alberta Viscofibre Barley- and oat-derived fiber concentrates.
Bio Serae NeoPuntia Dehydrated cactus leaves targeted at weight management.
ADM Fibresol-2 Digestive-resistant maltodextrin used mainly in juice and yogurt
with FOSHU (food for specified health use) status in Japan.
GraceLinc Glucagel Beta-glucans.
HIGH-FIBER FOOD
High-fiber food has a relatively lower glycemic index (GI), which helps diabetes patients
achieve better weight management, maintain lower postprandial glucose and improve
their overall lipid profile. The best evidence of the clinical efficacy for the GI is available
through studies of diabetic patients in whom low-GI foods have consistently shown
beneficial effects on blood glucose control in both the short term and the long term.

BETA-GLUCAN
Barley beta-glucan is a soluble fiber (nonstarch polysaccharide) found naturally in the cell
walls of barley that is perceived to have multiple health benefits. There is significant
market opportunity for beta-glucan as a value-added ingredient, given that approximately
27 million tons of oats are produced annually worldwide. A beta-glucan ingredient
researched by New Zealand firm GraceLinc is used in a range of bread and brioches by
Italy’s Barilla.
OMEGA-3
Omega-3 acids are a group of polyunsaturated fatty acids, and their importance is
underscored by the fact that the human body cannot naturally synthesize them. Omega-3
fatty acids are found in plants like flax, canola, walnuts and hemp, and in fish, particularly
ocean fish such as sardines, anchovies, salmon and mackerel. Plants contain omega-3
fatty acids, which include alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA) and
docosahexaenoic acid (DHA). DHA/EPA led the market with more than 70.0% market share,
followed by ALA. A number of dairy beverages containing omega-3 fatty acids from plant
and marine sources have been launched in the U.S., Canada, Europe and Australia. BASF
(Germany), Nissui (Japan) and Wuxi Xunda (China) are major players in global omega-3
fatty acids market.
The omega-3 fatty acids market was initially restricted, primarily due to insufficient
awareness of the “good fat” concept among consumers. Consumers are now becoming
more educated on the benefits, which include defense against several conditions including
hypertension, hyperlipidemia, CVD diseases, depression and dementia. The instability in
the formulation of omega-3 is inhibiting the growth of omega-3 products into the
mainstream marketplace. In addition, multiple servings or doses may be necessary to
achieve an effective dose. However, the market for omega-3 is expected to grow as it is
successfully integrated into beverages, including juices and milk. This does not include the
market for food in which omega-3 occurs naturally, such as flaxseed, salmon, walnuts,
canola oil and cranberry seeds.
TABLE 41
GLOBAL NUTRACEUTICAL OMEGA-3 MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 6.0 6.5 9.5 7.9
Asia-Pacific 5.4 5.8 8.3 7.4
Total 17.4 18.7 26.5 7.2

The global omega-3 market was estimated to be $17.4 billion in 2015 and is expected to
reach $26.5 billion by 2021, growing at a CAGR of 7.2% from 2016 to 2021.
In 2015, the global omega-3 market was dominated by Europe and Asia-Pacific, with
estimated 34.5% and 31.0% shares, respectively. Omega-3 is the most consumed
ingredient as compared with fiber because of its wide-ranging applications in food,
pharmaceuticals and dietary supplements. Various health concerns such as obesity,
cardiac failure and neural disorders are driving the consumers toward nutraceuticals that
contain omega-3 fatty acids as a main ingredient.
The European omega-3 market was estimated to be $6.0 billion in 2015 and is expected to
reach $9.5 billion by 2021, growing at a CAGR of 7.9% from 2016 to 2021. Consumers are
ready to spend premium amounts for quality nutraceutical products, which drive demand
for omega-3 fatty acids in Europe. Asia-Pacific’s market for omega-3 was estimated to be
$5.4 billion in 2015 and is expected to reach $8.3 billion by 2021, growing at a CAGR of
7.4% from 2016 to 2021. There is an increasing number of cardiac disorders due to
unhealthy food habits owing to changing lifestyles of the people in the Asia-Pacific region.
Omega-3 fatty acids control the cholesterol, which is raising demand for them in the
Asia-Pacific region.
The North American omega-3 market was estimated to be $4.8 billion in 2015 and is
Supplements are the largest application segment that drives North America’s omega-3
market.
TABLE 42
GLOBAL NUTRACEUTICAL OMEGA-3 MARKET, BY PRODUCT TYPE, THROUGH 2021

($ BILLIONS)
CAGR%
Type 2015 2016 2021 2016–2021
Food 8.7 9.4 12.8 6.4
Total 17.4 18.7 26.5 7.2
In 2015, Beverages and supplements had a 50% share in the global nutraceutical omega-3
market.. The omega-3 based nutraceutical beverages and supplements market was
Companies in the food and beverages sector have successfully introduced omega-3
fortified products into the mass market. Of the total omega-3 based products in the
market, 50.0% are sold in supermarkets in the U.S. Several supplements manufacturers
are seeing in the area of 31.0% annual growth in their sales as people have become
conscious of the benefits of omega-3.

Various companies have launched or are launching omega-3 products in different market:
Pepsi-owned Tropicana launched orange juice with omega-3 in the U.S. market. Coca-Cola
introduced omega-3 rich orange, mango and passion fruit juice blends in Canada under its
Minute Maid Fruit Solutions brand. Dean Foods (White Wave) has come out with omega-3
rich Silk Plus to extend its brand. Major dairies such as Dannon, Muller and
FrieslandCampina are seeing increased sales of omega-3 fortified yogurts and other dairy
products. General Mills has added DHA to its Yoplait Kids product line in the U.S.
TABLE 43
GLOBAL NUTRACEUTICAL OMEGA-3-BASED FOOD MARKET, BY PRODUCT,

THROUGH 2021
($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Snacks 2.5 2.6 3.6 6.7
Bakery 1.4 1.5 1.8 3.7
Meat 1.3 1.4 1.8 5.2
Cheese 0.1 0.3 0.4 5.9
Total 8.7 9.4 12.8 6.4
Confectionery accounted for the largest share of the overall nutraceutical omega-3 food
market with a 34.5% share worth $3.0 billion in 2015 and is expected to reach $4.7 billion
in 2021, growing at a CAGR of 8.0% from 2016 to 2021. Snacks commanded the
second-largest market share with 28.7% of the overall nutraceutical omega-3 food market
in 2015 at $2.5 billion and the category is expected to reach $3.6 billion in 2021, growing
at a CAGR of 6.7% from 2016 to 2021. The cheese market is the lowest in terms of value.
There has been a significant consumer movement in recent years to remove trans fats
from foods. Dairy ingredients group Land O’Lakes, vegetable oil producer Bunge, DuPont’s
Pioneer Hi-Bred subsidiary and the U.S.-based Asoyia are supplying omega-3 ingredients
to food manufacturers to help them remove trans fats from their formulations. McDonald’s
now uses a blend of canola, corn and soybean oils to cook fries and other products in an
effort to minimize trans fats.
Flax is a cheaper vegetarian source of omega-3 and is found in the ALA form, which
converts to EPA and DHA in the human body. Flax is gaining in recognition, and companies
are now developing innovative products to efficiently combine it with fish oils, which are a
more efficient source of omega-3s. A better source of vegetarian omega-3 is the algae
that are grown outside the ocean. One of the main advantages of using this source of
omega-3 is that its formulations eliminate the challenges inherent in combining fish and
flax oils. The other main vegetarian source of omega-3 is Croda (Seatons) vegetable oil.

Canada-based Ocean Nutrition Canada, U.S.-based Martek Biosciences and Cargill are
prominent companies manufacturing omega-3 products.
TABLE 44
OTHER MAJOR OMEGA-3 PRODUCTS
Company/Organization Omega-3 Initiative

Unilever’s Best Foods’ and Hellmann’s An excellent source of omega-3 (ALA) and
Canola Real Mayonnaise omega-6 fatty acids (LA) and no trans fats.
United Soybean Boards Encourages companies using soybean oil to
prominently display its health benefits on
their product packages.
Unilever’s Promise Margarine “Omega-3, ALA and no trans fat” on the
label.
Arnold Foods Co.’s 100% whole wheat bread Product is high in omega-3s
with DHA/EPA omega-3 fatty acids
Edensoy Extra Organic Vanilla Soymilk Omega-6 fortified product.
Kellogg will use Martek Bioscience’s DHA In future products as well as in Monsanto’s
Vestive low-linolenic soybeans.
IAMS Smart Puppy Formula and Nestle’s Have added omega-3 fatty acids to their
Purina One foods.
Bumble Bee Introduced a Bumble Bee omega-3 and -6
fish oil supplement.
Chicken of the Sea Flagged its natural omega-3 content on its
smoked Pacific Smoked Salmon pouches.
Barilla America Inc.’s Barilla Plus line This product line is rich in heart-healthy
omega-3s.
PROTEIN AND PEPTIDES
All proteins are comprised of 20 naturally occurring amino acids, nine of which are
absolutely essential for the human body. These nutraceutical products are used in the
weight and sports/energy sector, which has been a major growth driver for the
nutraceutical industry. Proteins are essential for muscle tissue, and the ingredient can also
help promote satiety and thus control weight. Proteins are also versatile and can be
delivered in foods, powders, beverages and gels.
The sport and weight management categories continue to lead the growth in protein
product sales as consumers seek to add or maintain weight and muscle mass. More
products targeting the weight management market are combining fiber and protein, based
on the ability of protein to promote satiety. Nearly one-third of weight management
products are manufactured with a combination of fiber and protein, though certain
products have only high-protein or high-fiber ingredients.

There is a growing market demand for a complete sports drink with a combination of
carbohydrates and protein to promote sports performance along with muscle recovery and
regeneration. Sports drinks typically rely heavily on protein, and this ingredient has driven
significant growth in this market. Manufacturers are seeking novel ways to approach the
market. DSM Food Specialties manufactures PeptoPro protein hydrolysate with protein in
the form of peptides that are connected amino acids that are easily absorbed by the
human body. Ireland-based Glanbia Nutritionals manufactures the citrus-flavored recovery
drink Provon Revive, popular in the hybrid carbohydrate and protein sports drinks market.
TABLE 45
GLOBAL PROTEIN AND PEPTIDES MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 5.0 5.3 7.5 7.2
Asia-Pacific 4.4 4.7 6.8 7.7
Total 15.7 16.9 23.9 7.2
The global protein and peptides market was estimated to be $15.7 billion in 2015 and is
expected to reach $23.9 billion by 2021, growing at a CAGR of 7.2% from 2016 to 2021. In
2015, the global protein and peptides market was dominated by North America and
Europe, with estimated 36.3% and 31.8% shares, respectively. The North American protein
and peptides market was estimated to be $5.7 billion in 2015 and is expected to reach
$8.7 billion by 2021, growing at a CAGR of 7.4% from 2016 to 2021.
The European protein and peptides market was estimated to be $5.0 billion in 2015 and is
expected to reach nearly $7.5 billion by 2021, growing at a CAGR of 7.2% from 2016 to
2021. The Asia-Pacific protein and peptide market was estimated to be $4.4 billion in 2015
2021.
TABLE 46
GLOBAL PROTEIN AND PEPTIDES MARKET, BY PRODUCT TYPE, THROUGH 2021

($ BILLIONS)
CAGR%
Type 2015 2016 2021 2016–2021
Food 14.1 15.2 21.2 6.9
Total 15.7 16.9 23.9 7.2

Foods dominate the global nutraceutical protein and peptide market with 89.8% of share
in 2015. The protein- and peptide-based nutraceutical food market was estimated to be
$14.1 billion in 2015 and is expected to reach nearly $21.2 billion by 2021, growing at a
CAGR of 6.9% from 2016 to 2021. Despite beverages and supplements’ second position in
the protein and peptide market, it will grow faster than the foods market in the coming
years with a CAGR of 9.7%.
TABLE 47
GLOBAL PROTEIN- AND PEPTIDE-BASED FOOD MARKET, BY PRODUCT, THROUGH

2021
($ BILLIONS)
CAGR%
Type 2015 2016 2021 2016–2021
Bakery 2.6 2.8 4.0 7.4
Snacks 2.5 2.7 3.8 7.1
Meat 2.4 2.6 3.7 7.3
Cheese 1.1 1.2 1.5 4.6
Total 14.1 15.2 21.2 6.9
Confectionery accounted for the largest share of overall nutraceutical protein and peptide
food market with a 25.5% share worth $3.6 billion in 2015, which is expected to reach
$5.5 billion in 2021, growing at a CAGR of 7.1% from 2016 to 2021. Bakery commanded
the second-largest market share with 18.4% of the overall nutraceutical protein and
peptide food market in 2015 at $2.6 billion and is expected to reach $4.0 billion in 2021,
growing at a CAGR of 7.4% from 2016 to 2021. However, the meat market, which has the
second highest CAGR at 7.3%, is expected to reach $3.7 billion by 2021, accounting for
17.0% of the market in the last year of the forecast. This growth is occurring due to the
fact of more poor countries becoming industrialized as well as to increases in overall meat
demand.
PROTEIN TYPES
The important protein sources are animal proteins, soy and whey. Currently, animal
proteins dominate the market with an estimated market share near 70.0%. A more
health-conscious generation is increasingly favoring healthier plant proteins, which are
safer and cheaper than animal proteins. For example, gelatin is now being replaced by
plant proteins in many products. Soy plant protein is the cheapest and is now being used
along with milk proteins in the manufacturing of dairy products.

Soy Protein
Soy protein derived from plants is the preferred choice of the health-conscious market due
to its perception as being safer than animal protein. The market for soy products is
steadily growing with the U.S. and Canadian markets and becoming prime movers of the
products. Soy products are becoming popular because they are gluten-free and can be
substituted for wheat. More than 3,000 new soy products were introduced in the U.S.
market between 2000 and 2015.
Soy is also making inroads into the health drink market. Soy proteins are more viscous
than dairy products but are not highly soluble. In beverages, use of a soy isolate is more
typical due to the higher protein content. Isolates have 90% protein, concentrates are
around 65% to 70% and flours are in the 50% range. Soy milk is a popular alternative for
consumers seeking dairy-free alternatives. In addition to the original milk flavor, soy milk
comes in vanilla, strawberry, chocolate and eggnog. There are nonfat, low-fat and lite
varieties of several brands on the market, but the fat is mostly unsaturated.
Whey
The protein by-product called whey is gaining in popularity, specifically in the sports sector
due to its high nutritional value and cheaper price point as compared to other ingredients.
Though overall demand is lower, the product has an attractive profit margin. Whey
products include whey protein concentrates (WPC) and whey protein isolates (WPI), which
are used to formulate beverages throughout the world. The products are gaining
popularity in Asia, especially in Japan, as dietary and nutritional supplements in dietary
formulas, sports foods and infant preparations.
As the protein level increases, the functionality of the whey protein also increases.
Inclusion of whey in products gives benefits like heat stability, acid stability, gelatin
functionality and emulsification. Whey is natural and is used by food manufacturers to
replace artificial additives in their products. The whey market in the U.S. is more than
double the next best-selling animal protein, casein.
Whey is comprised of protein, lactose (milk sugar), minerals (calcium, phosphorus and
magnesium) and fat. Whey protein contains alpha-lactalbumin, beta-lactoglobulin, bovine
serum albumin, heavy- and light-chain immunoglobulins (Igs) and protease-peptones.
Whey is now included in juices, beverage mixes, enhanced waters and teas. There is also
evidence that manufacturers will soon add whey to soft drinks. As whey protein is rich in
highly soluble amino acids and whey protein isolates, it lends itself well to drinks in
comparison to other proteins. Whey is now a common ingredient in smoothies, which are
growing in popularity in many markets, including the U.S. The biological components of
whey, including lactoferrin, beta-lactoglobulin, alpha-lactalbumin, glycomacropeptide and
immunoglobulins, have a range of immune-enhancing properties. Whey can act as an
antioxidant, antihypertensive, antitumor, hypolipidemic, antiviral, antibacterial and
chelating agent.
Companies have begun fortifying products such as snacks, cereals, confections, beverages
and meats with whey proteins and other bioactive ingredients to improve nutrition claims

and to make them more attractive to health-conscious consumers. Whey protein is also
used in gels as it helps the controlled release of bioactives. Manufacturers are marketing
whey products as an effective aid for weight loss.
AMINO ACIDS
Amino acids are increasingly replacing proteins since they don’t require being broken
down. To absorb proteins, the body needs to break them down into individual amino acids.
This process can often cause discomfort to the user. As a result, companies are
increasingly focusing on the development and manufacture of products based on amino
acids. The U.S. and Japanese markets are currently seeing rising demand for such
products. Research has shown that athletes have seen improved performances after
including the branched-chain amino acids (BCAAs) leucine, isoleucine and valine in their
dietary program. Some of the leading amino acids companies are Ajinomoto Group,
Glutamate (MSG), Kyowa Hakko, Degussa, ADM, BASF and Adessio.
Other major protein products along with manufacturers and respective ingredients are
shown in the below table.
TABLE 48
OTHER MAJOR PROTEIN PRODUCTS
Protein
Company Ingredient Product Comment
DSM InsuVital Functional food InsuVital, which was introduced
several months ago in Europe, is
a hydrolyzed protein derived
from casein. DSM is positioning it
as a natural ingredient to help
control blood sugar levels after
meals; the company is tapping
into the pre-diabetic market.

ADM Prolite 100 Cereal products Prolite 100 has been specifically
and developed for improved taste
Prolite 200 and texture in reduced-sugar
applications such as sweet goods,
fillings and desserts. Prolite 200
is better suited to low- sugar
bakery applications, frozen
dough and batter systems, and
reduced egg and dairy products.
NutriSoy Soy products An all-natural, high-quality,
cholesterol-free soy protein
ingredient that contains virtually
every essential amino acid.
SmartBind Bakery products Natural wheat proteins that are
an extension of the Prolite line
and can be used in health and
wellness applications such as
nutrition bars, cereal coatings
and whole-grain baked goods as
well as microwavable bakery
products.
Rice protein Gluten-free breakfast In meat coatings, rice protein can
at cereals, cereal bars, meat enhance the crunchiness after
70% protein coatings, rice and pasta frying.
applications.
AHD Luravida Baked goods, snacks, bars, The cranberry protein powder is
cranberry smoothies, protein blends produced using a patented cold
powder and dietary supplements. extrusion and filtration process of
the seeds of the American
cranberry. No enzymes or
extraction solvents are used in
this process. The new ingredient
contains 23% to 30% protein, 5%
to 20% soluble fiber and 40% to
47% insoluble fiber.
Kerry Group Pea protein, The main use of the pea Companies are relying on
30% to 80% protein is expected to be non-allergen sources of protein.
protein in nutritional bars, which
content, typically contain between
mainly for 8 g and 15 g of protein per
bars. serving.

Burcon Canola Supertein’solubility profile Mainly targeting vegetarians or

NutraScience Supertein also lends itself well to vegans. Burcon has seven
Corp. and beverage applications, patents in protein ingredients
Puratein and particularly low pH and is testing the product with
flax protein beverages in which ADM.
isolates traditional protein
ingredients experience
challenges.
Clarisoy soy A unique soy protein This soy protein isolate has good
protein isolate that is 100% flavor characteristics and is
isolate soluble and transparent in heatstable, permitting hot fill
acidic solutions, enabling applications. Beverage and food
food and beverage makers use the hot fill method
applications down to pH for filling containers for the
2.5 and lower. purposes of prolonging shelf life
and usually not requiring
refrigeration.
PHYTOCHEMICALS
All other bioactive ingredients are categorized as phytochemicals with the exclusion of
dietary fiber and prebiotics. The number of identified phytochemicals has increased in the
last decade. Some groups of phytochemicals with significant health potential include
carotenoids, phenolic compounds (flavonoids, phytoestrogens, phenolic acids),
phytosterols and phytostanols, tocotrienols, organosulfur compounds (allium compounds
and glucosinolates) and nondigestible carbohydrates (dietary fiber and prebiotics).
Lycopene, lutein and resveratrol have started to rise in popularity and will be in the next
wave of phytochemicals, after green tea, to gain mainstream recognition. Flavonoids and
carotenoids are just moving beyond the specialty/health food channel, while anthocyanins,
zeaxanthins and polyphenols are firmly entrenched in the health food arena.
Phytochemicals are finally moving into the mainstream market, and interest in
antioxidants is helping the products gain recognition among health-conscious consumers.
TABLE 49
GLOBAL NUTRACEUTICAL PHYTOCHEMICAL MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 6.6 7.0 8.8 4.7
Asia-Pacific 5.7 6.2 7.5 3.9
Total 21.2 22.8 27.4 3.7

The global phytochemical market was estimated to be $21.2 billion in 2015 and is
2015, global phytochemical market was dominated by North America and Europe, with
estimated 34.9% and 31.1% shares, respectively. The North American phytochemical
2021, growing at a CAGR of 2.8% from 2016 to 2021. The European phytochemical market
was estimated to be $6.6 billion in 2015 and is expected to reach $8.8 billion by 2021,
growing at a CAGR of 4.7% from 2016 to 2021. Asia-Pacific’s phytochemical market was
estimated to be $5.7 billion in 2015 and is expected to reach $7.5 billion by 2021, growing
at a CAGR of 3.9% from 2016 to 2021.
TABLE 50
GLOBAL NUTRACEUTICAL PHYTOCHEMICAL MARKET, BY PRODUCT TYPE,

THROUGH 2021
($ BILLIONS)
CAGR%
Type 2015 2016 2021 2016–2021
Food 10.6 11.4 13.5 3.4
Beverages 7.0 7.6 9.6 4.8
Supplements 3.6 3.8 4.3 2.5
Total 21.2 22.8 27.4 3.7

Food dominates the global nutraceutical phytochemical market with 50.0% of share in
2015. The phytochemical-based nutraceutical food market was estimated to be $10.6
billion in 2015 and is expected to reach nearly $13.5 billion by 2021, growing at a CAGR of
3.4% from 2016 to 2021.
TABLE 51
GLOBAL NUTRACEUTICAL PHYTOCHEMICAL-BASED FOOD MARKET, BY PRODUCT,

THROUGH 2021
($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Bakery 1.6 1.7 1.9 2.2
Snacks 0.8 0.8 0.9 2.4
Cheese 0.6 0.7 0.8 2.7
Other 1.2 1.3 1.4 1.5
Total 10.6 11.4 13.5 3.4

Confectionery accounted for the largest share of the overall nutraceutical phytochemical
food market with a 48.1% share worth $5.1 billion in 2015 and is expected to reach $6.9
billion in 2021, growing at a CAGR of 4.6% from 2016 to 2021. Bakery commanded the
second-largest market share with 15.1% of the overall nutraceutical phytochemical food
market in 2015 at $1.6 billion and is expected to reach $1.9 billion in 2021, growing at a
CAGR of 2.2% from 2016 to 2021.
TABLE 52
GLOBAL NUTRACEUTICAL PHYTOCHEMICAL-BASED BEVERAGE MARKET, BY

PRODUCT, THROUGH 2021
($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Dairy drinks 2.2 2.3 2.9 4.7
Frozen juice 1.1 1.2 1.5 4.6
Tea 0.9 1.0 1.1 1.9
Other 0.4 0.5 0.6 3.7
Total 7.0 7.6 9.6 4.8
Noncarbonated drinks accounted for the largest share of the overall nutraceutical
phytochemical beverage market with a 34.3% share worth $2.4 billion in 2015 and are
expected to reach $3.5 billion in 2021, growing at a CAGR of 6.1% from 2016 to 2021.
Although noncarbonated drinks is the largest market in nutraceutical phytochemical
beverages, carbonated cola beverages are losing popularity due to increasing health
conscious among the people.
Dairy drinks commanded the second-largest market share with 31.4% of the overall
nutraceutical phytochemical beverage market in 2015 at $2.2 billion and is expected to
reach $2.9 billion in 2021, growing at a CAGR of 4.7% from 2016 to 2021.
PLANT STEROLS
Plant sterols and plant stanols are called phytosterols. Plant sterols are plant compounds
with chemical structures similar to that of cholesterol, whereas plant stanols exist in more
concentrated form. Rice bran, wheat germ, corn oils and soybeans contain high levels of
sterol.
Consumers would likely be willing to utilize lower-priced nutraceutical alternatives rather

than prescription drugs to combat high cholesterol if effective alternatives were presented.
These products could also be used in combination with prescription therapies.

TABLE 53
MAJOR PLANT STEROLS PRODUCTS
Brand
Manu-facturer Name Composition Source Products
ADM CardioAid Sterols, sterol Vegetable oil,
Europe: spreads, yogurt
esters mostly fromdrinks, milk drinks
soybeans U.S.: spreads,
supplements
Japan: oil
Cargill CoroWise Sterols, sterol Vegetable oil U.S.: Minute Maid
esters Premium
Heart Wise Orange Juice;
Rice Dream Heart Wise
Rice Milk; GNC Heart
Advance dietary
supplement; Lifetime
low-fat cheeses
Cognis Vegapure Sterol esters Vegetable oil South America: milk
from rapeseed, Japan, Korea: salad oils,
sunflower, corn, drinks Europe: yogurts,
soybeans spreads, milk
FMI Holdings Reducol Non-GMO sterols, Tall oil pitch U.S.: dietary supplement
Ltd. stanols CholestOff by Nature
Made
Raisio Life Benecol Stanol esters Vegetable oil, Germany, Greece:
Sciences wood oil spreads
Teriaka Diminicol Non-GMO Tall oil Germany, Portugal:
sterols yogurt
drinks Spain, Portugal:
milk drinks Korea: yogurt
drinks
ANTIOXIDANTS
With affluent health-conscious consumers ready to spend money on products containing

antioxidants, several companies are introducing new products that exploit the ingredient.
The anti-aging effects and preventive properties of antioxidants have created a consumer
explosion, which has resulted in the growth of the global antioxidants market.
One major trend has been chocolate companies increasing antioxidant levels in their
products. Examples include Hershey’s Natural Flavanol Antioxidant Milk Chocolate in the
U.S. Some juice companies are also introducing “super” juices in various flavor profiles
that boast high levels of antioxidants. According to a Norwegian-U.S. study, “Spending on
antioxidants in health activists’ markets was estimated to be among the highest of all
health-related categories in terms of year-over-year growth.” The most popular product in
the antioxidant segment is currently liquid tea.

Important health products launched by some companies are shown in the below table.
TABLE 54
MAJOR ANTIOXIDANTS PRODUCTS

Minute Maid Juice blends 3 g of protein per serving and no sugar
Dole Food Co. Superfoods antioxidant Superfoods education campaigns, with
and Superfoods for package logos that help shoppers identify
immunity health benefits.
Starbucks Tazo Green Tea Latte and Omega-3 fortified.
a Blackberry Green Tea
Frappuccino blended
beverage
Hershey Co. Special Dark and Extra Higher levels of flavonols than regular dark
Dark Chocolates chocolates.
Lipton Teas Tea Lipton teas sport a trade named antioxidant
Unilever U.S. AOX Seal to tell shoppers that tea is a natural
source of antioxidants and that green and
black teas both have antioxidants.
Due to their unique properties, antioxidants act as cell protectors and can prevent the
occurrence of several diseases, including cancer and heart disease. They also offer
protection from high cholesterol and bring down triglyceride levels. Antioxidants also boost
the immune system and reduce risk of memory loss and dementia in older adults. They
are used in beauty treatments as they improve skin texture, reduce dryness of the skin
and reduce the fine lines that come with age.
The antioxidant market, particularly in the area of superfruits, is growing. Beverages

containing superfruits such as pomegranate or acai are healthy and provide good taste
profiles. While supplements incorporating botanicals such as cranberry, pomegranate and
red grapes are accelerating and offering opportunities for premium pricing, the markets
for vitamins C and E are slowing and exhibiting increased competition.
Various nutraceutical ingredients are shown in the below table.
TABLE 55
MAJOR NUTRACEUTICAL INGREDIENTS
Type Ingredients
Vitamins Vitamins C, B1, B2, B6, B12, folic acid, niacin, biotin, pantothenic
acid, Vitamins A, E, K, D and beta-carotene
PUFA/ specialty lipids DHA/EPA, ARA, GLA, CLA and structured lipids

Phytochemicals Phytosterols, Isoflavones, lignans, polyphenols, tocotrienols and

isothiocyanates
Prebiotics FOS, inulin, GOS, poly-dextrose and other oligosaccharides
Minerals Calcium, magnesium, zinc, iron, sodium, potassium and
selenium
Amino acids, peptides, Arginine, glutamic acid, lysine, leucine, isoleucine, valine,
proteins lactoferrin, immuno-globulins, bioactive peptides and digestive
enzymes
Fibers Inulin, poly-dextrose, beta-glucan, resistant starch, gums,
pectins,
resistant maltodextrin, psyllium, insoluble fibers
Carotenoids Beta-carotene, lycopene, lutein, zeaxanthin, astaxanthin
Polyols Xylitol, lactitol, isomalt, maltitol
Other CoQ10, glucosamine, chondroitin, lipoic acid, inositol

Chapter 6
NUTRACEUTICAL MARKET BY
APPLICATIONS
FOD013F
March 2017
Natraj Pandal
Project Analyst
ISBN: 1-62296-448-9
BCC Research
or (+1) 781-489-7301
www.bccresearch.com
CHAPTER 6
NUTRACEUTICAL MARKET BY APPLICATIONS
The market size for each health application includes both regulated and non regulated
health claims. Weight management includes products for boosting fat-burning/thermo
genesis, inhibiting protein breakdown, suppressing appetite/ boosting satiety (feeling of
fullness), blocking fat absorption and regulating mood.
The heart health market includes products that promote lower cholesterol and blood
pressure (BP) and fight against cardiovascular diseases. Gastrointestinal and digestive
health also considers the gut health market. The general wellness market includes foods
that promote better health outside of the specific categories shown in the following table.
The nutraceutical global application market is categorized as follows:
● Sports and energy.

● General wellness.
● Weight management.
● Heart health.
● GI and digestive health.
● Beauty and aging.
● Type 2 diabetes.
● Memory and mental health.
TABLE 56
GLOBAL NUTRACEUTICAL MARKET, BY APPLICATION, THROUGH 2021

($ BILLIONS)
CAGR%
Application 2015 2016 2021 2016–2021
Sports and energy 61.1 65.6 98.6 8.5
General wellness 28.0 30.2 40.5 6.0
Weight management 26.3 28.2 39.6 7.0
Heart health 25.9 27.8 39.9 7.5
GI and digestive health 22.9 24.6 36.2 8.0
Beauty and aging 11.5 12.3 16.0 5.4
Type 2 diabetes 5.6 6.0 8.8 8.0
Memory and mental health 3.7 4.0 5.4 6.2
Total 185.0 198.7 285.0 7.5
The sports and energy application accounted for the largest share with 33.0% of the
overall nutraceutical market at $61.1 billion in 2015. This application is expected to reach
nearly $98.6 billion in 2021, growing at a CAGR of 8.5% from 2016 to 2021. The general
wellness had the second-largest share of the overall nutraceutical market in 2015 with a
15.1% share, worth $28.0 billion in 2015 and is expected to reach $40.5 billion in 2021,

growing at a CAGR of 6.0% from 2016 to 2021. The weight management had the
third-largest share of the overall nutraceutical market in 2015 with a 14.2% share, worth
$26.3 billion in 2015 and is expected to reach $39.6 billion in 2021, growing at a CAGR of
7.0% from 2016 to 2021.
The heart health application accounted for the fourth-largest share with a 14.0% of the
overall nutraceutical market at $25.9 billion in 2015 and is expected to reach nearly $39.9
billion in 2021, growing at a CAGR of 7.5% from 2016 to 2021 due to an increase in
occurrence of heart disease and a rise in the number of health-conscious consumers. GI
and digestive health, beauty and aging, type 2 diabetes, and memory and mental health
applications together accounted for 23.6% of the global nutraceutical market in 2015.
SPORTS AND ENERGY
Sports and energy is one of the fastest growing and most highly specialized niches for the
overall functional foods and beverage market. With a continuing flood of young adults
entering the sports world globally, the sports and energy beverage market is accelerating
to keep pace with demand. The market is dominated by energy drinks, which is one of the
fastest selling categories in mass market retail outlets. Energy sodas and fruit-based
drinks are increasingly in demand, such as Blue Sky’s Blue Energy Soda and Bossa Nova
Beverages’ Amazon rainforest fruit drinks in Guarana Berry and Natural Energy.
Sports and energy drinks are enjoying greater distribution in supermarkets and other mass
retail outlets. Big players are making a foray into this segment after seeing the immense
success of blockbuster drinks like Red Bull. Sports and energy drinks offer the lucrative
combination or premium pricing and mass market appeal. Efforts by heavyweights such as
Pepsi and Coca-Cola in the sport and energy drink sector have not yet achieved great
success in comparison to Red Bull, but the attraction of the opportunity will persuade them
to continue their efforts.
There is great opportunity for innovation in sports and energy products. The diversity of
consumer needs and desires has created more potential for newer formulations of foods
and beverages that target specific lifestyles and specialized niches. Products that uniquely
target a specific need or a particular problem make the consumer purchase decision
easier.
The sports and energy drink market is currently focused predominantly on male
consumers. Some companies, however, are beginning to focus on the lucrative and
untapped market for energy drinks targeted for women. Women are now perceived as
needing more energy for lives that often include careers along with household and other
responsibilities. In addition, an increasing number of females are dedicating themselves to
health and sports activities. These factors make it logical for companies to undertake
product development, marketing and rebranding to appeal to the female segment.
Manufacturers have started positioning their female-oriented products with buzzwords like
“light,” “sugar-free,” “low-carb,” and so forth that have proven effective in marketing
other products to female consumers.

TABLE 57
GLOBAL SPORTS AND ENERGY MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
North America 19.8 21.3 30.9 7.7
Europe 20.0 21.5 32.5 8.6
Asia-Pacific 18.0 19.3 30.4 9.5
Total 61.1 65.6 98.6 8.5
In 2015, the global sports and energy market was dominated by Europe and North
America, with estimated 32.7% and 32.4% shares, respectively. The European sports and
energy market was estimated to be $20.0 billion in 2015 and is expected to reach $32.5
billion by 2021, growing at a CAGR of 8.6% from 2016 to 2021. U.K., Germany and France
are driving growth for the European sports and energy market.
The North American sports and energy market was estimated to be $19.8 billion in 2015
and is expected to reach nearly $30.9 billion by 2021, growing at a CAGR of 7.7% from
2016 to 2021. The Asia-Pacific sports and energy market was estimated to be $18.0 billion
in 2015 and is expected to reach $30.4 billion by 2021, growing at a CAGR of 9.5% from
2016 to 2021. Consumption of sports and energy drinks is rising in the Asia-Pacific market,
leading to a high rate sales forecast for Japan, China and Vietnam—a CAGR of 11.0% from
2016 to 2021.
There are several functional products for sports and energy in the market that include
sports drinks, confectionery, fruit bars and yogurts. Red Bull is the clear market leader,
and the Austrian product Dark Dog holds a leading position in Chile, Paraguay and France.
The majority of the players in the market, such as Pepsi, Coca-Cola, Dannon and
GlaxoSmithKline, target either the beverage market or the functional food segment. The
Japanese market is dominated by local companies such as Taisho, which has Lipovitan as
its signature brand.
Leading confectionery market companies include Paso Doble, Spice’n’bong and Energesso.
Hot Fuel from Nitrous Express (NX) located in Texas is meant to be mixed with colas and
other beverages and contains ginseng, guarana and fruity sour cherry. Tropical Buzz with
ginseng extract and tropical flavorings, and superfruit booster with blueberry, cranberry,
green tea and l-carnitine, are the leading fruit bars. Isotonic drinks such as Lucozade Sport,
POWERade and Gatorade dominate the U.K. sports beverage market. PepsiCo’s Gatorade
and Aquarius and Coca-Cola’s POWERade are not only consumed in the sports market but
also cross over into the soft drink market.

TABLE 58
OTHER SPORTS AND ENERGY PRODUCTS AND INGREDIENTS
Company Product/Ingredient Remarks

Tate & Lyle Sports drink Designed specifically for beverages that claim
to replenish water and minerals in the body
before, during and after exercise.
Tate & Lyle Sweetening solution for Helps the development of better-tasting
isotonic sports drinks isotonic sports drinks and also provides
technical benefits to beverage manufacturers.
Danisco A range of sports drinks Uses water-soluble citrus flavors and is
fortified with healthy ingredients; targeted at
the Asian market.
Danisco A line of light beverages. The beverages formulated for women and
fortified with vitamins and minerals; they
contain blend of sugar and artificial
sweeteners.
GENERAL WELLNESS
Celiac disease is an autoimmune disorder of the small intestine that occurs in genetically
predisposed people of all ages from middle infancy onward. According to the U.S.
Department of Agriculture (USDA), the gluten-free market is expected to reach $6.2 billion
in 2018, as one in 133 consumers suffers from celiac disease. The global gluten-free
market is dominated by North America with 59.2% of share in 2015. The gluten-free
bakery and confectionery is the largest segment in the market with more than 46.3% of
the total gluten-free market in terms of volume, followed by gluten-free snacks with a
20.0% share in 2015. The disorder is also prevalent in Italy where one in 250 people are
affected, with one in 300 people reporting the issue in Ireland. This makes Europe another
key market for gluten-free product offerings.
TABLE 59
GLOBAL GENERAL WELLNESS MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
North America 12.5 13.5 17.2 5.0
Europe 6.3 6.7 9.8 7.9
Asia-Pacific 6.7 7.2 9.1 4.8
Total 28.0 30.2 40.5 6.0

In 2015, global general wellness market was dominated by North America and Asia-Pacific,
with estimated 44.6% and 23.9% shares, respectively. The North American general
wellness market was estimated to be $12.5 billion in 2015 and is expected to reach $17.2
The Asia-Pacific general wellness market was estimated to be $6.7 billion in 2015 and is
European general wellness market was estimated to be $6.3 billion in 2015 and is
2021.
WEIGHT MANAGEMENT
The North American weight loss market is more than 3.1 times larger than the European
market, and it is expected to reach $23.6 billion by the end of 2021. The staggering
increase in the incidence and degree of obesity in the North American and European
markets has created a huge market opportunity for weight loss products manufacturers.
The market is divided into five categories, depending on the specific mechanism of action:
boosting fat burning/thermo genesis, inhibiting protein breakdown, suppressing
appetite/boosting satiety (feeling of fullness), blocking fat absorption and regulating mood,
which is linked to food consumption.
Snack bars, ice cream, cakes, biscuits, croissants, smoothies, soups, sandwich breads,
sausages and shakes are the most popular products for delivering weight loss benefits.
TABLE 60
GLOBAL WEIGHT MANAGEMENT APPLICATION MARKET, BY REGION, THROUGH

2021
($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
North America 15.4 16.5 23.6 7.4
Europe 5.1 5.5 7.3 5.8
Asia-Pacific 5.5 5.9 8.3 7.1
Total 26.3 28.2 39.6 7.0
In 2015, global weight management market was dominated by North America and
Asia-Pacific, with estimated 58.6% and 20.9% shares, respectively. The North American
weight management market was estimated to be $15.4 billion in 2015 and is expected to

Asia-Pacific’s weight management market was estimated to be $5.5 billion in 2015 and is
European weight management market was estimated to be $5.1 billion in 2015 and is
FUNCTIONAL BREAKFAST
Weight management product manufacturers are focusing major marketing efforts on

functional breakfast foods or snacks. People do not tend to skip breakfast even if they do
skip other meals during the day, but they tend to look for quick and easy breakfast
solutions. Cereal food bars are the most popular targeted functional breakfast as they
provide a convenient alternative related to a breakfast staple. Kraft has launched a
successful line of cereal bars based on the South Beach Diet name that promotes a natural
option based on lean protein, whole grains, vegetables, fiber-rich carbs and unsaturated
fats.
Despite the fact that the market has several products with GRAS (generally recognized as
safe) status that have proven their health claims of successful weight management to
some degree, it lacks a single product proven to provide 100% results. Safety is another
issue associated with currently available products, and potential side effects of these
weight management solutions are still unclear and feared by the general public.
Consumers tend to experiment with multiple products rather than relying on any single
product in the absence of guaranteed results. Therefore, manufacturers and marketers of
weight management products are focusing on creating a product with proven efficacy that
has potential for blockbuster sales. Functional food manufacturers generally target women,
who have proven to be early adopters of weight management solutions.
SATIETY PRODUCTS
The global satiety products market is a leader within the category, with the U.S.
contributing more than 50.0% of total satiety product sales. Products meant for appetite
suppression include a host of protein derivatives like lactoferrin, whey, colostrum casein
and other such ingredients. Plants such as cactus and green tea are also an ideal source of
ingredients that help regulate lean body mass and boost metabolism. Several protein
friction suppliers offer food and protein supplements specially developed for increased
satiety. Ingredient suppliers and functional food manufacturing companies are so attracted
by the satiety effects of such ingredients that they are investing in production and
marketing efforts. Unilever invested $40.0 million to get sole rights to market the South
African fruit hoodia gordonii, which has enjoyed significant media attention based on its
perceived success in satiety and appetite suppression.

TABLE 61
MAJOR WEIGHT MANAGEMENT PRODUCTS
Company Product Remarks

Unilever Hungershots, a High protein levels; has 5 g of fiber from inulin in a
satiety drink one-shot drink.
Slim-fast Broad line of products and support to control hunger
and manage weight through personalized programs.
Lipton Linea iced tea The product is catechin-rich; aids proper fat
distribution and helps in weight management.
DSM SlimShots Dietary supplement that can be mixed with other
Nutritional foods and beverages like cereals, shakes, yogurt and
coffee.
Campina Optimel Control Drinking yogurt that contains DSM’s weight
yogurt drink management ingredient Fabuless.
Probiotic ingredients are gaining increasing popularity in the weight loss market because
they are water-soluble and offer low-calorie and low-sugar profiles. Ingredient
manufacturers are aggressively pursuing research to explore newer functional ingredients
and potential application expansions. Some of the companies’ functional ingredient
categories are shown in the below table.
TABLE 62
MAJOR WEIGHT MANAGEMENT FUNCTIONAL INGREDIENTS
Ingredient
Company Category Product Name Ingredient Remarks
Kemin 1. Weight loss Slendesta, Potato extract, The organization
2. Sweetener Welcose and glucose formula operates in 60
3. Food SHIELD. and food countries.
preservatives preservatives.
DSM Calorie intake Fabuless. Dietary lipids coated DSM has partnered
with galactolipids. with larger
companies
to promote this
ingredient.
Bio Serae- 1. Heart NeOpuntia, Cactus lipophilic Available in more
French healthand Cacti-Nea, IDalG, fiber and milk than 150 foods,
diabetes ViNitrox and protein. beverages
2. Weight Osteol. and supplements.
management
3. Bone
supplement

Berkem 1. Weight Polyphenols, Grape seed, green Deep expertise in

management Svetol, coffee extract. pine bark and grape
2. Mental stress Powergrape. seed extraction.
3. Heart health
4. Antiaging
Interhealth 1. Weight Super CitriMax Fruit extracts
The company is
management and containing mainly
2. Heart health Chrome-Mate. hydroxycitric acid,
focusing on the
3. Diabetes polynicotinate,
development of new
4. Joint collagen. ingredients and
supplement quality management
of resent
products. It has reach
in more than 30
countries and a range
of more than 600
products.
Cognis 1. Increase lean Betatene, Synthetic Cognis is a leading
body mass Coviox, Covitol, ingredients for supplier of innovative
2. Oxidation Lipoec, Xangold, dietary supplements specialty chemicals
and energy Tonalin, and food products and nutritional
burning in sleep Vegapure and with varied ingredients, with a
vitamins. compositions and particular focus on
concentrations. the areas of wellness
and sustainability.
The company
operates production
sites and service
centers in 30
countries.
HEART HEALTH
Cardiovascular disease (CVD) is the main killer in Western countries, and the disease is
especially acute in the North America and Europe due to dietary habits. Ingredients
offering a reduction in the risk factors for heart disease are increasingly popular in these
and other markets. According to the American Heart Association, around 80 million
Americans had cardiovascular diseases in 2010. More than half of global heart disease
cases are attributed to high cholesterol levels. Coronary heart disease in the U.S. alone
costs the $108.9 billion each year. CVDs cause over 50% of the deaths in Europe and
account for more than $200 billion in medical costs every year.
In addition to medical treatment and exercise, functional foods containing omega-3s and
vitamin E are gaining popularity as a strategy for disease prevention. These supplements
have become popular among the aging baby boomer generation as a preventive measure
for heart disease. Therefore, inclusion of ingredients such as cholesterol-fighting omega-3s
in functional products targeted to CVD is highly recommended. Fish-, plant- and nut-based
omega-3 oils are gaining popularity not only among heart patients but also among the
general health-conscious public. Naturally fortified products typically utilized include

low-cholesterol soy milk, canola, soy and olive oil enriched with vitamin E and omega-3s,
and fortified nut butters and toppings.
Hypertension is one additional major driver of increasing heart diseases. The Institute of
Medicine (IOM, an American non-profit, non-governmental organization founded in 1970
under the congressional charter of the National Academy of Sciences) estimates that one
in three Americans has high blood pressure, and one in six will die from complications
related to the condition. The number of people suffering from high blood pressure is
increasing not only in America but also in Asia-Pacific countries like Japan and India, where
diets are beginning to incorporate more unhealthy food options. Further, Calpis Co, a
Japanese functional food company, has introduced a milk peptide called AmealPeptide to
control blood pressure.
TABLE 63
GLOBAL HEART HEALTH APPLICATION MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
North America 12.6 13.5 21.0 9.2
Europe 5.8 6.2 8.2 5.8
Asia-Pacific 6.8 7.3 9.8 6.1
Total 25.9 27.8 39.9 7.5
In 2015, the global heart health market was dominated by North America and Asia-Pacific,
with estimated 48.6% and 26.3% shares, respectively. The North American heart health
2021, growing at a CAGR of 9.2% from 2016 to 2021.
Asia-Pacific’s heart health market was estimated to be $6.8 billion in 2015 and is expected
to reach $9.8 billion by 2021, growing at a CAGR of 6.1% from 2016 to 2021. The
European heart health market was estimated to be $5.8 billion in 2015 and is expected to
Functional food manufacturers have focused on omega-3s, whole grains and antioxidants
to formulate specialty health supplements targeting the heart health market. They are
planning to develop newer foods and beverage products enriched with these ingredients
to garner additional attention and purchases from consumers becoming more aware of the
dangers of heart disease. Phytochemicals including flavonoids and plant sterols, high fiber
and soy are the major ingredients for cholesterol reduction. Protein and peptides are the
major ingredients for blood pressure (BP) reduction. Omega-3s, antioxidants and reduced
sodium intake, vitamins E and D and Coenzyme Q10 are the major ingredients for
products aimed at contending with CVD disease.

TABLE 64
MAJOR HEART HEALTH FUNCTIONAL PRODUCTS BY APPLICATION
Application Company Products Remarks

Lowering Fennobon Fennobon Regular use of this chewable
cholesterol gum reduces cholesterol.
Lowering Eugene CZ cooking oil and The product uses CholZero
cholesterol Science Inc. cholesterol-lowering (CZ) plant sterols.
chocolate ice cream
Maintaining BP Heart Health Terra’s Lemon Pepper The product has 90% less
sodium.
Maintaining BP Elma Chips Elma Chips’ Sensacoes The product has 25% less
(PepsiCo) sodium.
Flavonoids, Xocai (MXI Flavonoid-rich dark Improves coronary function in
improved Corp.) chocolate healthy adults; improves
coronary oxidative stress parameters,
function blood pressure and lipid profile.
Heart health for Kellogg Smart Start The product has low sodium
women Strawberry and contains whole grain oats
Oat Bites and potassium.
Heart disease Prestat Choxi and bar The product is high in
and antioxidants and has natural
cancer compounds to fight against
heart diseases and cancer.
GI AND DIGESTIVE HEALTH
Apart from weight management, the digestive health, GI (gastrointestinal tract) and
immune system supplement market has emerged as the second best growth opportunity
for functional food companies. The National Digestive Diseases Information Clearinghouse
(NDDIC) estimates that 50 million to 70 million people in the U.S. suffered from digestive
problems in 2015. Fifty million suffer from heartburn; 15 million from irritable bowel
syndrome; and around 15 million from stomach ulcers.

TABLE 65
GLOBAL GI AND DIGESTIVE HEALTH APPLICATION MARKET, BY REGION,

THROUGH 2021
($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 5.2 5.5 7.6 6.7
Asia-Pacific 10.6 11.3 17.7 9.4
Total 22.9 24.6 36.2 8.0
In 2015, the global GI and digestive health market was dominated by Asia-Pacific and
North America, with estimated 46.3% and 24.5% shares, respectively. Asia-Pacific’s GI and
digestive health was estimated to be $10.6 billion in 2015 and is expected to reach $17.7
The North American GI and digestive health market was estimated to be $5.6 billion in
2015 and is expected to reach $8.7 billion by 2021, growing at a CAGR of 7.7% from 2016
to 2021. The European GI and digestive health market was estimated to be $5.2 billion in
2015 and is expected to reach nearly $7.6 billion by 2021, growing at a CAGR of 6.7%
from 2016 to 2021.
In Japan, more than 70.0% of sales for FOSHU products and almost 30.0% of sales of
non-FOSHU products are related to GI health. Probiotic products comprise the largest
segment of the functional food market for digestive health.
TABLE 66
MAJOR GI PRODUCTS
Company Products Remarks

Dannon Activia and ActimelThe sales growth for the Activia and Actimel will be
4.5% to 5.5% in 2016.
Skanemejerier ProViva The product has achieved annual growth in excess
of 30.0%.
Yakult Yakult 400, Yakult The world’s first probiotic product. The company
300V and Thorpedo has a presence in 32 countries and it claims that
more than 30 million people drink Yakult every day.

BEAUTY AND ANTI-AGING
Traditionally, most of the companies that are targeting functional foods for health
applications have expanded their focus to include beauty and anti-aging applications.
“Beauty from within” has emerged as a new trend in the health and cosmetics market,
allowing consumers to affect their appearance based on the foods they consume.
Functional food and cosmetic companies are working together more and more to develop
new functional foods and beverages for beauty and anti-aging applications.
Pioneering this trend, Nestle and L’Oreal jointly formed a new venture called Inneov to
develop and market nutritional supplements with cosmetic applications. As well, Danish
biotechnology firm Fluxome Sciences joined with CP Kelco to develop and commercialize
fermentation-derived resveratrol for the dietary supplement, food, beverage and
cosmetics markets. Coca-Cola established Yokuasa Purun especially for the Asian market
to offer a milk-based beverage fortified with cysteine, hyaluronic acid, ceramide, vitamin C
and biotin. A bedtime drink, the product claims to promote attractive skin with a soft,
velvety feel.
TABLE 67
GLOBAL BEAUTY AND ANTI-AGING MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 3.4 3.6 3.9 1.6
Asia-Pacific 2.9 3.1 4.5 7.7
Total 11.5 12.3 16.0 5.4
The global beauty and anti-aging market was estimated to be $11.5 billion in 2015 and is
2021. In 2015, global beauty and anti-aging market was dominated by North America and
Europe, with estimated 41.7% and 29.6% shares, respectively.
The North American beauty and anti-aging market was estimated to be $4.8 billion in 2015
2021. The European beauty and anti-aging market was estimated to be $3.4 billion in
to 2021. The Asia-Pacific beauty and anti-aging market was estimated to be $2.9 billion in
2015 and is expected to reach nearly $4.5 billion by 2021, growing at a CAGR of 7.7%
from 2016 to 2021.

Use of bioactive ingredients is increasing in cosmetic products for anti-aging and beauty
applications. However, the foods intended for beauty and anti-aging have yet to claim a
wide market share, and new product introductions have lagged behind those in other
market categories.
The functional FBS market for beauty applications is dominated by aloe vera with 53.0% of
the total market, followed by collagen at 33.0% and coenzyme Q10 at 14.0% in 2015. The
skin care segment dominates the U.S. cosmeceuticals market with more than 64.3% in
2015, followed by hair care with 19.1% and Other category with 16.6%. Skin care products,
which mainly include age-defying products, acne preparation, medicated lotions and sun
protection products, offer the greatest opportunities in this market. Increased awareness
of skin cancer dangers has helped drive growth in the sun protection market.
Lutein is one of the functional ingredients widely used in beauty products. Other
ingredients used by functional food manufacturers for anti-aging and beauty applications
are shown in the following table.
TABLE 68
ANTI-AGING AND BEAUTY INGREDIENTS AND APPLICATIONS
Ingredient Application and Remarks

Alpha lipoic acid (ALA) Used for reduction of fine lines and wrinkles, diminishes
pores and gives skin a healthy glow.
Alpha-hydroxy acid (AHA) Used to exfoliate the skin, reducing fine lines, age spots,
acne scars and irregular pigmentation.
Antioxidants To reduce free radicals that can cause wrinkles, dry skin,
dark circles under eyes and dull skin.
Caffeine To help fight skin cancer.
Dimethylaminoethanol (DMAE) To increase skin integrity.
Retinol A vitamin A derivative that promotes collagen production
and plumps out skin, reducing fine lines and wrinkles,
improves skin tone and color and reduces mottled
patches on the skin.
Rosmaric acid An antioxidant found in herbs.
Carotenoid LycoRed’s ingredient for skin-protecting supplements for
sunburn: a composition of lycopene, phytoene,
phytofluene and, optionally, vitamin E.
Lutein Part of the Cognis’s positioning for the “beauty from
within” market.

TABLE 69
MAJOR ANTI-AGING AND BEAUTY PRODUCTS

Danone Essensis This vitamin-rich beauty yogurt contains anti-aging
antioxidants.
Olay Regenerist Cream with high concentration of signature
amino-peptide complex infused with intracellular fortifier to
restore elasticity, volume and shape.
Magic Fruits Beauty Snacks Contain vitamins and micronutrients that enhance looks
and charisma; directly helps to achieve healthy skin and
strong hair.
BORBA Skin Balance Available in half a dozen varieties; contains zero-calorie
Water waters, rendered murky with pulverized vitamins, extracts
and other ingredients designed to improve the complexion.
University of Primula Contains more magnesium and iron and three times more
Naples with anti-aging fiber than ordinary pizza; eight vegetables or sauces,
La pizza. including tomato, rocket, garlic, basil, courgettes,
Fabbrica dei mushrooms, carrots and spinach; contains antiaging
Sapori antioxidants.
Regenesis Regenesis Pro High-tech nutraceutical product meant for anti-aging; to be
Health taken orally, the product stimulates growth hormones;
contains naturally-derived, biologically active growth
hormones in a special polymer matrix that is absorbed
directly into the cells of the oral mucosa and avoids
inactivation in the digestive process.
TYPE 2 DIABETES
Diabetes increased by one-third during the 1990s due to the growing obesity epidemic
and an aging population. The World Health Organization (WHO) has estimated that the
number of worldwide cases will soon reach more than 300 million, while the number was
only around 30 million two decades ago. The number is predicted to reach 380 million by
2025. According to American Diabetes Association, the number of people with diabetes in
North America and South America are expected to increase by 165.0% from 11 million in
2000 to 29 million in 2050.
Approximately 90% of the total diabetes cases are of the type-2 variety, which experts
believe can be effectively treated. Alzheimer’s, another disease that is increasing in
number, is being referred to as type 3 diabetes. Diabetes also has a massive effect on
health care budgets. The World Diabetes Foundation estimates that an average of 878
international dollars will be spent globally per person on diabetes healthcare. There is also
a vast economic impact from lost worker productivity as well. The EU Diabetes Working
Group has estimated that 8.6% of the European adult population suffers from diabetes.
This figure is projected to increase by 25.0% to 38 million by 2025.

Low-GI (glycemic index) foods help consumers maintain healthier blood sugar levels. Sales
of low-glycemic foods and beverages are expected to exceed the $3 billion mark in next
five years. Low-GI foods and beverages in the U.S. have been growing at a double-digit
annual growth rate with increased consumer awareness of their benefits.
TABLE 70
GLOBAL TYPE 2 DIABETES MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 1.3 1.4 1.8 5.2
Asia-Pacific 2.2 2.3 3.6 9.4
Total 5.6 6.0 8.8 8.0
The global type 2 diabetes market was estimated to be $5.6 billion in 2015 and is
2015, global type 2 diabetes market were dominated by Asia-Pacific and North America,
with estimated 39.3% and 35.7% shares, respectively.
Asia-Pacific’s type 2 diabetes market was estimated to be $2.2 billion in 2015 and is
North American type 2 diabetes market was estimated to be $2.0 billion in 2015 and is
European type 2 diabetes market was estimated to be $1.3 billion in 2015 and is expected
to reach $1.8 billion by 2021, growing at a CAGR of 5.2% from 2016 to 2021.
Presently, snacks, nutritional bars and meal-replacement bars control the low-glycemic
food and beverage market with an estimated 60% share. Beverages come in second with
approximately 30%. The remainder of the market is fragmented, with cookies proving to
be a significant category. Candies, frozen desserts and table sweeteners, making up a
“sweets” category, help round out the market. Because of the somewhat complex nature
and relatively low consumer understanding of phrases like “glycemic index” or “glycemic
response,” companies often avoid incorporating such phrases in their packaging. Sufficient
quantities of high-maize whole grain corn flour and Nutriose soluble fiber help in
controlling the blood sugar level.
A wide array of key bioactive ingredients have proven effective in combating diabetes,
including alpha-lipoic acid, bitter melon (Momordica charantia), cinnamon, hydroxycitric
acid (HCA), chromium, Maitake mushrooms, biotin; trace minerals selenium, zinc and
vanadium; fiber, fenugreek, resistant starch; beta-glucan, salba, tea, coffee, wine and
pomegranate.

Top-selling low-glycemic products includes Emmi’s Evolus, Gullon Maria Biscuits, Slim
Slammers, Dannon’s Danaten, Ab Kultura, FIFTY 50 food brands, Nom Mix diet, Yoplait
yogurt, Boost Diabetic, Glucerna Shakes, Diasense Multivitamin, Wellion Zimt Plus, Insulow,
Diabetes Formula and Nature Made’s Diabetes Health Pack.
MEMORY AND MENTAL HEALTH
More than 50% of new product development in mental health is being targeted at infants
and children. The different health claims made for the mental health category are mainly
in terms of “DHA supporting brain and eye development.” The market for mental health
supplements targeting the elderly is also growing due to an aging population and
increased fear of conditions such as Alzheimer’s disease that affect older consumers.
TABLE 71
GLOBAL MEMORY AND MENTAL HEALTH MARKET BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
Europe 1.0 1.1 1.5 6.4
Asia-Pacific 1.1 1.2 1.7 7.2
Total 3.7 4.0 5.4 6.2
The global memory and mental health market was estimated to be $3.7 billion in 2015 and
is expected to reach $5.4 billion by 2021, growing at a CAGR of 6.2% from 2016 to 2021.
In 2015, the global memory and mental health market were dominated by North America
and Asia-Pacific, with estimated 32.4% and 29.7%, respectively.
The North American memory and mental health market was estimated to be $1.2 billion in
to 2021. Asia-Pacific’s memory and mental health market was estimated to be $1.1 billion
in 2015 and is expected to reach $1.7 billion by 2021, growing at a CAGR of 7.2% from
2016 to 2021. The European memory and mental health market was estimated to be $1.0
billion in 2015 and is expected to reach $1.5 billion by 2021, growing at a CAGR of 6.4%
from 2016 to 2021.
The most popular memory product includes DHA (brain, eye development), Horizon
Organic milk, Yoplait Kids, Asturiana natural milk, Nutrisoda, GABA and superbitter GABA.
Another nutritional supplement suggested to improve memory is lecithin-derived
phospholipids. The worldwide leader in lecithin products, Lucas Meyer Group (Germany),
was acquired by international chemical firm SKW and incorporated into its bioactives unit.
Other nutritional ingredients that have been shown to aid memory are huperzine,
vinpocetine, phosphatidylserine (PS), centella asiatica, panax ginseng and ginkgo biloba.

Chapter 7
NUTRACEUTICAL MARKET BY REGION
FOD013F
March 2017
Natraj Pandal
Project Analyst
ISBN: 1-62296-448-9
BCC Research
or (+1) 781-489-7301
www.bccresearch.com
CHAPTER 7
NUTRACEUTICAL MARKET BY REGION
North America and Asia-Pacific are major drivers for growth in the global nutraceutical
market due to the facts of facing an aging population and increasing rates of chronic
diseases such as hypertension and diabetes.
GLOBAL NUTRACEUTICAL MARKET
TABLE 72
GLOBAL NUTRACEUTICAL MARKET, BY REGION, THROUGH 2021

($ BILLIONS)
CAGR%
Region 2015 2016 2021 2016–2021
North America 74.0 79.5 113.7 7.4
Europe 48.1 51.7 72.7 7.1
Asia-Pacific 53.8 57.8 84.9 8.0
Total 185.0 198.7 285.0 7.5
GLOBAL NUTRACEUTICAL MARKET
The global nutraceutical market was estimated to be worth $185 billion in 2015 and is
expected to reach $285 billion by 2020, growing at an estimated compound annual growth
rate (CAGR) of 7.5% from 2016 to 2021. North America and Asia-Pacific led the
nutraceutical market and together accounted for 69.1% of the market in 2015.
North America’s nutraceutical market was estimated to be worth $74 billion in 2015 and is
2021. Higher levels of awareness of health, physical fitness and mental well-being are
driving the North American nutraceutical market.
The European nutraceutical market was estimated to be worth nearly $48.1 billion in 2015
2021. The Asia-Pacific nutraceutical market was estimated to be worth $53.8 billion in
2016 to 2021. Developing countries in Asia-Pacific such as China and India are showing
rapidly increasing consumption of functional foods and beverages due to the rising of per
capita income.

FIGURE 2
GLOBAL NUTRACEUTICAL MARKET BY REGION, 2015-2021

($ BILLIONS)
NORTH AMERICA
The North American nutraceutical market is a matured market that is being replicated by
developing regions such as Asia-Pacific (China, India and Japan). The people in this region
are more conscious about their health, physical fitness and mental well-being, which is the
driving the North American nutraceutical market. The U.S. is has the highest number of
consumers of nutraceutical products with $58.8 billion in 2015, which is expected to reach
$93.2 billion in 2021 and to grow at a CAGR of 8.1% from 2016 to 2021.
TABLE 73
NORTH AMERICAN NUTRACEUTICAL MARKET, BY COUNTRY, THROUGH 2021

($ BILLIONS)
CAGR%
Country 2015 2016 2021 2016–2021
U.S. 58.8 63.2 93.2 8.1
Canada 12.3 13.2 16.6 4.7
Mexico 2.9 3.1 3.9 4.7
Total 74.0 79.5 113.7 7.4
The U.S. market is leading the entire global nutraceutical market; however, the U.S.
market for certain segments, such as probiotics and digestive health, is less mature than
the markets in Asia-Pacific and Europe. Increasing numbers of new product launches

across all segments in the U.S. are due to increasing awareness of the benefits of
functional food and beverages. The U.S. market for dietary supplements is mature and
growing. The strength of the U.S. economy and the buying power of its consumers make
the region extremely attractive for nutraceutical companies.
Canada’s nutraceutical market is expected to increase significantly from $12.3 billion in

2015 to $16.6 billion in 2021, rising at a CAGR of 4.7% from 2016 to 2021. Mexico’s
nutraceutical market is expected to grow from $2.9 billion in 2015 to $3.9 billion in 2021,
at an estimated CAGR of 4.7% from 2016 to 2021. A majority of the population in Mexico
falls under the category of middle-aged—ranging from 40 to 64 years of age—which is the
primary target customer for the nutraceutical industry.
TABLE 74
NORTH AMERICAN NUTRACEUTICAL MARKET, BY PRODUCT, THROUGH 2021

($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Functional beverage 21.0 22.6 32.7 7.7
Total 74.0 79.5 113.7 7.4
Dietary supplements currently dominate the North American nutraceutical market with a
37.4% share. The dietary supplements market was $27.7 billion in 2015 and is expected to
reach $42.2 billion by 2021, growing at a CAGR of 7.3% from 2016 to 2021. The North
American functional food market was $25.3 billion in 2015 and is expected to reach $38.8
billion by 2021, growing at a CAGR of 7.4% from 2016 to 2021. North America’s functional
beverage market held a 28.4% of share in 2015 and is expected to reach $32.7 billion by
2021, growing at a CAGR of 7.7% from 2016 to 2021 due to the increased consumption of
sports drinks and growth in the ready-to-drink segment.

TABLE 75
NORTH AMERICAN NUTRACEUTICAL FOOD MARKET, BY PRODUCT, THROUGH

2021
($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Bakery 5.1 5.5 8.1 8.0
Snacks 5.0 5.4 7.6 7.1
Meat and poultry 1.8 1.9 2.8 8.1
Other 1.0 1.1 1.2 1.8
Total 25.3 27.2 38.8 7.4
The confectionery segment accounted for the largest share of the overall North American
nutraceutical food market with a 27.7% share worth $7.0 billion in 2015 and is expected to
reach $10.8 billion in 2021, growing at a CAGR of 7.6% from 2016 to 2021. Bakery
commanded the second-largest market share with 20.2% of the overall North American
nutraceutical food market in 2015 at $5.1 billion and is expected to reach $8.1 billion in
2021, growing at a CAGR of 8.0% from 2016 to 2021. The grain and flour segment is
expected to grow from $700 million in 2015 to $1.1 billion in 2021, at an estimated CAGR
of 9.5% from 2016 to 2021.
TABLE 76
NORTH AMERICAN NUTRACEUTICAL BEVERAGE MARKET, BY PRODUCT, THROUGH

2021
($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Dairy drinks 4.0 4.3 6.5 8.6
Frozen juice 1.1 1.2 1.7 7.2
Other 0.8 0.8 0.9 2.4
Total 21.0 22.6 32.7 7.7

The noncarbonated drinks segment accounted for the largest share of the overall North
American nutraceutical beverage market with a 67.1% share worth $14.1 billion in 2015
2021. Dairy drinks commanded the second-largest market share with 19.0% of the overall
North America nutraceutical market in 2015 at $4.0 billion and is expected to reach $4.3
billion in 2021, growing at a CAGR of 8.6% from 2016 to 2021. North America’s frozen
juice market segment is expected to increase from $1.1 billion in 2015 to $1.7 billion in
2021, rising at a CAGR of 7.2% from 2016 to 2021. The North American tea and coffee
market is expected to grow from $1.0 billion in 2015 to $1.4 billion in 2021, at an
TABLE 77
NORTH AMERICAN NUTRACEUTICAL MARKET, BY APPLICATION, THROUGH 2021

($ BILLIONS)
CAGR%
Application 2015 2016 2021 2016–2021
Heart health 12.6 13.5 21.0 9.2
GI and digestive health 5.6 6 8.7 7.7
Type 2 diabetes 2.0 2.1 3.1 8.1
Total 74.0 79.5 113.7 7.4
The sports and energy application accounted for the largest share with a 26.8% of the
North American nutraceutical market at $19.8 billion in 2015. This application is expected
to reach nearly $30.9 billion in 2021, growing at a CAGR of 7.7% from 2016 to 2021. The
weight management application had the second-largest share of the North American
nutraceutical market in 2015 with a 20.8% share worth $15.4 billion in 2015 and is
expected to reach nearly $23.6 billion in 2021, growing at a CAGR of 7.4% from 2016 to
2021. Due to an increased national focus on exercise as a supplement to healthy diet,
sports and energy is the largest nutraceutical application market in the U.S.
Heart health had the third-largest share of the North American nutraceutical market in
2015 with a 17.0% worth $12.6 billion in 2015 and is expected to reach nearly $21.0
billion in 2021, growing at a CAGR of 9.2% from 2016 to 2021. The general wellness
application accounted for the fourth largest share with a 17.0% of the North American
nutraceutical market at $12.6 billion in 2015 and is expected to reach $17.6 billion in 2021,
growing at a CAGR of 5.3% from 2016 to 2021. Weight management and heart health are
the next largest application markets owing to increased consumer awareness of the
dangers of obesity and CVD.

EUROPE
The European market is a mix of more mature markets among the Western region and
Eastern markets with greater future growth potential. Unlike the U.S. and Japan, Europe
can hardly be considered a single, unified entity with respect to functional foods. There are
various differences in tastes and customs among European countries that make it harder
for manufacturers to introduce true mass market blockbusters, but there are many
country-specific niches that can be exploited.
TABLE 78
EUROPEAN NUTRACEUTICAL MARKET, BY COUNTRY, THROUGH 2021

($ BILLIONS)
CAGR%
Country 2015 2016 2021 2016–2021
France 12.0 12.9 18.9 7.9
Germany 9.9 10.6 14.8 6.9
Spain 6.5 7.0 9.7 6.7
Italy 6.0 6.5 8.9 6.5
U.K 4.3 4.6 6.5 7.2
Other 9.4 10.1 13.9 6.6
Total 48.1 51.7 72.7 7.1
France accounted for the largest share of the overall European nutraceutical market with a
24.9% share worth $12.0 billion in 2015 and is expected to reach $18.9 billion in 2021,
growing at a CAGR of 7.9% from 2016 to 2021. Germany was the second-largest market
share with 20.6% of the overall European nutraceutical market in 2015 at $9.9 billion and
is expected to reach $14.8 billion in 2021, growing at a CAGR of 6.9% from 2016 to 2021.
Spain’s nutraceutical market is expected to increase from $6.5 billion in 2015 to $9.7
billion in 2021, rising at a CAGR of 6.7% from 2016 to 2021. Italy’s nutraceutical market is
expected to grow from $6.0 billion in 2015 to $8.9 billion in 2021, at an estimated CAGR of
6.5% from 2016 to 2021. The U.K. nutraceutical market is expected to grow from $4.3
billion in 2015 to $6.5 billion in 2021, at an estimated CAGR of 7.2% from 2016 to 2021.

TABLE 79
EUROPEAN NUTRACEUTICAL MARKET, BY PRODUCT, THROUGH 2021

($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Total 48.1 51.7 72.7 7.1
The functional beverage segment currently dominates the European nutraceutical market
with a 45.9% share. The functional beverage market was $22.1 billion in 2015 and is
Europe’s dietary supplements held a 19.5% of share in 2015, worth $9.4 billion and are
The European functional food market was $16.6 billion in 2015 and is expected to reach
$25.1 billion by 2021, growing at a CAGR of 7.1% from 2016 to 2021 due to a much more
restrictive regulatory climate and a lack of harmonization. Moreover, many products have
not become commercially successful, but it is unstable growth just like in the U.S. and
Japanese markets that creates similar expectations for the European nutraceutical market.
Further, consumers in Europe are buying and using a variety of functional food.
TABLE 80
EUROPEAN NUTRACEUTICAL FOOD MARKET, BY PRODUCT, THROUGH 2021

($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Bakery 3.6 3.9 5.4 6.7
Snacks 3.1 3.3 4.5 6.4
Meat 1.1 1.2 1.6 5.9
Other 1.0 1.1 1.5 6.4
Total 16.6 17.8 25.1 7.1

The confectionery segment accounted for the largest share of the overall European
commanded the second-largest market share with 21.7% of the overall European
nutraceutical food market in 2015 at $3.6 billion and is expected to reach $5.4 billion in
2021, growing at a CAGR of 6.7% from 2016 to 2021. The grain and flour segment is
expected to grow from $400 million in 2015 to $800 million in 2021, at an estimated CAGR
of 14.9% from 2016 to 2021.
TABLE 81
EUROPEAN NUTRACEUTICAL BEVERAGE MARKET, BY PRODUCT, THROUGH 2021

($ MILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Dairy drinks 9.1 9.7 14.8 8.8
Frozen juice 1.2 1.3 1.8 6.7
Other 0.0 0.2 0.2 0.0
Total 22.1 23.8 36.0 8.6
The noncarbonated drinks segment accounted for the largest share of the overall
European nutraceutical beverage market with a 49.3% share worth $10.9 billion in 2015
2021. Dairy drinks commanded the second-largest market share with 41.2% of the overall
European nutraceutical market in 2015 at $9.1 billion and is expected to reach $14.8
billion in 2021, growing at a CAGR of 8.8% from 2016 to 2021. The European frozen juice
market is expected to increase from $1.2 billion in 2015 to $1.8 billion in 2021, rising at a
CAGR of 6.7% from 2016 to 2021. Europe’s tea and coffee market is expected to grow
from $900 million in 2015 to $1.2 billion in 2021, at an estimated CAGR of 5.9% from 2016
to 2021.

TABLE 82
EUROPEAN NUTRACEUTICAL MARKET, BY APPLICATION, THROUGH 2021

($ BILLIONS)
CAGR%
Application 2015 2016 2021 2016–2021
Heart health 5.8 6.2 8.2 5.8
Type 2 diabetes 1.3 1.4 1.8 5.2
Total 48.1 51.7 72.7 7.1
European nutraceutical market at $20.0 billion in 2015. This application is expected to
reach nearly $32.5 billion in 2021, growing at a CAGR of 8.6% from 2016 to 2021. The
general wellness segment had the second-largest share of the European nutraceutical
market in 2015 with a 13.1% share worth nearly $6.3 billion in 2015 and is expected to
reach nearly $9.9 billion in 2021, growing at a CAGR of 7.5% from 2016 to 2021.
The heart health segment had the third-largest share of the European nutraceutical
market in 2015 with a 12.1% share worth $5.8 billion in 2015 and is expected to reach
$8.2 billion in 2021, growing at a CAGR of 5.8% from 2016 to 2021. GI and digestive health
applications accounted for the fourth-largest share with 10.8% of the European
nutraceutical market at $5.2 billion in 2015 and is expected to reach $7.6 billion in 2021,
ASIA-PACIFIC
Overall, the nutraceutical market has attained maturity in North America and Europe. India,
China and other Southeast Asian countries are considered key growth countries in spite of
their current low per capita spending on nutraceutical products.
The Asia-Pacific region is densely populated with rapidly changing consumer lifestyles and
increasing disposable income among consumers. These facts are driving the Asia-Pacific
nutraceutical market. Increasing consumption levels of nutraceutical products is also
positively affected by growth of the aging population.
Higher socioeconomic classes and upper middle classes consumers are looking for
supplements and functional foods to achieve a nutritional balance. Moreover, these
consumers are interested in energy-boosting products in order to improve their physical
stamina, mental awareness and level of activity—in essence, living consciously. Due to

this trend, many local and international pharmaceutical and fast-moving consumer goods
(FMCG) manufacturers have launched numerous nutraceutical products in the Asia-Pacific
region.
India is one of the largest economies among developing nations to have high purchasing
power parity. The per capita income of individuals has increased over the past decade,
which is resulting in changing lifestyles in India. Further, changing food habits, lack of
physical activity and increasing numbers of people involved in desk jobs has increased,
which contributes to the occurrence of lifestyle diseases. As well, a lack of proper nutrients
in the fast foods and packaged foods many of these workers have turned to is playing a
major role for occurrence of lifestyle diseases such as obesity in India.
According to Indian statistical data, various lifestyle diseases showed an increase in

2015—such as 67 million diabetic patients and 30 million more in a pre-diabetic condition.
Further, an increase of 40.0% of deaths in India are associated with cardiovascular
diseases (CVDs); as well, obesity rates increased by 20.0% in 2015.
TABLE 83
ASIA-PACIFIC NUTRACEUTICAL MARKET, BY COUNTRY, THROUGH 2021

($ BILLIONS)
CAGR%
Country 2015 2016 2021 2016–2021
Japan 28.5 30.6 43.3 7.2
China 20.6 22.1 33.1 8.4
India 2.7 2.9 5.9 15.3
Australia 0.3 0.3 0.4 5.9
Other 1.7 1.9 2.2 3.0
Total 53.8 57.8 84.9 8.0
Japan commanded the largest market share with 53.0% of the overall Asia-Pacific
nutraceutical market in 2015. Japan’s nutraceutical market was $28.5 billion in 2015 and is
expected to reach $43.3 billion in 2021, growing at a CAGR of 7.2% from 2016 to 2021 due
to the fact that more than 48.0% of Japan’s population are consuming nutraceuticals in
2015. Japan was the first country to recognize and regulate functional food with a name:
FOSHU, meaning food for specified health uses, in 1980. Since 1988 more than 1,400
functional foods and beverages were launched in Japan, with major ingredients including
oligosaccharides, dietary fiber and calcium.
China commanded the second-largest market share with 38.3% of the overall Asia-Pacific
nutraceutical market in 2015 at $20.6 billion and is expected to reach $33.1 billion in 2021,
growing at a CAGR of 8.4% from 2016 to 2021. China will become largest global producer
and consumer of nutraceutical ingredients by 2020 due to rising consumer incomes and
investment levels in this industry.

India’s nutraceutical market is expected to increase from $2.7 billion in 2015 to $5.9
billion in 2021 with highest growth rate of 15.3% during the same period. Australia’s
nutraceutical market is expected to increase from $300 million in 2015 to $400 million in
2021. Historically, the Indian nutraceutical ingredient market was viewed as an
export-focused industry, but, due to changing market trends, most Indian companies have
started to introduce products in local markets and also to expand their product lines as
determined by consumer needs.
The major brands in the functional food market in Japan are Yakult, Dannon, Aloe Nomu
Yogurt, Bikkle, Maiasa Sokai, One a Night, Yakult 80 Ace, Bifiel and Oligo CC. The main
players among nutraceuticals manufacturers in Japan are Yakult, Dannon, Ajinomoto,
Calpis, Morinaga and Suntory. Yakult is one of the oldest nutraceutical companies in the
world, with recognized brand name for more than seven decades in the market.
TABLE 84
ASIA-PACIFIC NUTRACEUTICAL MARKET, BY PRODUCT, THROUGH 2021

($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Total 53.8 57.8 84.9 8.0
Dietary supplements currently dominate the Asia-Pacific nutraceutical market with a

38.8% share. The dietary supplements market was $20.9 billion in 2015 and is expected to
reach $32.8 billion by 2021, growing at a CAGR of 7.8% from 2016 to 2021. Asia-Pacific’s
functional beverage market was $17.0 billion in 2015 and is expected to reach $27.0
billion by 2021, growing at a CAGR of 8.2% from 2016 to 2021. Asia-Pacific’s functional
food segment held a 29.6% of share in 2015 and is expected to reach $25.1 billion by
2021, growing at a CAGR of 8.0% from 2016 to 2021.

TABLE 85
ASIA-PACIFIC NUTRACEUTICAL MARKET, BY FOOD PRODUCT, THROUGH 2021

($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Bakery 3.1 3.3 4.8 7.8
Snacks 2.7 3.0 4.3 7.5
Meat 1.0 1.0 1.5 8.4
Other 0.7 0.8 0.9 2.4
Total 15.9 17.1 25.1 8.0
The confectionery segment accounted for the largest share of the overall Asia-Pacific
commanded the second-largest market share with 19.5% of the overall market Asia-Pacific
nutraceutical food market and is expected to grow from $3.1 billion in 2015 and it is
expected to reach $4.8 billion in 2021, growing at a CAGR of 7.8% from 2016 to 2021. The
grain and flour segment in the Asia-Pacific markets is expected to grow from $400 million
in 2015 to $600 million in 2021, at an estimated CAGR of 8.4% from 2016 to 2021.
TABLE 86
ASIA-PACIFIC NUTRACEUTICAL BEVERAGE MARKET, BY PRODUCT, THROUGH

2021
($ BILLIONS)
CAGR%
Product 2015 2016 2021 2016–2021
Dairy drinks 7.6 8.1 12.1 8.4
Frozen juice 1.3 1.4 1.9 6.3
Other 0.1 0.1 0.1 0.0
Total 17.0 18.2 27.0 8.2
Noncarbonated drinks and dairy drinks together accounted for 88.2% of the Asia- Pacific
nutraceutical beverage market in 2015. The Asia-Pacific noncarbonated drinks market is

expected to increase from $7.4 billion in 2015 to $12.0 billion in 2021, rising at a CAGR of
8.4% from 2016 to 2021. Asia-Pacific’s dairy drinks market is expected to grow from $7.6
billion in 2015 to $12.1 billion in 2021, at an estimated CAGR of 8.4% from 2016 to 2021.
The Asia-Pacific frozen juice market is expected to increase from $1.3 billion in 2015 to
$1.9 billion in 2021, rising at a CAGR of 6.3% from 2016 to 2021. Asia-Pacific’s tea and
coffee market is expected to grow from $600 million in 2015 to $900 million in 2021, at an
TABLE 87
ASIA-PACIFIC NUTRACEUTICAL MARKET, BY APPLICATION, THROUGH 2021

($ BILLIONS)
CAGR%
Application 2015 2016 2021 2016–2021
Heart health 6.8 7.3 9.8 6.1
Type 2 diabetes 2.2 2.3 3.6 9.4
Total 53.8 57.8 84.9 8.0
Asia-Pacific nutraceutical market at $18.0 billion in 2015. This application is expected to
reach nearly $30.4 billion in 2021, growing at a CAGR of 9.5% from 2016 to 2021. The GI
and digestive health had the second-largest share of the Asia-Pacific nutraceutical market
in 2015 with a 19.7% share worth $10.6 billion in 2015 and is expected to reach $17.7
billion in 2021, growing at a CAGR of 9.4% from 2016 to 2021.
The heart health application accounted for the fourth-largest share with a 12.6% of the
Asia-Pacific nutraceutical market at $6.8 billion in 2015 and is expected to reach $9.8
billion in 2021, growing at a CAGR of 6.1% from 2016 to 2021. The general wellness
application had the third-largest share of the Asia-Pacific nutraceutical market in 2015
with a 12.5% share worth $6.7 billion in 2015 and is expected to reach $8.9 billion in 2021,
SOUTH AMERICA
Emerging countries such as Brazil are turning out to be lucrative markets for nutraceutical
manufacturers. The confectionary industry is gaining momentum in South America due to
increasing influences of Western countries.

TABLE 88
SOUTH AMERICA NUTRACEUTICAL MARKET, BY COUNTRY, THROUGH 2021

($ BILLIONS)
CAGR%
Country 2015 2016 2021 2016–2021
Brazil 5.5 5.8 8.4 7.7
Argentina 3.6 3.9 5.3 6.3
Total 9.1 9.7 13.7 7.1
The South America nutraceutical market is expected to grow from $9.1 billion in 2015 to
$13.7 billion in 2021, rising at an estimated CAGR of 7.1% from 2016 to 2021. Brazil’s
nutraceutical market is expected to increase from $5.5 billion in 2015 to $8.4 billion in
2021, rising at a CAGR of 7.7% from 2016 to 2021. Argentina’s nutraceutical market is
expected to grow from $3.6 billion in 2015 to $5.3 billion in 2021, at an estimated CAGR of
6.3% from 2016 to 2021.

Chapter 8
PATENT EVALUATION
FOD013F
March 2017
Natraj Pandal
Project Analyst
ISBN: 1-62296-448-9
BCC Research
or (+1) 781-489-7301
www.bccresearch.com
CHAPTER 8
PATENT EVALUATION
This chapter presents an analysis of nutraceutical patents registered in the U.S., Europe
and Japan from 2011 to 2015. During this period, a total of 687 patents were registered in
the U.S., Europe and Japan combined. The global nutraceuticals market is witnessing rapid
development in terms of new products, innovations and technologies. Major participants in
the nutraceuticals industry, including Nestec S.A., Noevir Co. Ltd. (Japan), Probiotical S.p.a.
(Italy), Sumitomo Chemical Co Ltd. (Japan), KAO Corp. (Japan), Zimmer Inc. (U.S.), Mead
Johnson Nutrition Company (Germany), The IAMS Company (Netherlands), Kracie Home
Products Ltd. (Japan), Master Supplements Inc. (U.S.), Ab-biotics Produccione (Spain) are
expected to increase their research and development efforts to achieve product
innovation and gain a competitive edge. Driven by development and standardization of
nutraceutical regulations, companies are moving toward offering more nutraceutical
products in the market.
NUTRACEUTICAL PATENTS BY COMPANY
TABLE 89
NUTRACEUTICAL PATENT ANALYSIS, BY COMPANY, 2011-2015

(NUMBER/%)
Total Number Percentage

Company of Patents of Patents
Nestec S.A. (Switzerland 82 11.9
Probiotical S.p.a. (Italy) 14 2.0
Noevir Co Ltd (Japan) 10 1.5
Sumitomo Chemical Co. Ltd. (Japan) 9 1.3
Mead Johnson Nutrition Company (Germany) 8 1.2
Kao Corp. (Japan) 7 1.0
The IAMS Company (Netherlands) 7 1.0
Kracie Home Products Ltd. (Japan) 7 1.0
Master Supplements Inc. (U.S.) 7 1.0
Zimmer Inc. (France) 7 1.0
The Procter & Gamble Company (U.S.) 6 0.9
AB-Biotics S.A. (Spain) 6 0.9
Naris Cosmetics Co. Ltd. (Japan) 5 0.7
N.V. Nutricia (Netherlands) 5 0.7
Other 507 73.9
Total 687 100.0

The most patents were registered by Nestec S.A., accounting for 11.9% of overall patents,
followed by Probiotical S.p.a. (Italy) with 2%, Noevir Co Ltd. with 1.5%, Sumitomo Chemical
Co Ltd. with 1.3%, Zimmer Inc. with 1%, KAO Corp. with 1%, and AB-Biotics S.A. (Spain)
with 6% of registered patents from 2011 to 2015. The other major companies had lower
shares of registered patents compared to Nestec S.A., Probiotical S.p.a. and Noevir Co. Ltd.
PATENTS BY COUNTRY/REGION
FIGURE 3
NUTRACEUTICAL PATENT SHARES BY COUNTRY/REGION, 2011-2015

(%)
LEGEND
(%)
Region/
Country Percentage
U.S 31.3
Europe 38.0
Japan 30.7
Total 100.0
Europe accounted for the largest share of nutraceutical patents at 38.0% of overall
patents from January 2011 to December 2015. The U.S. accounted for the second largest
share of nutraceutical patents at 31.3% of all patents from January 2011 to December
2015. The fewest patents as compared to the U.S and Europe were registered in Japan,
with a 30.7% share of the total number of patents in these regions.

U.S. NUTRACEUTICAL PATENTS
TABLE 90
U.S. NUTRACEUTICAL PATENTS, 2011-2015
Institution/ Patent
Date Patent Holder/Company Title Number
2015 4Life Patents LLC (Sandy, Utah) Nutraceutical gels 9028882
2015 Nitromega Corp. (Pittsburgh, Pa.) Nutraceuticals containing nitro 8933255
fatty acids
2015 GAO SONG Compositions containing enriched 9211298
natural crocin and/or crocetin, and
their therapeutic or
nutraceutical uses
2015 Evonik Röhm GmbH (Darmstadt, Coated pharmaceutical or 9011907
Germany) nutraceutical preparation with
enhanced pulsed active substance
release
2015 SHER JUSTIN Nutraceutical composition for 9149457
PDE4 inhibition, enhanced
dopamine metabolism and long
term potentiation
2015 Auburn University (Auburn, Ala.) Nutraceutical compositions 9168277
produced from co-products of corn
or milo ethanol fermentation and
methods of making and using
thereof
2015 AB-Biotics S.A. (Cerdanyola, Spain) Probiotic composition for oral 9192634
health
2015 Nestec S.A. (Vevey, Switzerland) Extruded non-replicating probiotic 8961952
micro-organisms and their health
benefits
2015 Nestec S.A. (Vevey, Switzerland) Nutritional composition 9034314
comprising probiotics and
improving sleep patterns
2015 Compagnie Gervais Danone (Paris, Probiotic strains for use in 9198940
France) improving the enteric nervous
system
2015 The Board of Trustees of the Methods of selecting and using 9107938
University of Arkansas (Little Rock, therapeutic and prophylactic
Ariz.) probiotic cultures to reduce
The United States of America, as bacterial pathogen loads
Represented by the Secretary of
Agriculture (Washington, D.C.)
2015 Wyeth LLC (N.Y.) Multi-vitamin and mineral 8927012
nutritional supplements

2015 The Board of Trustees of the Process for forming films, fibers, 9096743
University of Alabama (Tuscaloosa, and beads from chitinous biomass
Ala.)
2015 TRB Chemedica International S.A. Ophthalmic compositions based 8957110
(Geneva, Switzerland) on polyunsaturated omega-3 and
omega-6 fatty acids
2015 Omthera Pharmaceuticals Inc. DPA-enriched compositions of 9050309
(Princeton, N.J.) omega-3 polyunsaturated fatty
Chrysalis Pharma AG (Sacheln) acids in free acid form
2014 Nestec S.A. (Vevey, Switzerland) Probiotics, secretory IgA and 9173937
infection
2014 Vita-Herb Nutriceuticals Inc. Probiotic and preservative uses of 8846082
(Placentia, California) oil-emulsified probiotic
encapsulations
2014 Probiohealth LLC (Beverly Hills, Prebiotic and preservative uses of 8758742
Calif.) oil emulsified probiotic
encapsulations
2014 Probiotical S.p.A. (Novara, IT) Composition comprising probiotic 8734783
bacteria for use in the treatment
of immune disorders
2014 I did It Inc (Far Hills, N.J.) Joint preserving nutritional vitamin, 8703174
mineral and herbal pet
supplement
2014 Stillman, Suzanne Jaffe (Los Angeles, Water containing soluble fiber 8663721
Calif.)
2014 T.F.H. Publications Inc. (Neptune City, Pet chew product containing 8875663
N.J.) natural animal fibers, methods of
manufacture and use thereof
2014 Weyerhaeuser NR Company (Federal Catalytic carboxylation of 8641863
Way, Wash.) cellulose fibers in a continuous
process with multiple additions of
catalyst, secondary oxidant and
base to a moving slurry of
cellulose fibers
2014 GP Cellulose GmbH (Zug, Switzerland) Modified cellulose from chemical 8778136
kraft fiber and methods of making
and using the same
2014 Rosedale, Ronald E. (Bellevue, Omega-3 fatty acid nutriceutical 8697676
Wash.) composition and optimization
method
2014 Hill's Pet Nutrition Inc. (Topeka, Kan.) Omega-3 fatty acids for 8633246
osteoarthritis
2014 Perlman Consulting LLC (Arlington, TRB Chemedica International S.A. 8828470
Mass..) (Geneva, CH)
2014 University of Manitoba (Manitoba, Yellow pea seed protein-derived 8815806
Calif.) peptides
2014 HARPER TOM G. Phytoplankton 8658182
based nutraceuticals
2014 Laila Nutraceuticals (Vijayawada, Nutraceutical composition from 8853261
Ind.) Garcinia mangostana

2014 Valent BioSciences Corp. (Libertyville, Pharmaceutical and nutraceutical 8729122

(Ill.) compositions of abscisic acid
2014 GILAD GAD Agmatine containing dietary 8916612
GILAD VARDA supplements, nutraceuticals, and
foods
2014 Bioman S.R.L. (Turin, IT) Copper-enriched biomass, method 8679786
for the preparation thereof and
pro-biotic, cosmetic, dietary
and nutraceutic products
comprising the same
2014 Centro Internacional de Biomedicina Nutraceutical composition that 8784804
(ICC) (Santiago, CL) comprises extract of andean
shilajit, for preventing and/or
treating neurodegenerative
diseases and/or the cognitive
deterioration associated with
cerebral aging
2014 UNIAO Brasileria de Educacao e Composition containing 8912234
Assistencia—Mantenedora da PUCRS resveratrol and/or derivatives
(Porto Alegre, BR) thereof and plant oil, process for
producing said composition,
nutraceutical and/or
pharmaceutical product, and
method for enhancing the
potential of resveratrol
2014 Chrono Therapeutics Inc. (Cambridge, Biosynchronous transdermal drug 8741336
Mass,) delivery for longevity, anti-aging,
fatigue management, obesity,
weight loss, weight management,
delivery of nutraceuticals, and the
treatment of hyperglycemia,
Alzheimer'S disease, sleep
disorders, Parkinson'S disease,
AIDS, epilepsy, attention deficit
disorder, nicotine addiction,
cancer, headache and pain control,
asthma, angina, hypertension,
depression, cold, flu and the like
2014 Laboratoires Expanscience Cosmetic composition for the 8758833
(Courbevoie, France) treatment of acne comprising a
peptide extract of Schisandra
2014 Emerald Fisheries AS (Norway) Reduced fluoride content 8758829
phospholipids/peptide complex
meal
2014 POM Wonderful LLC (Los Angeles, Oral or enteral dosage forms 8758832
Calif..) containing phytochemicals from
pomegranates
2013 Kraft Foods Group Brands LLC Dairy composition with probiotics 8617625
(Northfield, Ill) and anti-microbial system
2013 Bolder Biotechnology Inc. (Boulder, Methods of making proteins and 8617531
Colo.) peptides containing a single free
cysteine

2013 ExxonMobil Research and Method for improving the deposit 8618031
Engineering Company (Annandale, formation resistance performance
N.J.) of turbine oils containing amine
antioxidants
2013 University of Ottawa (Ottawa, Antioxidant producing bacterium 8617870
Ontario, Canada) and uses thereof
2013 Sangart Inc. (San Diego, Calif.) Methods for preparing stable 8609815
deoxygenated PEG-hemoglobin
conjugate solutions comprising an
antioxidant
2013 Nestec S.A. (Switzerland) Complete liquid nutrition for 8603492
children the age of 1-10 years
comprising probiotics
2013 The University of British Columbia AP-ECD methods and apparatus 8598514
(Vancouver, British Columbia, for mass spectrometric analysis of
Canada) peptides and proteins
2013 Polnox Corp. (Lowell, Mass.) Macromolecular antioxidants 8598382
based on sterically hindered
phenols and phosphites
2013 Hill’s Pet Nutrition Inc. (Topeka, Kan.) Antioxidant-containing food 8592478
composition
2013 Premier Micronutrient Corp. Multiple antioxidant 8592392
(Greenwood Village, Colo.) micronutrients
2013 Tegenero AG (Wuerzburg, Germany) Peptide or protein comprising a 8586386
C′-D loop of the CD28 receptor
family
2013 BASF SE (Ludwigshafen, Germany) Encapsulated phenolic 8580876
antioxidants
2013 Albermarle Corp. (Richmond, Va.) Multi-ring antioxidants with 8580718
antiwear properties
2013 Master Supplements Inc. (Victoria, Enzyme and probiotic 8568712
Minn.,) combinations for enhancing
probiotic efficacy
2013 Van Andel Research Institute (Grand Parathyroid hormone peptides and 8563513
Rapids, Mich.,), The General Hospital parathyroid hormone-related
Corp. (Boston, Mass.) protein peptides and methods of
use
2013 Bio-Botanica Inc. (Happauge, NEW Stabilizing and antioxidant 8551540
YORK,) composition containing saw
palmetto berry component and
method of use
2013 Brookhaven Science Associates LLC Facilitating protein solubility by 8535908
(Upton, N.Y.) use of peptide extensions
2013 Premier Research Labs, LP (Austin, Method for producing probiotically 8530209
Texas,) derived compounds
2013 Nestec S.A. (Switzerland.) Probiotics in a pre- and/or post 8529887
surgical environment

2013 Yissum Research Development Multi-component antioxidant 8530407

Company of the Hebrew University of compounds, pharmaceutical
Jerusalem (Jerusalem, Israel) compositions containing same and
their use for reducing or
preventing oxidative stress
2013 The Coca-Cola Company (Atlanta, High-potency sweetener 8524304
Ga.) composition with
probiotics/prebiotics and
compositions sweetened
therewith
2013 PBM Pharmaceuticals Inc. Oral compositions comprising 8524269
(Charlottesville, Va.) edible oils and vitamins and/or
minerals and methods for making
oral compositions
2013 University of Idaho (Moscow, Idaho,) Probiotic bacterial strains for use 8518413
to decrease mortality in fish due
to bacterial disease
2013 Envoy Therapeutics Inc. (Jupiter, Fla.) Non human transgenic mammal 8513485
comprising a transgene
comprising a nucleotide sequence
encoding a ribosomal protein
fused to a peptide tag
2013 Reata Pharmaceuticals Inc. (Irving, Pyrazolyl and pyrimidinyl tricyclic 8513436
Texas) enones as antioxidant
inflammation modulators
2013 Kauffman, Robert E. (Centerville, Voltammetric technique to 8512547
Ohio) determine the individual
concentration of different
antioxidants of the same class
2013 James Madison Innovations Inc. Probiotic compositions and 8506952
(Harrisonburg, Va.) process thereof
2013 The Board of Trustees of the Leland Protein kinase C peptides for use 8507440
Stanford Junior University (Stanford, in withdrawal
Calif.)
2013 Jarrow Formulas Inc. (Los Angeles, Methods of using a nitroxide 8507529
Calif.) antioxidant in cosmetic and
dermatological compositions
2013 Eidgenossische Technische Method for high throughput 8501421
Hochschule Zurich (Zurich, peptide/protein assay generation
Switzerland) and assays generated therewith
2013 Imagilin Technology LLC. (Frederick, Probiotic treatment for infectious 8496923
Md.) gastrointestinal diseases
2013 Corning Incorporated (Corning, N.Y.) Organic antioxidant based 8496739
filtration apparatus and method
2013 Master Supplements Inc. (Victoria, Prebiotic compositions for use 8491919
Minn.) with probiotics to increase
probiotic growth rate and activity
2013 Ritter Pharmaceuticals Inc. (Los Prebiotic formulations and 8492124
Angeles, Calif.,) methods of use

2013 Nestec S.A. (Switzerland Methods for increasing absorption 8492331

of peptides, peptidomimetics and
other gastrointestinal transport
protein substrates
2013 Melaleuca Inc. (Idaho Falls, Idaho) Antioxidant dietary supplement 8491939
compositions
2013 Ritter Pharmaceuticals Inc. (Los Prebiotic formulations and 8486668
Angeles, Calif.) methods of use
2013 Sigma-Aldrich Co. LLC (St. Louis, Mo.) High stability polyionic liquid salts 8481722
2013 The Lubrizol Corp. (Wickliffe, Ohio,) Aminic antioxidants to minimize 8476209
turbo sludge
2013 University of Rochester (Rochester, Mitochondria-targeted antioxidant 8470861
N.Y.) prodrugs and methods of use
2013 ELC management LLC (New York, Probiotic color cosmetic 8465731
N.Y.) compositions and methods
2013 Natural Immune Systems Inc. Cell-based antioxidant protection 8465988
(Klamath Falls, Ore.) assay
2013 Advanced BioNutrition Corp. Dry food product containing live 8460726
(Columbia, Md.) probiotic
2013 Master Supplements Inc. (Victoria, Prebiotic formulations for use with 8449878
Minn.) probiotics to increase probiotic
growth rate and activity
2013 CIPLA Medpro Research and Probiotic strain and antimicrobial 8444998
Development (Pty) Ltd. (Bellville, peptide derived therefrom
South Africa)
2013 Master Supplements Inc. (Victoria, Treatment including prebiotic 8444967
Minn.) composition for use with
probiotics
2013 Bath & Body Works Brand Topical compositions for inhibiting 8435541
Management Inc. (Reynoldsburg, matrix metalloproteases and
Ohio) providing antioxidative activities
2013 The United States of America as Liquid chromatographic fraction of 8431176
Represented by the Secretary of the enzymatically polymerized
Army (Washington, D.C.) flavonoid as an antioxidant
2013 New York University (New York, N.Y.) Immunotherapy targeting of the 8409584
shared abnormal conformational
state of amyloidogenic
peptides/proteins
2013 Puratos Naamloze Vennootschap Method to increase the 8409652
(Groot-Bijgaarden, Belgium) antioxidant activity of chocolate
2013 Gorbach, Sherwood L. (Weston, Food containing a probiotic and an 8404228
Mass.,), Goldin, Barry R. (West isolated beta-glucan and methods
Newton, Mass.,) of use thereof
2013 University College Cardiff HPV vaccine comprising peptides 8399610
Consultants Limited (Cardiff, U.K.) from host cell proteins
2013 Zimmer Inc. (Warsaw, Ind.,) Polymer [[s]] compositions 8399535
including an antioxidant
2013 Abbott Cardiovascular Systems Inc. Methods of providing antioxidants 8394446
(Santa Clara, Calif.,) to implantable medical devices

2013 Centro de Investigacion y de Estudios Employment of rotavirus proteins, 8383129

Avanzados del Instituto Politecnico derived proteins and peptides for
Nacional (Col. San Pedro Zacatenco, the modulation of tissue
Mexico City, Mex.) permeability
2013 Mcmahon, Geoff (Farmington, N.M.,) Extraction of fulvic minerals, 8383840
vitamins, amino acids, enzymes,
and phytonutrients from humic
substances
2013 Honeywell International Inc. Titanium carbide or tungsten 8383197
(Morristown, N.J.),University of Notre carbide with combustion synthesis
Dame Du Lac (Notre Dame, Ind.) to block porosity in C-C brake
discs for antioxidation protection
2013 Natura Cosmeticos S.A. (Itapecerica Antioxidant complex, cosmetic 8383168
da Serra-SP, Brazil) and pharmaceutical compositions
containing said complex and use
of said complex
2013 BASF SE (Ludwigshafen, Germany) Coumestan-like antioxidants and 8383088
UV absorbants
2013 Aranda Cotero, Javier (Zapopan, Dielectric fluid composition 8383020
Mex.),Guerra Zubiaga, David containing vegetable oils and free
Apolinar (Monterrey, Mex.), of antioxidants
Contreras De, León José Eulalio (San
Nicolás de los Garza, Mex.),Alvárez
Contreras, Lorena (Chihuahua, Mex.)
2013 Nestec S.A. (Switzerland Use of probiotic lactic acid 8377679
bacteria for balancing the skin’s
immune system
2013 Nestec S.A. (Switzerland Infant formula with probiotics 8377430
2013 Palmer, Debbie M. (Greenwich, Antioxidant skin care 8361520
Conn.) compositions
2013 Philip Morris USA Inc. (Richmond, Combination treatment of tobacco 8360072
Va.) extract using antioxidants and
antioxidant scavengers
2013 Kraft Foods Global Brands LLC Dairy composition with probiotics 8349313
(Northfield, Ill.,) and anti-microbial system
2013 Compugen Ltd. (Tel-Aviv, Israel) Peptide ligands for G-protein 8349801
coupled receptors
2013 The Research Foundation of State Reconstitution medium for protein 8349794
University of New York (Amherst, and peptide formulations
N.Y,)
2013 Immunomedics Inc. (Morris Plains, Methods and compositions for 8343460
N.J.) F-18 labeling of proteins, peptides
and molecules
2012 Cognis IP Management GmbH Oral and/or topical compositions 8329672
(Duesseldorf, Germany) comprising prebiotics and fatty
acid
2012 ADA Technologies Inc. (Littleton, Electrochemical device and 8329024
Colo.) method for long-term
measurement of hypohalites

2012 Ciba Specialty Chemicals Corp. Aqueous functional fluids with 8329625
(Tarrytown, N.Y.) antioxidants
2012 Trustees of the University of Antioxidant polymer nanocarriers 8329225
Pennsylvania (Philadelphia, Pa.) for use in preventing oxidative
injury
2012 Chakravarthy, Balu (Ottawa, Canada) Amyloid-beta-binding protein and 8323925
its peptide derivatives and uses
thereof
2012 Abbott Cardiovascular Systems Inc. Poly(ester-amide) and poly(amide) 8323676
(Santa Clara, Calif.) coatings for implantable medical
devices for controlled release of a
protein or peptide and a
hydrophobic drug
2012 Alcon Research Ltd. (Fort Worth, Self-preserved aqueous 8323630
Texas) pharmaceutical compositions
2012 Imagilin Technology LLC (Frederick, Effects of probiotics on humans 8318152
Md.) and animals under environmental
or biological changes
2012 Nestec S.A. (Switzerland.) Lactobacillus rhamnosus NCC4007, 8318151
a probiotic mixture and weight
control
2012 The U.S., as represented by the Inhibition of HIV-1 replication by 8318425
Secretary, Department and Human disruption of the processing of the
Services (Washington, D.C.),Myrexis viral capsid-spacer peptide 1
Inc. (Salt Lake City, Utah) protein
2012 Cedars-Sinai Medical Center (Los Antioxidant polymers containing 8318795
Angeles, Calif.) [1,2]-dithiolane moieties and uses
thereof
2012 The Dial Corp. (Scottsdale, Ariz.) Combinations of herb extracts 8313783
having synergistic antioxidant
effect, and methods relating
thereto
2012 Chemtura Corp. (Middlebury, Conn.) Antioxidant additive for biodiesel 8313542
fuels
2012 The Regents of the University of Methods for enhancing bacterial 8293685
California (Oakland, Calif.) cell display of proteins and
peptides
2012 Dyax Corp. (Burlington, Mass.) Methods of constructing libraries 8288322
comprising displayed and/or
expressed members of a diverse
family of peptides, polypeptides or
proteins and the novel libraries
2012 King Fahd University of Petroleum System for electrostatic 8287710
and Minerals (Dhahran, Saudi Arabia) desalination
2012 The Procter & Gamble Company Absorbent structure with 8287999
(Cincinnati, Ohio) improved water-absorbing
material comprising polyurethane,
coalescing aid and antioxidant
2012 Biomedal, S.L. (Sevilla, Spain) Peptide and protein preservation 8283125
method

2012 Ganeden Biotech, Incorporated Inhibition of pathogens by 8277799

(Mayfield Heights, Ohio) probiotic bacteria
2012 Campina Nederland Holding B.V. Protein hydrolysate enriched in 8273710
(Netherlands) peptides inhibiting DPP-IV and
their use
2012 Alcon Research Ltd. (Fort Worth, Self preserved aqueous 8268299
Texas) pharmaceutical compositions
2012 Panduit Corp. (Tinley Park, Ill.) Antioxidant joint compound and 8268196
method for forming an electrical
connection
2012 Nestec S.A. (Switzerland) Consumable product containing 8263146
probiotics
2012 University of Sunderland (Sunderland, Melatonin derivatives and their 8258173
Great Britian) use as antioxidants
2012 Bio-Botanica Inc. (Hauppauge,N.Y.) Stabilizing and antioxidant 8252347
composition containing saw
palmetto berry component and
method of use
2012 Conopco Inc. (Englewood Cliffs, N.J.) Prebiotic composition 8246943
2012 The Dial Corp. (Scottsdale, Ariz.) Synergistic antioxidant 8241678
combinations of herb extracts and
methods relating thereto
2012 Max-Planck-Gesellschaft zur Tyrosine- and 8232243
Forderung der Wissenschaften E.V. tryptophan-containing peptides as
(München, Germany) antioxidants
2012 Mannatech Incorporated (Coppell, Antioxidant compositions and 8231914
Texas) methods thereto
2012 Institute for Systems Biology (Seattle, Mass spectrum-based 8227251
Wash.) identification and quantitation of
proteins and peptides
2012 Island Kinetics Inc. (Chandler, Ariz,) Chiral complexes of ascorbic acid 8227426
with natural antioxidant and
anti-inflammatory ketones
including aloe, citrus, ginger, and
mango for skin and hair care
2012 Premier Micronutrient Corp. Multiple antioxidant optimal 8221799
(Nashville, Tenn.) health/veterans ultimate complete
formulations
2012 Brunswick Laboratories LLC (Norton, Method for assaying the 8198091
Mass.) antioxidant capacity of a skin care
product
2012 Laila Impex (Vijayawada, Ind.) Synergistic anti-inflammatory and 8192768
antioxidant dietary supplement
compositions
2012 Ganeden Biotech Inc. (Mayfield Probiotic, lactic acid-producing 8187590
Heights, Ohio) bacteria and uses thereof

2012 Isconova AB (Uppsala, Sweden) Vaccine composition comprising a 8187585

fibronectin binding protein or a
fibronectin binding peptide
2012 Socomer NV. (Machelen, Belgium) Volta metric technique to 8187455
determine the individual
concentration of different
antioxidants of the same class
2012 Temple University of the Assay for screening/ranking 8183048
Commonwealth System of Higher antioxidants based on their effects
Education (Philadelphia, Pa.) on membrane sterol lateral
organization
2012 Zimmer Inc. (Warsaw, Ind.) Antioxidant stabilized cross linked 8178594
ultra-high molecular weight
polyethylene for medical device
applications
2012 PBM Pharmaceuticals Inc. Compositions comprising edible 8173160
(Charlottesville, Va.) oils and vitamins and/or minerals
and methods for making the
compositions
2012 G.V.T. – Gene Vector Technologies Viral capsid proteins and any 8158576
Ltd. (Jerusalem, Israel) peptides or compositions thereof
for the treatment of pathologic
disorders
and other molecules
and other molecules
and other molecules
N.J.) improved F-18 labeling of proteins,
peptides and other molecules
2012 Biro, Jan (San Francisco, Calif.) System and method to obtain 8145437
oligo-peptides with specific high
affinity to query proteins
2012 The Dial Corp. (Scottsdale, AZ, U.S.) Synergistic antioxidant 8142824
combinations of herb extracts and
methods relating thereto
2012 Mead Johnson Nutrition Company Probiotic infant products 8137718
(Germany)
2012 Glycologic Limited (Glasgow, GB) Prebiotic 8137706
2012 Zimmer Inc. (Warsaw, Ind., U.S.) Antioxidant stabilized crosslinked 8129440
applications
2012 Nestec S.A. (Switzerland) Probiotics for pet food applications 8124070

2012 Wisconsin Alumni Research Methods for determining protein 8119572

Foundation (Madison, Wis. binding specificity using peptide
libraries
2012 Helix BioMedix Inc. (Bothell, Wash.) Peptide fragments for inducing 8110658
synthesis of extracellular matrix
proteins
2012 Soft Gel Technologies Inc. (Los Formulation and delivery method 8110600
Angeles, Calif., U.S.) to enhance antioxidant potency of
vitamin E
2012 Unigen Inc. (Lacey, Wash.) 7-hydroxy chromones as potent 8110555
antioxidants
2012 Chemtura Corp. (Middlebury, Conn.) Antioxidant compositions 8110532
2012 Master Supplements Inc. (Victoria, Prebiotic composition for 8105577
Minn.) increasing probiotic growth rate
and activity
2012 Master Supplements Inc. (Victoria, Increasing probiotic growth rate 8105576
Minn.) and activity using prebiotic
composition
2012 Koninklijke Philips Electronics N.V. Vehicle headlamp 8106590
(Eindhoven, NL)
2012 Merck Patent GmbH (Darmstadt, Antioxidant compounds 8106233
Germany)
2012 Erber Aktiengesellschaft Probiotic health or fitness 8101170
(Herzogenburg, Austria) promoting human or animal
foodstuff and/or drinking water
additive and use thereof
2012 Rayborn Sr., Jerry (Franklinton, Spotting fluids containing syrups 8101555
La.),Delarosa, Dan M. (Coral Springs,
Fla.)
2012 Ganeden Biotech Inc. (Mayfield Probiotic, lactic acid-producing 8097247
Heights, Ohio) bacteria and uses thereof
2012 Advanced Bionutrition Corp. Delivery vehicle for probiotic 8097245
(Columbia, Md.) bacteria comprising a dry matrix
of polysaccharides, saccharides
and polyols in a glass form and
methods of making same
2012 Sigma-Aldrich Co. LLC (St. Louis, Mo.) High stability polyionic liquid salts 8097721
2012 Nestec S.A. (U.S.) Composition comprising a 8092608
prebiotic for decreasing
inflammatory process and
abnormal activation of
non-specific immune parameters
2012 R.T. Vanderbilt Company Inc. Lubricant antioxidant 8093190
(Norwalk, Conn.) compositions containing a metal
compound and a hindered amine
2011 Philadelphia College of Osteopathic Method of perfusing an organ with 8084195
Medicine (Philadelphia, Pa.) a solution comprising a peptide
which inhibits protein kinase C
betaII

2011 PBM Pharmaceuticals Inc. Oral compositions comprising 8075910

(Charlottesville, Va.) edible oils and vitamins and/or
minerals and methods for making
oral compositions
2011 Eastman Chemical Company Antioxidant compositions useful in 8075804
(Kingsport, Tenn.) biodiesel and other fatty acid and
acid ester compositions
2011 Cenestra LLC (New Haven, Conn.) Omega-3 fatty acid formulations 8071646
2011 Master Supplements Inc. (Victoria, Formulations including digestive 8066986
Minn.) enzymes and polysorbate
surfactants that enhance the
colonization of administered
probiotics microoganisms
2011 ExxonMobil Research and Catalytic antioxidants 8048833
Engineering Company (Annandale,
N.J.)
2011 Afton Chemical Corp. (Richmond, Dispersant reaction product with 8048831
Va.) antioxidant capability
2011 The Dial Corp. (Scottsdale, Ariz.) Combinations of herb extracts 8043637
having synergistic antioxidant
effect, and methods relating
thereto
comprising differing antioxidant
moieties: structures, methods of
making and using the same
2011 The Procter & Gamble Company Feline probiotic bifidobacteria 8034601
(Cincinnati, Ohio)
N.J.)
2011 Wyeth LLC (Madison, N.J.) Parenteral CCI-779 formulations 8026276
containing cosolvents, an
antioxidant, and a surfactant
2011 Nestec S.A. (Switzerland) Probiotics for gut neuromuscular 8021656
functions
2011 The Coca-Cola Company (Atlanta, High-potency sweetener 8017168
Ga.) composition with rubisco protein,
rubiscolin, rubiscolin derivatives,
ace inhibitory peptides, and
combinations thereof, and
compositions sweetened
therewith
2011 Soroushian, Parviz (Okemos, MI, Adaptive composite materials 8017227
US),Balachandra, Anagi Manjula
(Okemos, Mich.)
2011 Soft Gel Technologies Inc. (Los Formulation and delivery method 8013013
Angeles, Calif.) to enhance antioxidant potency of
vitamin E

2011 Amylin Pharmaceuticals Inc. (San Methods and compositions for 8008255
Diego, Calif.) enhanced transmucosal delivery
of peptides and proteins
2011 Isconova AB (Uppsala, Sweden) Vaccine composition comprising a 8007806
fibronectin binding protein or a
fibronectin binding peptide
2011 Xanodyne Pharmaceuticals Inc. Vitamin/mineral composition with 8007853
(Newport, Ky.) DHA
2011 Wyeth (Madison, N.J.) Use of antioxidants to prevent 8007737
oxidation and reduce drug
degradation in drug eluting
medical devices
2011 Proteotech Inc. (Kirkland, Wash.) Small peptides for the treatment 8003612
of Alzheimer's disease and other
beta-amyloid protein disorders
2011 The Procter & Gamble Company Methods of treatment or 7998473
(Cincinnati, Ohio) prevention of gastrointestinal
disorders using canine probiotic
bifidobacterium
2011 Mannatech, Incorporated (Coppell, Antioxidant compositions and 7999003
Texas) methods thereto
and other molecules
2011 Nestec S.A. (U.S.) Probiotics in primary prevention of 7988960
atopic diseases
2011 Soft Gel Technologies Inc. (Los Natural vitamin E compositions 7989493
Angeles, Calif.) with superior antioxidant potency
N.J.)
2011 Gorbach, Sherwood L. (Weston, MA, Food containing a probiotic and an 7981412
US),Goldin, Barry R. (West Newton, isolated beta-glucan and methods
Mass.) of use thereof
2011 The Regents of the University of Method of promoting delivery of 7972601
California (Oakland, Calif.) an antioxidant agent to a cell
expression neuroligin
2011 Bader, Mansour S. (College Station, Methods to treat produced water 7963338
Texas)
2011 Chemtura Corp. (Middlebury, Conn.) Antioxidant additive for biodiesel 7964002
fuels
2011 Universite de Liege (Angleur, Probiotic bifidobacterial species 7959912
Belgium)
2011 Mosaiques Diagnostics and Method and device for the 7955862
Therapeutics AG (Hanover, Del.) qualitative and/or quantitative
determination of a protein and/or
peptide pattern of a fluid sample,
which has been taken from a
human or animal body

2011 Merck Patent GmbH (Darmstadt, Fc-fusion proteins for enhancing 7955590
Germany) the immunogenicity of protein and
peptide antigens
2011 Cipla Medpro Research and Probiotic strain and antimicrobial 7951385
Development (Pty) Ltd. (Bellville, peptide derived therefrom
South Africa)
2011 Instituti Fisioterapici Ospitalieri Peptide able to break the 7939624
(Rome, Italy) m-p53/p63, m-p53/p73 and
m-p53/respective isoform proteins
complex formed in the tumor cells
and uses thereof in the
pharmacological field
2011 Imagilin Technologies LLC (Frederick, Probiotics as alternative 7935334
Md.) medicines against infectious
diseases
2011 The Procter & Gamble Company Canine probiotic Lactobacilli 7906112
(Cincinnati, Ohio)
EUROPEAN NUTRACEUTICAL PATENTS
TABLE 91
EUROPE NUTRACEUTICAL PATENTS, 2011-2015
Institution/
Patent Holder/ Patent
Date Company Title Number
2015 Evonik Röhm GmbH Pharmaceutical or nutraceutical EP2538955
(Kirschenallee 45, 64293 formulation
Darmstadt, Germany)
2015 HAMLET Pharma AB (Lilla Prophylactic and nutraceutical therapy EP2882446
Fiskaregatan 10, 222 22
Lund, Sweden)
2015 Ophthalmopharma AG Nutraceutical chocolate or compound EP2542096
(Bahnhofplatz 5, 6060 chocolate product
Samen, Obwalden)
2015 Universiti, Putra Malaysia Anti-diabetic nutraceutical composition EP2411033
(UPM Serdang, 43400 from palm leaf extract
Selangor Darul Ehsan,
Malaysia)
2015 SC, Teso Spec Srl (Str. Nutraceutic supplement for bees EP2949220
Muncii, Nr. 53 Parter, families and process for its
915200 Fundulea, Jud. administration
Calarasi, Romania)

2015 Rottapharm S.P.A. (Galleria A nutraceutical compound for treating EP2601847

Unione 5, 20122 Milano, excess of weight
Italy)
2015 Evonik Industries AG Pharmaceutical or nutraceutical EP2887926
(Rellinghauser Strasse composition with sustained release
1-11, 45128 Essen, characteristic and with resistance
Germany) against the influence of ethanol
2015 Laboratoires, Expanscience Extract of passionflower seeds and EP2934702
(10, Avenue de l'Arche, cosmetic, pharmaceutical,
92400 Courbevoie, dermatological and nutraceutical
France) compositions comprising same
2015 Evonik Industries AG Gastric resistant pharmaceutical or EP2887925
(Rellinghauser Strasse nutraceutical composition with
1-11, 45128 Essen, resist-ance against the influence of
germany) ethanol
2015 BioMan S.r.l. (Via Alfieri 18, Zinc-enriched biomass, method for the EP2173195
10121 Torino, Italy) preparation thereof and pro-biotic,
cosmetic, dietary and nutraceutic
products comprising the same
2015 Labomar S.r.l. (Via Nazario Oral composition comprising a low- EP2849732
Sauro 35/I, 31036 Istrana availability active ingredient, for use as
(TV), Italy) a medicament or a dietary/ supplement/
nutraceutical
2015 Compagnie, Des Peches Fish protein hydrolysate having a EP2247745
Saint Malo Sante (40 quai bone-stimulating and maintaining
Duguay Trouin, 35400 activity, nutraceuticaland
Saint-Malo, France) pharmacological compositions
comprising such a hydrolysate and
method for obtaining same
2015 Dupont, Nutrition Emulsified probiotic product EP1732395 B1
Biosciences Aps (Denmark)
2015 Biotmicrogen S. L. (Spain) Lactobacillus fermentum cect 7472 EP2707476 B1
Cajamar Caja, Rural strain with probiotic properties
Sociedad Cooperativa De
Crédito (Spain)
Sociedad, Cooperativa
Andaluza la Pastora de
Taberno (Spain)
Sociedad, Cooperativa
Andaluza Los Filabres
(Spain)
2015 Nestec S.A. (Switzerland) Non-replicating probiotic EP2637677
micro-organisms protect children B1
against gastrointestinal infections
2015 CARINSA. Creaciones Strains of lactobacillus plantarum as EP2220210
Aromáticas Industriales, probiotics with immunomodulatory B1
S.A (Spain) specific effect
2015 N.V. Nutricia (Netherlands) Combination of a leucine source and an EP2435039 B1
omega-3 unsaturated fatty acid source
for use in the treatment of
hypercalcaemia

2015 SIGMA-TAU Industrie Homogeneous formulations comprising EP2952209 A1

Farmaceutiche Riunite omega-3 polyunsaturated fatty acids
S.p.A. (Italy) (n-3 PUFA) and resveratrol for oral
administration
2015 SIGMA-TAU Industrie Solid formulations containing resveratrol EP2952180 A1
Farmaceutiche Riunite and omega-3 polyunsaturated fatty
S.p.A. (Italy) acids (n-3 PUFA)
2015 Universidad, De Santiago Method for the formulation of a EP2796054
De Chile (Chile) gel-format foodstuff for use as a B1
nutritional foodstuff enriched with
peptides and maltodextrins obtained
from quinoa flour
2014 Promo Pharma S.p.A. (Via A nutraceutical compound EP2745707
Biagio di Santolino, 156,
47892 Acquaviva, SM)
2014 Promo Pharma S.p.A. (Via A nutraceutical compound EP2745710
Biagio di Santolino, 156,
47892 Acquaviva, SM)
2014 Quincy Bioscience LLC Nutraceutical compositions containing EP2545934
(455 Science Drive Suite aequorin
120, Madison WI 53711,
US)
2014 Dacy Tech Pty Ltd (7 The Nutraceutical composition and methods EP2231173
Avenue, Delacombe, VIC of use
3356, AU)
2014 VALENT BIOSCIENCES Pharmaceutical and nutraceutical EP2616059
CORP. compositions of abscisic acid
2014 Evonik Röhm GmbH Coating composition suitable for EP2720682
(Kirschenallee, 64293 pharmaceutical or nutraceuticaldosage
Darmstadt, GERMANY) forms
2014 Khirug, Stanislav Phytogenic nutraceutical composition EP2817016
(Havukallionkatu 9 B 19, and methods of use thereof
01360 Vantaa, FI)
2014 Evonik Röhm GmbH Coating composition suitable for EP2720681
(Kirschenallee, 64293 pharmaceutical or nutraceuticaldosage
Darmstadt, GERMANY) forms
2014 Evonik Röhm GmbH Gastric resistant pharmaceutical or EP2720683
(Kirschenallee 45, 64293 nutraceutical composition with
Darmstadt, GERMANY) resistance against the influence of
ethanol
2014 Siegfried Ltd. (Untere Kit comprising a packaging material and EP2748000
Brühlstrasse 4, 4800 a solid pharmaceutical
Zofingen, CH) ornutraceutical product contained in the
packaging material
2014 Laboratoire Clemascience Nutraceutical composition for limiting EP2683256
(SARL) (Cité de la the absorption of dietary lipids and for
Cosmétique, Bât. B2 Rue inducing weight loss, comprising, as
Odette Jasse, 13015 active agent, at least one extract of
Marseille, France) carrot
2014 Nestec S.A. (Switzerland) Probiotics, secretory iga and EP2700412 A1
inflammation

2014 Nestec S.A. (Switzerland) Probiotics, secretory iga and infection EP2318047 B1
2014 Nestec S.A. (Switzerland) Probiotics, secretory iga and infection EP2700411 A1
2014 Compagnie, Gervais Probiotic strains for use in improving EP2575834
Danone (France) transepithelial resistance B1
2014 Compagnie, Gervais Probiotic strains for use in improving the EP2575837 B1
Danone (France) enteric nervous system
2014 Probiotical S.p.a.(Italy) Method for the preparation of anallergic EP2169050
probiotic bacterial cultures and related B1
use
2014 CARGILL, INCORPORATED Improved dietary fiber containing EP1608236
(U.S.) materials comprising low molecular B1
weight glucan
2014 Weyerhauser NR Company Catalytic carboxylation of cellulose EP2574633 B1
(U.S.) fibers in a continous process with
multiple additions of catalyst, secondary
oxidant and base to a moving slurry of
cellulose fibers
2014 Visiotact Pharma (France) Composition comprising OPC and EP2476425 B1
Omega-3 for preventing and/or
inhibiting the development of diabetic
retinopathy
2014 Heliae Development LLC Methods of and systems for isolating EP2556136 B1
(U.S.) carotenoids and omega-3 rich oils from
algae
2014 Amorphical Ltd.(Israel) Stable amorphous calcium carbonate EP2251018
comprising phosphorylated amino acids, B1
synthetic phosphorylated peptides, and
gastrolith proteins
2014 Université, Bordeaux Selective nox-1 inhibitor peptides and EP2752196
Segalen (France) and uses thereof A1
Inserm (France)
2014 E.I. Du Pont De Nemours Clay-binding peptides and methods of EP1999140
And Company (U.S.) use B1
2014 Laboratorios Ordesa S. A novel strain of bifidobacterium and EP2179028 B1
l.(Spain) active peptides against rotavirus
infections
2013 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids (EPA, EP2675445A1
(Canada) DHA and DPA) for use in cardiovascular
diseases
2013 Pivotal Therapeutics Inc. A formulations comprising omega-3 EP2675444A1
(Canada) fatty acids and an anti obesity agent for
the reduction of body weight in
cardiovascular disease patients (CVD)
and diabetics
2013 Pivotal Therapeutics Inc. Omega-3 fatty acid diagniostic assay for EP2675443A1
(Canada) the dietary management of patients
with cardiovascular disease (CVD)

2013 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor EP2675442A1

(Canada) (azetidinone) and omega-3 fatty acids
(EPA, DHA, DPA) for the reduction of
cholesterol and for the reduction of
cardiovascular events
2013 Agilent Technologies Inc. A computational method for mapping EP2674758A1
(Germany) peptides to proteins using sequencing
data
2013 Merz Pharma GmbH & Co. Balneotherapeutic lipid-containing EP2670385A2
KGaA (Germany) probiotic preparations and their
applications
2013 LR Health & Beauty Probiotic compound and use of same EP2228067B1
Systems GmbH (Germany)
2013 Instituto Mediterráneo Para Use of antioxidants for the treatment of EP2671580A1
el Avanced de la cognitive and behavioural disorders in
Biotecnologia y la individuals with fragile x syndrome
Investigacion Sanitaria
(Fundacion IMABIS) (Spain)
2013 Nestec S.A. (Switzerland) Probiotics for use in expecting female EP2668854A1
mammals for enhancing the immunity of
their offsprings
2013 Labomar S.r.l. (Italy) Nutraceutical compositions containing EP2461705B1
probiotics in an oily vehicle
2013 Nestec S.A. (Switzerland) Probiotics, secretory iga and EP2318046B1
inflammation
2013 Innavirvax (France) Immunogenic compounds comprising EP2668959A1
HIV gp41 peptide coupled to CRM197
carrier protein
2013 Vesale Pharma Sa Microencapsulated probiotic substance EP2665378A1
(Germany) and process of manufacture
2013 F. Holzer GmbH (Germany) Composition and medication containing EP2664330A1
Omega-3 fatty acids and a
glucosaminoglucan
2013 L'AIR LIQUIDE (France) Antimicrobially active compositions EP2664318A1
based on zinc compound, glycerine
monoalkyl ether and antioxidant
2013 AB-Biotics S.A. (Spain) Probiotic composition for use in the EP2528610B1
treatment of bowel inflammation
2013 Seiko Epson Corp. Antibody to signal peptide of amyloid EP2662387A1
(Germany) precursor protein
2013 Wyeth-Pharma GmbH Improved stability in vitamin and EP2111126B1
(Germany) mineral supplements
2013 Nestec S.A. (Switzerland) A nutritional composition comprising EP2658560A1
fiber and probiotics for reducing
stress-related intestinal symptoms
2013 Nestec S.A. (Switzerland) Fiber and probiotics for reducing EP2658559A1
intestinal symptoms related to stress
2013 Nestec S.A. (Switzerland) Fiber and probiotics for reducing EP2658558A1
intestinal symptoms related to chronic
stress

2013 Nestec S.A. (Switzerland) Probiotics to increase iga secretion in EP2315595B1

infants born by caesarean section
2013 Ferrosan, A/S (Denmark) Probiotic tablet formulations EP1699474B2
2013 Fraunhofer-gesellschaft V, Nucleic acid sequences and EP2647646A1
Zur Förderung Der peptides/proteins of the FT family
Angewandten Forschung e. providing flower-repressing properties in
(Germany) tobacco and transgenic plants
transformed therewith
2013 Nestec S.A. (Switzerland) Array of age-tailored nutritional formula EP2640201A1
with probiotics
2013 Papathanasiou, Georgios Composition of an oral dosage form of EP2641599A1
(Greece) vitamin E esters combination with
enhanced antioxidant activity.
2013 Nestec S.A. (Switzerland) Non-replicating probiotic EP2637678A1
micro-organisms protect against upper
respiratory tract infections
micro-organisms protect children
2013 Nestec S.A. (Switzerland) Non-replicating probiotic bacteria and EP2637676A1
prevention or treatment of infections to
reduce absence from school or daycare
2013 Nestec S.A. (Switzerland) Extruded non-replicating probiotic EP2637517A1
benefits
2013 Nestec S.A. (Switzerland) Frozen confections containing probiotic EP2637513A2
micro-organisms
2013 Nestec S.A. (Switzerland) Spoonable yogurt preparations EP2637510A1
containing non-replicating probiotic
micro-organisms
2013 Nestec S.A. (Switzerland) Probiotics for use in expecting female EP2348890B1
their offsprings
2013 Nestec S.A. (Switzerland) Drinking yoghurt preparations EP2635139A1
micro-organisms
2013 Nestec S.A. (Switzerland) Powdered cereal compositions EP2635138A1
comprising non-replicating probiotic
microorganisms
2013 Nestec S.A. (Switzerland) Rice pudding preparations containing EP2635136A1
probiotic micro-organisms
2013 Nestec S.A. (Switzerland) Pet food preparations containing EP2635132A1
2013 Otkrytoe, Aktsionernoe Antioxidant additive composition, a EP2636722A1
Obschestvo “Sterlitamaxky solution thereof, and a method for
Neftekhimichesky Zadov” improving the storage stability of
(Russia) biodiesel fuel
2013 Nippon Steel and Antioxidant and method for producing EP2634289A1
Sumitomo Metal Corp. metal material
(Japan)

2013 Probiotical S.p.a. (Italy) Composition based on probiotic bacteria EP2219658B1

in association with a prebiotic and use
thereof in the prevention and/or
treatment of respiratory pathologies
and/or infections and in the
improvement of intestinal functionality
2013 Probiotical S.p.a. (Italy) Composition comprising probiotic EP2626076A1
bacteria for the treatment of pathologies
associated with alterations of the
immune system
2013 Nestec S.A. (Switzerland) Probiotics to improve gut microbiota EP2131680B1
2013 PROBI AB (Sweden) Probiotic lactobacillus strains for EP1824500B1
improved vaginal health
2013 Centro Superior de Anticaries compositions and EP2612904A2
Investigación en Salud probiotics/prebiotics
Pública (CSISP) (Spain)
their offsprings
2013 AB-Biotics S.A. (Spain) Probiotic composition for oral health EP2606155A1
2013 Dupont, Nutrition Method for improving the survival rate EP2605669A1
Biosciences Aps (Denmark) of probiotic
2013 Graf, Dr. Federico Lactic acid bacteria as probiotic strains EP2561880A3
(Switzerland) and compositions containing same
2013 Nestec S.A. (Switzerland) Use of green coffee and probiotic for EP2598104A2
regulating skin pigmentation
2013 Biolek Sp. z o.o.(Poland) Use of a mixture of probiotic bacteria in EP2597972A1
a mixture with short - chain fatty acids
2013 Micuri, Aps (Denmark) A packaged probiotic composition and EP2596776A1
uses thereof
2013 Fakulta V, Rybárstvi Feed for common carp and method of EP2462814A3
Ochrany Vod Jihoceská rearing common carp with increased
Univerzita Ceskych a. content of omega-3 fatty acids
(Czech Republic)
2013 Synbiotec S.r.l. (Italy) Lactic acid bacteria strains exhibiting EP1743042B1
probiotic properties and compositions
comprising the same
2013 Heinrich-heine-universität, Agents and methods for the expression EP2583975A1
Düsseldorf (Germany) and secretion of peptides and proteins
2013 Histocell S. L. (Spain) Antioxidant composition EP2583682A1
2013 Probiotical S.p.A. (Italy) Vitamin B12 producing probiotic EP2580316A2
bacterial strains
2013 Nestec S.A. (Switzerland) Dispensing container for probiotics EP2580131A1
2013 Celac Sweden AB (Sweden) New probiotic strains EP2578090A1
2013 Compagnie, Gervais Probiotic strains for use in improving the EP2575837A1
Danone (France) enteric nervous system
2013 Compagnie, Gervais Probiotic strains for use in improving EP2575834A1
Danone (France) transepithelial resistance

2013 Borealis AG (Austria) Process for the production of polyolefins EP2578606A1

wherein an antioxidant is fed to the
reaction mixture during the process
2013 Zimmer Inc. (France) An antioxidant stabilized crosslinked EP2578248A1
applications
2013 Universita', Della Calabria Cosmetic, pharmaceutical or EP2535087A3
(Italy) nutraceutical formulations containing
antioxidant molecules and polymeric
materials
2013 Cornelli Consulting S.A.S. Antioxidant composition for reducing EP2567695A1
Di Umberto Cornelli & C. oxidative stress ascribable to treatment
(Italy) with hormonal contraceptives
2013 Kloarys Investment Ltd. Topical cosmetic or pharmaceutical EP2364712B1
(Virgin Islands) composition comprising probiotic
lactobacillus strains and use of same
applications
2013 Neo Cremar Co. Ltd. Yeast hydrolysate having obesity EP2564860A2
(SICOX Tower 118 513-14 treatment effects and antioxidant
Sangdaewon 1-dong activity
Jungwong-gu, Seongnam-si,
Gyeonggi-do 462-737,
Korea)
2013 Graf, Dr. Federico Lactic acid bacteria as probiotic strains EP2561880A2
2013 Henkel AG & Co. KGaA Cleaning agent that reinforces the skin EP2556823A2
(Germany) barrier comprising a ferment bases on
probiotic microorganisms
2013 Probiotical S.p.A. (Italy) Composition comprising probiotic EP2544698A1
bacteria for use in the treatment of
immune disorders
2013 Probiotical S.p.A. (Italy) Food product comprising probiotic EP2544547A1
bacteria coated with a coating of
vegetable origin
2013 Borealis AG (Austria) Use of carbon black and antioxidants for EP2543715A1
reducing taste and/or odour in a
polyolefin composition
2012 Mead Johnson Nutrition Probiotic infant products EP2323494B8
Company (Germany)
Company (Germany)
2012 Graf, Dr. Federico Lactic acid bacteria as probiotic strains EP1812023B8
2012 The Procter & Gamble Stabilized compositions comprising EP1680501B1
Company (U.S.), probiotics
Alimentary Health Limited
(Ireland)

2012 Universita', Della Calabria Cosmetic, pharmaceutical or EP2535087A2

(Italy) nutraceutical formulations containing
antioxidant molecules and polymeric
materials
2012 AB-Biotics S.A. (Spain) Probiotic composition for use in the EP2528610A1
treatment of bowel inflammation
2012 Biotmicrogen S. L. (Spain) Lactobacillus fermentum CECT 7472 EP2520644A1
strain with probiotic properties
2012 Suomen, Punainen Risti Probiotic bifidobacterial composition in EP2519256A2
Veripalvelu (Finland) accordance with secretor blood group
status
2012 Suomen, Punainen Risti Probiotic bifidobacterial composition in EP2519255A2
Veripalvelu (Finland) accordance with secretor blood group
status
2012 Probi AB (Sweden) Non-fermented compositions comprising EP2515937A1
a cereal based fraction and a probiotic
and uses thereof
2012 Biopolis S. L. (Spain) Obtainment of bioactive products from EP2517567A1
cocoa having inhibitory activity against
the pep enzyme and antioxidant and/or
antineurodegenerative activity
2012 Probiotical S.p.A. (Italy) Conjugated linoleic acid-producing EP2513292A2
strains of probiotic bacteria and use
thereof for the preparation of a food,
dietetic or pharmaceutical composition
Company (Germany)
Company (Germany)
2012 Obshestvo, Ogranichennoj Antioxidant EP2514429A1
Otvetstvennostju
"PARAFARM" S. (Russia)
2012 Nestec S.A. (Switzerland) Probiotic microorganisms as active EP2509581A1
agents against changes in the skin's
micro relief
2012 L'oréal (France), Nestec Probiotic microorganisms as active EP2509580A1
(Switzerland) agents for enhancing the radiance of the
skin's complexion
2012 Nestec S.A. (Switzerland) An infant formula delivery system EP2509451A1
comprising probiotics and an infant
nutritional formulation
2012 Nestec S.A. (Switzerland) Infant formula with probiotics and milk EP2509429A1
fat globule membrane components
2012 Arla, Foods Amba Probiotics to influence fat metabolism EP1945235B1
(Denmark) and obesity
2012 Probiotical S.p.a. (Italy) Probiotic bacteria based composition EP1773361B2
and use thereof in the prevention and/or
treatment of respiratory pathologies and
2012 Alimentary Health Limited Probiotic bifida bacterium strain EP2498789A1
(Ireland)

2012 Chr, Hansen A/S (Denmark) New probiotic bifida bacterium longum EP2318513B1
2012 Biosearch S.A. (Spain) The process for the selection of new EP1565547B2
probiotic strains, to new probiotic
microorganisms of the genus
lactobacillus
2012 BASF Plant Science GmbH Pythium omega-3 desaturase with EP2500420A1
(Germany) specificity to all omega- 6 fatty acids
longer than 18 carbon chains
2012 Otkrytoe, Aktsionernoe Antioxidant additive composition, a EP2500402A1
Obschestvo "Sterlitamaxky solution thereof, and a method for
Neftekhimichesky Zadov" improving the storage stability of
(Russia) biodiesel fuel (variants)
2012 Obschestvo, Pharmaceutical substances on the basis EP2500336A1
Ogranichennoi of mitochondrially addressed
Otvetstvennostyu antioxidants
"Mitotekh" S. (Russia)
2012 Nestec S.A. (Switzerland) Nutritional compositions comprising EP2493336A1
lactoferrin and probiotics and kits of
parts thereof
2012 Wyeth-Pharma GmbH Improved stability in vitamin and EP2491800A1
(Germany) mineral supplements
2012 Instytut, Biochemii Synthetic genes encoding peptide EP2436693A3
Biofizyki Pan I. (Poland) fragments of natural myelin proteins for
induction of oral tolerance, DNA
fragment comprising these genes,
means of obtaining these peptides in a
microbial (bacterial) system and their
medical application
applications
2012 Graf, Dr. Frederico Lactic acid bacteria as probiotic strains EP1812023B1
2012 F.Hoffmann-La Roche AG Method of processing protein peptide EP2000935A3
(Switzerland) data and system
2012 Affiris AG (Austria) Vaccines based on peptides of the EP2468295A1
complement protein C5a
2012 Fakulta V, Rybárstvi Feed for common carp and method of EP2462814A2
Ochrany Vod Jihoceská rearing common carp with increased
Univerzita Ceskych a. content of omega 3 fatty acids
(Czech Republic)
micro-organisms protect children
2012 Nestec S.A. (Switzerland) Non-replicating probiotic bacteria and EP2455093A1
prevention or treatment of infections in
children
micro-organisms protect against upper
respiratory tract infections

2012 Suomen Punainen, Risti Use of animal cells for screening EP2454594A1
Veripalvelu (Finland) probiotic bacteria strains
2012 Nestec S.A. (Switzerland) Extruded non-replicating probiotic EP2452576A1
benefits
2012 Nestec S.A. (Switzerland) Array of age-tailored nutritional formula EP2452575A1
with probiotics
2012 INSERM - Institut National Recombinant probiotic bacteria for the EP2451467A1
de la Santé et de la prevention and treatment of
Recherche Médicale inflammatory bowel disease (IBD) and
(France), Institut, Pasteur irritable bowel syndrome (IBS)
(France),Université, Paris
Diderot Paris (France)
2012 Rubin, Israel (47 Sheshet Heat resistant probiotic compositions EP2451300A1
HaYamim Street, 44269 and healthy food comprising them
Kfar Saba, IL), Zimand,
Henri (Israel)
2012 Nestec S.A. (Switzerland) Drinking yoghurt preparations EP2449891A1
micro-organisms
2012 Nestec S.A. (Switzerland) Powdered cereal compositions EP2449890A1
comprising non-replicating probiotic
microorganisms
2012 Nestec S.A. (Switzerland) Rice pudding preparations containing EP2449889A1
2012 Nestec S.A. (Switzerland) Pet food preparations containing EP2449887A1
2012 Consejo, Superior De Method for identifying peptides and EP2450815A1
Investigaciones Científicas proteins according to mass
(Spain) spectrometry data
2012 Zimmer Inc. (France) Polymers compositions including an EP2395048A3
antioxidant
2012 Nestec S.A. (Switzerland) A suction device with external deposit of EP2441432A1
probiotics
2012 Cornelli, Umberto (Italy) Antioxidant composition for reducing the EP2441450A1
oxidative stress and side effects
ascribable to treatment with
levothyroxine
probiotics and improving sleep patterns
2012 Instytut, Biochemii Synthetic genes encoding peptide EP2436693A2
Biofizyki Pan I. (Poland) fragments of natural myelin proteins for
induction of oral tolerance, DNA
fragment comprising these genes,
means of obtaining these peptides in a
microbial (bacterial) system and their
medical application
2012 Bayer Pharma Medication for oral administration, EP2432474A1
Aktiengesellschaft comprising at least one estrogen and/or
(Germany) at least one gestagen and at least one
probiotic bacterial strain

2012 PROBI AB (Sweden) Probiotic juice drink EP2432334A1

2012 Arla, Foods Amba Probiotics to influence fat metabolism EP2431044A1
(Denmark) and obesity
2012 Henkel AG & Co. KGaA Probiotic cleaner for hard surfaces EP2430138A1
(Germany)
2012 Henkel AG & Co. KGaA Probiotic hand dishwashing product EP2430135A1
(Germany)
2012 Nestec S.A. (Switzerland) Infant feeding formulas comprising EP2429557A2
2012 Nestec S.A. (Switzerland) Growing up milks containing probiotic EP2429556A2
micro-organisms
2012 Valio Ltd. (Finland) Novel use of probiotics EP2429555A2
2012 Nestec S.A. (Switzerland) Probiotic containing modules for tube EP2429554A1
feeding
2012 Nestec S.A. (Switzerland) Complete liquid nutrition for children at EP2429553A1
the age of 1-10 years comprising
probiotics
2012 Nestec S.A. (Switzerland) Oral nutritional supplement comprising EP2429552A1
probiotics
2012 Nestec S.A. (Switzerland) Dry whole milk preparations containing EP2429551A1
2012 Nestec S.A. (Switzerland) Nutritionally balanced standard tube EP2429550A1
feeding formula containing probiotics
2012 Nestec S.A. (Switzerland) Breakfast cereals containing probiotic EP2429549A1
micro organisms
2012 Nestec S.A. (Switzerland) Oral nutritional supplement for children EP2429548A1
comprising probiotics
2012 Nestec S.A. (Switzerland) Infant cereal comprising non-replicating EP2429546A1
probiotic microorganisms
2012 Nestec S.A. (Switzerland) Instant thickener comprising probiotics EP2429545A1
for hot or cold foods and beverages to
be administered to dysphagic patients
2012 Nestec S.A. (Switzerland) Specialized nutritional formula for adult EP2429543A1
patients with gastrointestinal
intolerance containing probiotics
2012 Nestec S.A. (Switzerland) Specialized medical nutrition for surgical EP2429541A1
and trauma patients containing
probiotics
2012 Nestec S.A. (Switzerland) Infant and young children feeding EP2429540A1
formula comprising probiotics for infants
and young children
2012 Eurolactis Group S.A. Probiotic microorganisms isolated from EP2427566A1
(Luxembourg) donkey milk
2012 TEAGASC, The Agriculture Probiotic composition suitable for EP1874917B1
and Food Development animals
Authority (Ireland),
University College
Cork-National University of
Ireland, Cork (Ireland)

2012 Bacterfield, OÜ (Estonia) Probiotic oil suspension and use thereof EP2421384A1
2012 Forschungsverbund V, Peptide and protein affinity tag from EP2423217A1
Berlin E. (Germany) mistic protein
2012 AB-Biotics, S.A. (Estonia) Probiotic composition for oral health EP2420580A1
2012 Chemotherapeutisches, Scaffold proteins for recombinant EP2392585A3
Forschungsinstitut peptide aptamers)
Georg-speyer-haus
(Germany)
2012 Dikovskiy, Aleksander Pharmaceutical composition comprising EP2415475A2
Vladimirovich (Russia) a proton pump inhibitor and a prebiotic
for the treatment of ulcerous lesions of
the stomach and duodenum
2012 Chr, Hansen A/S (Denmark) Use of a probiotic to regulate body EP2411027A1
weight
2012 Chr, Hansen A/S (Denmark) Use of probiotics to ameliorate EP2411026A1
diet-induced insulin resistance
2012 The IAMS Company Methods of use of probiotic lactobacilli EP1737477B1
(Netherlands), Alimentary for companion animals
Health Limited (Ireland)
2012 Hero España, S.A. (Spain) Isolation, identification and EP2407532A2
characterisation of strains with probiotic
activity, from faeces of infants fed
exclusively with breast milk
2012 Probiotical S.p.A. (Italy) Oily suspension containing probiotic EP2405894A2
bacteria for paediatric uses
2012 Lesaffre, et Compagnie Stable probiotic granulate, and method EP2405767A1
(France) for preparing same
2012 Lazarev, Mikhail Ivanovich Vitamin/mineral complex EP1360957B1
(Russia)
2012 Statens, Serum Institut Expanding the t cell repertoire to EP2402024A1
(Denmark) include subdominant epitopes by
vaccination with antigens delivered as
protein fragments or peptide cocktails
2012 Statens, Serum Institut Expanding the T cell repertoire to EP2402023A1
(Denmark) include subdominant epitopes by
vaccination with antigens delivered as
protein fragments or peptide cocktails
2011 Nestec S.A. (Switzerland Lactobacillus rhamnosus ncc4007, a EP2396014A1
probiotic mixture and weight control
2011 Histocell S. L. (Spain) Antioxidant composition EP2397125A1
2011 Nestec S.A. (Switzerland) Dispensing container for probiotics EP2394920A1
2011 Oü, Tervisliku Piima Isolated lactobacillus plantarum strain EP2288360B1
Biotehnoloogiate inducia dsm 21379 as probiotic that
Arenduskeskus (Estonia) enhances natural immunity and food
products and medicinal preparations
comprising it
2011 Zimmer Inc. (France) Polymers compositions including an EP2395048A2
antioxidant
2011 Baltadjieva, Maria (Estonia) Probiotic strain lactobacillus delbrueckii EP2076139B1
subsp. Bulgaricus

2011 Chemotherapeutisches, Scaffold proteins for recombinant EP2392585A2

Forschungsinstitut peptide aptamers
Georg-speyer-haus
(Germany)
2011 Wyeth-Pharma GmbH A multivitamin/mineral formulation to EP2389177A1
(Germany) combat the effects of environmental
stress; improve immunity and improve
energy while addressing vitamin and
mineral deficiencies without the
negative side effects of a mega dose
nutritional supplement
2011 Raw Materials Internatinal Pharmaceutical aqueous compositions EP2389931A1
LLC (Switzerland) comprising lipoic acid as an antioxidant
2011 Nestec S.A. (Switzerland) Synergistic antioxidant composition EP2389816A1
2011 Nestec S.A. (Switzerland) Probiotics for gut neuromuscular EP1531841B1
functions
2011 DNR S.r.l. (Italy) Antioxidant composition for reducing EP2388011A1
oxidative stress in dogs
2011 Pfizer Italia S.r.l. (Italy) Compositions comprising probiotic and EP2385837A2
prebiotic components and mineral salts,
with lactoferrin
2011 Chr, Hansen A/S (Denmark) Additive to food or drinking water EP2385765A1
containing botanical antioxidants
together with probiotic microorganisms
2011 Tartu Ülikool (Estonia) Bacillus smithii strain tbmi12 mscl p737 EP2101796B1
and use of endospores thereof as a
probiotic or a food supplement
2011 Probiotical S.p.a. (Italy) Chocolate flavoured probiotic EP2381799A2
supplement
2011 Wyeth-Pharma GmbH Use of proteins and peptides of the EP2377876A1
(Germany) TGF-BETA superfamily for purification
and therapeutic methods
2011 Bracco Imaging S.p.A (Italy) Probiotic formulations EP2373322A1
2011 N.V. Nutricia (Netherlands) Nutritional composition with probiotics EP1855550B1
2011 3T-Science S. L. (Estonia) Production of peptides and proteins by EP2369000A1
accumulation in mitochondria
2011 Friesland Brands B.V. Long-life probiotic food EP2276357B1
(Netherlands)
2011 Institut, De Recherche Pour Proteins/peptides having immunogenic EP2361634A1
Le Developpement (France) properties and their biological
applications
2011 Cor.Con. International S.r.L. Method for determining the antioxidant EP2362227A1
(Italy) power of biological and vegetal fluids
2011 N.V. Nutricia (Netherlands) Uronic acid and probiotics EP2353601A1
probiotics and improving sleep patterns
2011 N.V. Nutricia (Netherlands) Nutritional composition with probiotics EP2351492A1
their offsprings)

2011 Université, de la Method for obtaining foie gras including EP2255675A3

Méditerranée (France) the administration of probiotic bacteria
2011 Abiogen Pharma S.p.A. Cyclic hydroxylamine derivatives, their EP2345639A1
(Italy) preparation and use as antioxidants
2011 Dikovskiy, Aleksander Antimycotic and prebiotic EP2343088A1
Vladimirovich (Russia) pharmaceutical composition and a
method for treating candidal vaginitis
2011 Heil, Bettina (Austria) Suppository for rectal, vaginal or EP2338476A1
urethral administration containing a
probiotic, an antibiotic and an
unsaturated non-esterified fatty acid
2011 Nestec S.A. (Switzerland) An infant formula delivery system EP2335502A1
comprising probiotics and an infant
nutritional formulation
2011 The IAMS Company Methods of use of probiotic EP1718155B1
(Netherlands), Alimentary bifidobacteria for companion animals
2011 Campina Nederland Probiotic lactic acid bacteria EP2332557A1
Holding B.V. (Netherlands)
2011 L'oréal (France) Probiotic microorganisms as actives EP2332521A1
against changes in the skin's microrelief
2011 L'oréal (France), Nestec Probiotic microorganisms as an active EP2332520A1
S.A. (Switzerland). ingredient for enhancing skin radiance
2011 Technische, Universität Prebiotic EP2332426A1
Graz (Austria)
2011 Universität, Des Benzoquinone-based antioxidants EP2332898A1
Saarlandes (Germany)
2011 The IAMS Company Feline probiotic lactobacilli EP1880001B1
(Netherlands), Alimentary
2011 Mead Johnson Nutrition Probiotic infant products EP2323494A1
Company (Germany)
2011 Mead Johnson Nutrition Probiotic infant products EP2323493A1
Company (Germany)
2011 DSM IP Assets B.V. Production of beadlets comprising EP2320749A1
(Netherlands) probiotic compounds
2011 Chr, Hansen A/S (Denmark) New probiotic bifidobacterium longum EP2318513A1
2011 Nestec S.A. (Switzerland) Probiotics, secretory iga and infection EP2318047A1
2011 Nestec S.A. (Switzerland) Probiotics, secretory iga and EP2318046A1
inflammation
2011 The IAMS Company Canine probiotic lactobacilli EP1718154B1
2011 Nestec S.A. (Switzerland) Probiotics to increase iga secretion in EP2315595A1
infants born by caesarean section
2011 Ab-biotics Producciones, Lactobacillus plantarum strains as EP2311473A1
Industriales De Microbiotas probiotics
S.L. (Spain)

2011 Oü, Tervisliku Piima Isolated microorganism strain EP2309870A2

Biotehnoloogiate lactobacillus plantarum tensia dsm
Arenduskeskus (Estonia) 21380 as antimicro-bial and
antihypertensive probiotic, food product
and composition comprising said
microorganism and use of said
microorgan-ism for preparation of
antihypertensive medicine and method
for suppressing pathogens and
non-starter lactobacilli in food product
2011 The Procter & Gamble Use of orally administered probiotic EP2308566A1
Company (U.S.), bifidobacteria for human beauty benefits
Alimentary Health Limited
(Ireland)
2011 Nestec S.A. (Switzerland) Probiotics to improve gut microbiota EP2303294A1
2011 The IAMS Company Probiotic supplement, process for EP2299841A1
(Netherlands) making, and packaging
2011 The IAMS Company Probiotic supplement, process for EP2299840A1
(Netherlands) making, and packaging
2011 Mead Johnson Nutrition Probiotic material EP2295535A1
Company (Germany)
2011 Oü, Tervisliku Piima Isolated lactobacillus plantarum strain EP2288360A1
Biotehnoloogiate inducia dsm 21379 as probiotic that
Arenduskeskus (Estonia) enhances natural immunity and food
products and medicinal preparations
comprising it
2011 N.V. Nutricia (Netherlands) Use of probiotics and fibers for diarrhoea EP2173196B1
2011 Probiotical S.p.a. (Italy) Use of probiotic bacteria for the EP2276498A1
treatment of hyperhomocysteinaemia
2011 Probiotical S.p.a. (Italy) Use of probiotic bacteria for the EP2276498A1
treatment of hyperhomocysteinaemia
2011 Friesland Brands B.V. Long-life probiotic food product EP2276357A1
(Netherlands)
2011 Enterprise Ireland (Ireland) Probiotic strains from lactobacillus EP1002051B1
University College salivarius and antimicrobial agents
Cork-National University of obtained therefrom
Ireland (Ireland)
2011 The IAMS Company Feline probiotic lactobacilli EP2270131A1

JAPANESE NUTRACEUTICAL PATENTS
TABLE 92
JAPANESE NUTRACEUTICAL PATENTS, 2011-2015
Institution/
Patent Holder/
Date Company Title Patent Number
2015 Laboratoires Twirl Bee Compositions containing probiotics and JP2015514720
Pratt and Alexandra bee pollen / clay complex, the use of
Furegonezu (France) the preparation method, and the
compositions in nutrition and
therapeutics
2015 Dee SM IPD Assets Bee. Use of a protein hydrolyzate enriched JP2015524265
buoy.(Switzerland) in tryptophan
2015 Toriaruko Industries Method increased the protease JP2015501661
(Japan) enzymes for digestion rate and
absorption of the protein using the
same
2014 Pfizer Inc. (U.S.) and EDN3-like peptides and their use JP2014513923
The Scripps Research
Institute (U.S.)
2014 Dee SM IPD Assets Bee. Blood pressure lowering peptides in a JP5580273
buoy.(Switzerland) single enzymatic steps
2013 Agilent Technologies Method for mapping peptide onto JP2015257311
Inc. (U.S.) protein by using array data
2013 Probiotical SpA (Italy) Method for preparing anallergic JP2015252141
probiotic bacterial culture and related
use
2013 Kagoshima Univ. (Japan) Method for producing liquefied koji with JP2015252125
enhanced antioxidative activity
2013 Kao Corp. (Japan) Antioxidant JP2015249285
2013 National Taiwan Normal Novel nickel complex, derivative of the JP2015241385
Univ. (Japan) same, method of producing the same
and application to antioxidant
2013 Toyota Motor Corp. Metal surface treatment agent and JP2015237906
(Japan) antioxidant coating
2013 Immunomedics Inc. Method and composition for improved JP2015231059
(Japan) f-18 labeling of protein, peptide and
other molecule
2013 Kobayashi Shigeki (Japan) Method for decontaminating soil and JP2015231678
incineration ash by ionization of
radioactive cesium
2013 Sumitomo Chemical Co. Antioxidant for rubber JP2015231155
Ltd. (Japan)
2013 Kyowa Hakko Bio Co. Antioxidant composition comprising JP2015230987
Ltd. (Japan) oxidized glutathione

2013 Tokyo Metropolitan Univ, Antioxidant agent JP2015227388

Tokyo Medical Univ.
(Japan)
2013 Nestec SA (Switzerland) Probiotics in pre- and/or post-surgical JP2015216658
environment
2013 Showa Sangyo Co. Ltd. Burst restraining material in microwave JP2015215160
(Japan) heating cooking, and method for
preventing burst of food in microwave
heating cooking
2013 Ogawa Tatehiko, Kubota Reduction powder, and method of JP2015212498
Shoji (Japan) producing the same
2013 Kao Corp. (Japan) Antioxidant composition JP2015209436
2013 Sunstar Inc. (Japan) Antioxidant function enhancer JP2015209351
2013 Chube Univ., Nippon Nivalenol and deoxynivalenol analysis JP2015195359
Filcon Co. Ltd. (Japan) method
2013 Shiseido Co. Ltd. (Japan) Antioxidant JP2015194020
2013 Scios Inc. (Japan) Controlled release and delivery of JP2015189448
peptide or protein
2013 Asahi Glass Co. Ltd. Crosslinked rubber article JP2015189655
(Japan)
2013 NPO APSD (Japan) Novel flavanone compound, novel JP2015189421
stilbene compound, antimicrobial agent,
antioxidant, and highly antimicrobial/
Antioxidant apiculture composition
2013 Ottochi Green Station Vegetable of excellent antioxidant JP2015188163
KK (Japan) capability using electrolytic hydrogen
water, and method of processing the
same
Ltd. (Japan)
2013 Toyo Tire & Rubber Co. Antioxidant for rubber compounding, JP2015185050
Ltd. (Japan) rubber composition, and pneumatic tire
2013 Kose Corp. (Japan) Antioxidant and dna damage inhibitor JP2015184942
2013 Asahi Food & Healthcare Vitamin mineral containing tablet and JP2015179905
Ltd., (Japan) manufacturing method thereof
2013 Nikken Seil Co. Ltd. Antioxidation ability determination tool JP2015181851
(Japan)
2013 Maruzen Pharmaceut Co. Antioxidant, anti-aging agent, JP2015177439
Ltd. (Japan) anti-inflammatory agent, hair-growth
agent, anti-obesity agent, and
skin-whitening agent, and cosmetic and
aesthetic eatable and drinkable
2013 Kanazawa Inst. Of Antioxidant composition, composition JP2015172711
Technology, Ishikawa inhibiting activity of disaccharide
Prefecture, hydrolase, composition for intestinal
Habutaetoufu Co. Ltd. regulation, diet composition, food and
(Japan) drink, and method of selectively
producing arabinose
2013 Ogawa & Co. Ltd. (Japan) Oil-soluble antioxidant and method for JP2015159730
producing the same

2013 Iwate Univ., Tsuwano Immunostimulator, cancer cell JP2015151558

Machi (Japan) proliferation inhibitor,
anti-inflammatory agent or antioxidant
including cordyceps sinensis as active
ingredient
2013 Hill’s Pet Nutrition Inc. Composition and method for enhancing JP2015151505
(Japan) antioxidant status of animal
2013 Nihon Yamamura Glass Antioxidation/antiallergic agent JP2015151451
Co. Ltd. (Japan) containing extract of impatiens
2013 Kracie Home Products Cosmetic, elastase inhibitor, and JP2015151448
Ltd, Akashi Isamu antioxidant
(Japan)
2013 Fuji Oil Co. Ltd. (Japan) Antioxidant JP2015147456
2013 Nordisk Rebalance AS Treatment of IBD and IBS using both JP2015144712
(Denmark) probiotic bacteria and fermented cereal
as treatment effector
2013 T Hasegawa Co. Ltd. Antioxidative perfume composition JP2015144800
(Japan)
2013 Technologies Biolactis Use of probiotics and lactobacillus JP2015139462
Inc. (Japan) kefiranofacience as synbiotic
2013 Kracie Home Products Antioxidant and elastase activity JP2015139409
Ltd. (Japan) inhibitor, and cosmetic including them
2013 Nordisk Rebalance AS Treatment of IBD and IBS using JP2015136644
(Denmark) probiotic bacteria and fermented cereal
as treatment effector
2013 Misawa Koichi (Japan) Method for producing cellulase using JP2015132250
intestinal probiotic bacterium in animal
2013 Tropical Plant Resources Antioxidant, food browning inhibitor, JP2015133424
Institute Inc. (Japan) antioxidant beverage and method for
producing homogentistic acid
2013 Tropical Plant Resources Antioxidant and antioxidant beverage JP2015133423
Institute Inc. (Japan)
2013 Yokohama City Univ. Method for specific cleavage of JP2015130570
(Japan) N-Cαbond or Cα-C bond in peptide
main chain of protein and
phosphorylated peptide
2013 Amorepacific Corp. Cosmetic composition for antioxidation JP2015126980
(South Korea) or skin-whitening containing mixed
extract of korean drug material
2013 Shimadzu Corp. (Japan) Method for selectively recovering JP2015124242
c-terminal peptide of protein, and
amino acid sequence determination
method for c-terminal peptide of
protein, using the same
Ltd. (Japan)
Ltd. (Japan)
Ltd. (Japan)


Ltd. (Japan)
2013 Abbott Laboratories Pharmaceutical composition having JP2015121976
(U.S.) improved dissolution profile for poorly
soluble drug
2013 Wyeth LLC (U.S.) Improved stability in vitamin and JP2015106619
mineral supplement
2013 Kawaguchi Kagaku Zinc alkyldithiocarbamate compound, JP2015108046
Kogyo KK (Japan) antioxidant for mineral oil and mineral
oil composition
2013 Fine Co. Ltd. (Japan) Maqui berry-containing antioxidant JP2015107825
composition
2013 Hatsuratsu Co. Ltd. Thickening composition and skin JP2015103910
(Japan) external preparation
2013 Shizuoka Prefecture, Antioxidant and skin-whitening agent, JP2015103915
Dainichiseika Color & and food and drink, cosmetic, and
Chem Mfg. Co. Ltd. quasi drug containing them
(Japan)
2013 Ogawa & Co. Ltd. (Japan) Antioxidant plant extract, and JP2015079242
preparation for external use, cosmetic,
bathing agent, and detergent, each
containing the extract
2013 Kirin Holdings Co. Ltd., Method for determining antioxidant JP2015068545
Okayama Univ. (Japan) activity of polyphenol in vivo
2013 Kagawa Univ. (Japan) Jatropha extract, antioxidant, and JP2015064123
method for producing antioxidant
2013 Iwate Prefecture (Japan) Adsorbent and virus adsorption method JP2015059754
2013 Japan Carlit Co. Ltd. Electrolyte for dye-sensitized solar cell JP2015058400
(Japan) and dye-sensitized solar cell using the
same
2013 Semiconductor Energy Method for forming graphene and JP2015056818
Lab Co. Ltd. (Japan) graphene oxide salt, and graphene
oxide salt
2013 Watanabe Oisutaa Method for producing oyster meat JP2015051937
Kenkyusho: KK (Japan) extract containing large amount of
antioxidant of high orac value
2013 Mannkind Corp. (Japan) Purification and stabilization of peptide JP2015049684
and protein pharmaceutical agents
2013 Osaka Gas Co. Ltd. Device and method for determining JP2015050414
(Japan) water quality
2013 Doshisha (Japan) Method of measuring antioxidation JP2015044613
ability of living body
2013 Life Design KK, Kyushu Bark extract of bamboo shoot, and JP2015043856
Univ. (Japan) melanin synthesis inhibitor, whitening
agent, antioxidant, antiaging agent and
antimicrobial agent including the bark
extract of bamboo shoot as active
constituent

2013 Univ. Of Tsukuba, Kyorin Antioxidation stress enzyme expression JP2015043851

Pharmaceutical Co. inducing agent
Ltd. (Japan)
2013 Danisco AS (Denmark) Probiotics for use in relieving symptom JP2015040186
associated with gastrointestinal
disorder
2013 R.T. Vanderbilt Co. Inc. Lubricating antioxidant composition JP2015040342
(U.S.) using organotungstate salt component
having synergistic effect
2013 Daiichi Sankyo Antioxidant and/or anti-inflammatory JP2015040200
Healthcare Co. Ltd. and analgesic agent
(Japan)
2013 Back, Kwang Sung, LS Multiple separator-filter, manufacturing JP2015034984
Nova Co. Ltd. (Japan) method of the same, and antioxidation
water by using the same
2013 Hitachi Cable Ltd. (Japan) Deterioration degree determination JP2015032958
method of resin material containing
antioxidant, life determination method,
life prediction method, life test method,
and computer program
2013 Ginza Tomato KK, Skin external preparation composition JP2015014582
BIO-FD&C Co. Ltd. (Japan) including culture with rose placental
tissue or its extract, method for
producing the same, functional food
and antioxidant composition
2013 National Institute Of High-efficiency secretory signal peptide JP2015009685
Advanced Industrial and protein expression system using
Science & Technology the peptide
(Japan)
2013 Chigira Masaki (Japan) Separation recovery system of JP2015007699
radioactive material
2013 Sanken Electric Co. Ltd. Semiconductor device JP2015004860
(Japan)
2013 Kao Corp. (Japan) Process for producing antioxidant JP2015001904
2013 Systec:KK (Japan) Water-soluble antioxidant-covered tea, JP2015000076
tea packaged with filter body and using
the same, aggregate of tea-packaged
bodies and method for producing the
same
2012 Toyobo Co Ltd. (Japan) Novel ionizable group-containing JP2012241090
polymer and application of the same
2012 Tokyo Metropolitan Antioxidant to skin fibroblast and JP2012240992
Geriatric Center, Tsukiji pathological condition improving agent
Eiichi, Saito Takeshi for skin
(Japan)
2012 Dr's Choice Co. Ltd., Composition having antioxidation JP2012236794
activity, and beverage, food and
cosmetic obtained by blending the
same
Daiana KK (Japan)

2012 Takasago Internatl Cell augmenting agent, antioxidant, JP2012236792

Corp. (Japan) aroma composition and skin care
preparation
2012 Johns Hopkins Univ Albumin-bound protein/peptide JP2012233907
(Maryland) complex as biomarker for disease
2012 Ebara Corp. (Italy) Electroplating method JP2012224944
2012 Microalgae Corp., Gifu Isoprenoid compound, method for JP2012224576
Univ. (Japan) producing the same, and antioxidant
2012 Watanabe Oisutaa Method for producing oyster meat JP2012217398
Kenkyusho KK (Japan) extract containing large amount of
antioxidant having high antioxidative
activity
2012 Sunstar Inc. (Switzerland) Method for producing antioxidant JP2012214452
composition and health food
2012 Naris Cosmetics Co. Antioxidant agent, and antioxidant JP2012214393
Ltd. (Japan) cosmetic
2012 Naris Cosmetics Co. Antioxidant agent, and antioxidant JP2012214392
Ltd. (Japan) cosmetic
2012 Japan Aviation Electrode antioxidation organic device JP2012212828
Electronics Industry Ltd. and manufacturing method therefor
(Japan)
2012 Solt Industry Center Of Monovalent anion-permselective anion JP2012201693
Japan (Japan) exchange membrane for salt
production, and method for producing
the same
2012 Bloom Classic Co. Ltd. Antioxidant and skin cosmetic JP2012201598
(Japan)
2012 Chikuno Shokuhin Kogyo Antioxidant and cosmetic and the like JP2012188574
KK, Wakayama containing the same
Prefecture (Japan)
2012 National Institute Of Method for measuring antioxidant JP2012185156
Advanced Industrial & capacity
Technology (Japan)
2012 Chemtura Corp. (U.S.) Antioxidant for synthetic lubricant, and JP2012184433
preparation method
2012 Kracie Foods Ltd. (Japan) Low-density lipoprotein antioxidant and JP2012184257
food and drink product using the same
2012 Kobe Gakuin (Japan) Cyclic peptide compound having JP2012180315
protein tyrosine kinase inhibiting
activity
2012 Kose Corp. (Japan) Antioxidant, tenseness- and JP2012176923
slack-ameliorating agent, radical
scavenger, elastase activity inhibitor
and antiaging agent
2012 Kose Corp. (Japan) Antioxidant, agent for improving skin JP2012171877
turgor or sagging, radical scavenger
and elastase activity inhibitor
2012 Kimura Sangyo KK Tablet containing probiotic agent, JP2012167131
(Japan) digestive enzyme agent, or both of
them

2012 Inst Pasteur, Centre Use of proteins and peptides encoded JP2012165750
National De La by genome of novel sars-associated
Recherche Scientifique, coronavirus strain
Univ. Paris 7 (Japan)
2012 Gekkeikan Sake Co. Anti-inflammatory agent and JP2012162566
Ltd., (Japan) antioxidant
2012 Watanabe Oisutaa Antioxidant, antioxidant composition, JP2012153852
Kenkyusho KK, Hokkaido and method for producing the same
Univ. (Japan)
2012 Chikuno Shokuhin Kogyo Antioxidant composition JP2012153799
KK (Japan)
2012 Genmont Biotech Inc. Composition in which probiotics strain JP2012149026
(Taiwan) gm-263 (adr-1) is used for treating
kidney fibrosis caused by diabetes and
use thereof
2012 Kracie Home Products Antioxidant, cosmetic, food and drink JP2012144457
Ltd. (Japan) composition and pharmaceutical
composition
2012 Shiseido Co. Ltd. (Japan) Antioxidant and collagen production JP2012144446
promotor
2012 Kao Corp. (Japan) Process for producing antioxidant JP2012140618
2012 Toyo Tire & Rubber Co. Antioxidant for rubber compounding, JP2012140510
Ltd. (Japan) method for producing the same and
rubber composition
Ltd. (Japan) composition, and pharmaceutical
composition
composition
composition
2012 Konica Minolta Business Method for producing aqueous JP2012136617
Technologies Inc. (Japan) dispersion solution of antioxidant and
aqueous dispersion solution of
antioxidant
2012 Ibis Biosciences Inc. Method for rapidly purifying nucleic JP2012132924
(Japan) acid by solution capture for subsequent
analysis by mass spectrometry
2012 L’air Liquide Sante Improved microbicidal composition JP2012131793
Internatl (Japan) based on formaldehyde donor
compound and antioxidant
2012 Sawada Shoji (Japan) Method for producing composition JP2012126873
containing antioxidative component

2012 Inst Pasteur (Japan) Peptide originated from human bplp JP2012120533
protein, polynucleotide encoding the
peptide and antibody directed against
the peptide
2012 Mishimadenshi Co. Ltd. Applied battery and emergency power JP2012124142
(Japan) supply device
2012 Fujifilm Corp. (Japan) Antioxidation method of metal film JP2012124398
surface and liquid antioxidant
2012 Fuji Oil Co. Ltd. (Japan) Antioxidant containing hydrolysate of JP2012116817
protein composition
2012 Maruzen Pharmaceut Co. Antioxidant and anti-inflammatory JP2012102041
Ltd. (Japan) agent
2012 Tada Masahiro (Japan) Method of producing antioxidant active JP2012097058
substance of rosemary
2012 Toppan Printing Co. Antireflection film and method for JP2012093623
Ltd. (Japan) manufacturing the same
2012 JSV Co. Ltd. (Japan) Ultrasonic ion phase synchronization JP2012090903
drug injection/discharge device
2012 Sumitomo Metal Ind. Antioxidant and method for producing JP2012092207
Ltd. (Japan) metal material
2012 Sumitomo Metal Ind. Method for predicting corrosion rate of JP2012083140
Ltd. (Japan) metal, and prediction system of
corrosion life of metal
2012 Kracie Home Products Antioxidant, tyrosinase activity inhibitor, JP2012067026
Ltd, Arika Co. Ltd., skin care preparation, and food and
Fuseeds Inc., Celless drink
Comtech Co. Ltd.
(Japan)
2012 Kaneka Corp. (Japan) Affinity carrier for purifying or removing JP2012062259
protein or peptide having kringle
sequence and method for purifying and
removing the same
2012 Adeka Corp. (Japan) Antioxidant composition, and JP2012062348
lubricating oil composition containing
the same
2012 Adeka Corp. (Japan) Antioxidant for lubricant and lubricant JP2012062347
composition containing the same
2012 Kaneka Corp. (Japan) Probiotic preparation JP2012056921
Ltd. (Japan) producing the same
2012 Genmont Biotech Inc. Composition of probiotic strain gm-080 JP2012051869A
(Taiwan) to be used in treating of cardiac
inflammation and cardiac cell apoptosis,
and use thereof
2012 Toray Ind. Inc. (Japan) Cyclic peptide and modified peptide of JP2012051826
the same, and screening method of
binding inhibition substance of
kelch-like ech-associated protein 1

2012 Dia Betym KK (Japan) Antiallergic agent, lipolysis inhibitor, JP2012051852

antioxidant and human fibroblast
proliferation promoter obtained from
camellia sasanqua flower and novel
saponin compound
2012 Institute Of Physical & Method for manufacturing metal coated JP2012046822
Chemical Research with antioxidizing film, and metal
(Japan) coated with antioxidizing film
2012 Gekkeikan Sake Co. Method for producing antioxidant and JP2012046480
Ltd. (Japan) its application
2012 Toyo Beauty KK (Japan) Antioxidative polyhydroxybenzene JP2012041292
derivative and skin care preparation for
anti-inflammation
2012 Noevir Co. Ltd. (Japan) Anti-aging agent, whitening agent, JP2012041284
antioxidant, slimming agent and
anti-inflammatory agent
2012 Asahi Kasei Fibers Carboxylethyl cellulose ammonium salt JP2012036346
Corp. (Japan)
2012 Api Co. Ltd., Antioxidant containing subcritical JP2012036296
Shizuokaken Koritsu treatment royal jelly and method for
Daigaku Hojin, Shizuoka manufacturing the same
Shoko Kaigisho (Japan)
2012 Toyo Shinyaku Co. Ltd, Antioxidant and cosmetic material JP2012031086
Artnature Co. Ltd. (Japan)
2012 Panasonic Corp. (Japan) Method for providing anchor peptide for JP2012025701
protein immobilization
2012 National Institute Of Antioxidant and use thereof JP2012025706
Advanced Industrial
Science & Technology,
Toyobo Co. Ltd. (Japan)
2012 Sumitomo Metal Ind. Antioxidant agent, process for JP2012021121
Ltd. (Japan) producing antioxidant agent, and
process for producing metallic material
2012 Asahi Kasei Fibers Corp Metal salt of carboxyl ethyl cellulose JP2012012554
(Japan)
2012 Ueda Oils & Fats Mfg. Co. Antioxidant formulation and method of JP2012007125
2012 Ube Industries Ltd, New indazole derivative or its salt, its JP2012006920
Santen Pharmaceut Co. production intermediate, and
Ltd. (Japan) antioxidant using the same
2012 Katayama Chem Works Antioxidant composition and method of JP2012001640
Co. Ltd. (Japan) producing the same
2011 Seiko Kagaku KK (Japan) Antioxidant for biodiesel fuel and JP2011256314
biodiesel fuel
2011 Fuji Oil Co. Ltd. (Japan) Soybean protein hydrolyzate-containing JP2011246425
antioxidant

2011 Noevir Co. Ltd. (Japan) Anti-aging agent, antioxidant, JP2011246376

anti-inflammatory agent, whitening
agent, humectant, skin care
preparation and functional oral
composition
2011 Noevir Co. Ltd. (Japan) Whitening agent, antioxidant, skin JP2011246375
external preparation, and functional
oral composition
2011 Takayasu Masakatsu, Method of enriching electrolyte solution JP2011240323
Nuchimasu KK (Japan)
2011 Univ Of Miyazaki (Japan) Method for preparing complex JP2011234682
containing peptide and heme iron
derived from heme protein obtained
from fish blood
2011 Ogawa & Co. Ltd. (Japan) In-vivo antioxidant JP2011236149
2011 Neo Cremar Co. Ltd. Composition containing yeast JP2011231097
(Japan) hydrolysate having obesity treatment
effect and antioxidant activity and
method for preparing the same
2011 Ikeda Shokken KK Production method for antioxidative JP2011229428
(Japan) composition
2011 Ikeda Shokken KK Production method for antioxidative JP2011229427
(Japan) composition
2011 Tdk Corp. (Japan) Method of manufacturing electrode, JP2011228048
electrode, and electrochemical element
2011 Kimura Hirotoshi (Japan) Antioxidant composition and beverage JP2011225785
using the same, pharmaceuticals, and
quasi drug
2011 Noevir Co. Ltd. (Japan) Anti-aging agent, antioxidant, external JP2011225477
preparation for skin, and functional oral
composition
2011 Smartfish AS (Norway) Drink containing combination of fish oil JP2011217757
and probiotic
2011 NSK Ltd. (Japan) Antioxidant for lubricant, lubricating JP2011219690
grease composition and rolling device
2011 Naris Cosmetics Co. Antioxidant, ultraviolet hazard inhibitor JP2011213660
Ltd. (Japan) and anti-photoageing cosmetic
2011 Cci Corp., Gifu Antioxidative stress agent JP2011207815
Prefecture Kenkyu
Kaihatsu Zaidan (Japan)
2011 Meiji Co. Ltd. (Japan) Probiotics-containing composition filled JP2011201840
with small content
2011 Noevir Co. Ltd. (Japan) Antioxidant agent and external JP2011195538
preparation for skin

2011 Noevir Co. Ltd. (Japan) Antioxidant, whitening agent, JP2011195537

anti-aging agent, hair tonic, humectant,
skin care preparation and functional
oral composition
2011 Univ Of Tsukuba (Japan) Composition containing low-molecular JP2011184429
antioxidant and high-molecular formed,
cyclic nitroxide radical compound
2011 Okinawa Satoukibi Kino Non-centrifugal sugar having JP2011182719
Kenkyusho KK, Mottainai antioxidant ability and method for
Biomass KK, Endo Seian producing the same
KK, Koyo Sangyo Co. Ltd.
(Japan)
2011 Glico Dairy Products Co. Bifidobacterium animalis subspecies JP2011172506
Ltd. (Japan) lactis strain for probiotics and probiotic
lactobacillus fermented food and other
probiotic oral foods using the strain
2011 Noevir Co. Ltd. (Japan) Anti-aging agent, antioxidant, JP2011168560
whitening agent, immunoactivator, skin
care preparation and functional oral
composition
2011 Noevir Co. Ltd. (Japan) Antioxidant, anti-inflammatory agent, JP2011168559
anti-aging agent, skin care preparation
for external use and functional oral
composition
2011 Heart Shokuhin Tottori Production method combining vitamin JP2011160791
KK (Japan) and mineral promoting absorption of
orally ingested collagen into body
2011 JSR Corp. (Japan) New compound, and method for JP2011157507
synthesizing the same, and antioxidant,
resin composition and resin molded
form each including the same
2011 Noevir Co Ltd (Japan) Humectant, anti-aging agent, JP2011157299
antioxidant, skin whitening agent,
antiinflammatory agent, skin external
preparation and functional oral
composition
2011 Tokyo Univ. Of Antioxidant JP2011157293
Agriculture &
Technology, Tms Co.
Ltd. (Japan)
2011 JSR Corp. (Japan) New compound and synthesis method JP2011148713
of the compound, and antioxidant,
resin composition and resin molded
body each comprising the compound
2011 Noevir Co. Ltd. (Japan) Moisturizing agent, anti-ageing agent, JP2011148708
antioxidative agent, slimming agent,
beautifying and whitening agent,
anti-inflammatory agent,
immunoactivating agent, skin care
preparation for external use and
functional oral administration
composition

2011 Biochemical Laboratory Method for producing antioxidative JP2011142904

Co. Ltd. (Japan) substance
2011 Jiangsu Sinorgchem Solid acid catalyst, method for JP2011136330
Technology Co. Ltd. preparing the same and method for
(Japan) synthesizing rubber antioxidant rd
2011 Able Corp. (U.S.) Method of determining antioxidant JP2011133447
potential, and reagent for determining
antioxidant potential used therefor
2011 Lvmc Inc. (Japan) Simple screening method of JP2011133417
antioxidation substance for skin
cosmetics using sensor for active
oxygen species concentration
measurement
2011 Kirin Kyowa Foods Co. Seasoning liquid having antioxidative JP2011130689
Ltd. (Japan) ability, method for producing the same,
and food and drink containing the
seasoning liquid
2011 Sawa Sangyo KK (Japan) Method for producing functional JP2011125323
antioxidation tea
2011 Yamada Bee Farm Antioxidative peptide derived from JP2011116761
Corp. (Japan) royal jelly
2011 Kumamoto Univ. (Japan) Gene encoding peptide lowly JP2011101639
expressing protein and method for
using the same
2011 Proteotech Inc. (Japan) Low molecular weight peptide for JP2011093916
treating alzheimer's disease and other
beta-amyloid protein fibrillogenesis
disorder
2011 Shin Nihonsha KK (Japan) Chemical cell using metal with carbon JP2011086596
powder coated on surface
2011 Nestle SA (Switzerland) Probiotic delivery system JP2011055832
2011 Yakult Honsha Co. Ltd. Probiotics proliferation promoter JP2011036203
(Japan)
2011 Mannkind Corp. (U.S.) Purification and stabilization of peptide JP2011026330
and protein pharmaceutical agent
2011 Kyoorin Food Kogyo KK Feed added with probiotics JP2011015626
(Japan)
2011 Shimadzu Corp. (Japan) Method of selectively recovering JP2011010649
terminal peptide fragment from
protein-cutting treated product by
using transamination reaction and
determination method for terminal
sequence of protein
2011 Canon Inc. (Japan) Biological tissue extract holding JP2011013013
substrate
2011 Shiomi Shuichi, Matsui Method for breeding livestock and JP2011004636
Saburo (Japan) poultry by probiotics

2011 Uha Mikakuto Co. Ltd. Dna fragment, transformed yeast cell JP2011004649
(Japan) and method for producing protein or
peptide using the dna fragment and/or
the transformed yeast cell
2011 Univ. Of Miami (Japan) Modified heat shock protein-antigenic JP2011001378
peptide complex

Chapter 9
INDUSTRY STRUCTURE
FOD013F
March 2017
Natraj Pandal
Project Analyst
ISBN: 1-62296-448-9
BCC Research
or (+1) 781-489-7301
www.bccresearch.com
CHAPTER 9
INDUSTRY STRUCTURE
FACTORS INFLUENCING DEMAND
The fact of increasingly aging populations is expected to drive the global nutraceutical
market. Increasing demand for nutraceutical products and significant technological
advancements are expected to complement the growth of nutraceuticals in the future.
TABLE 93
DRIVERS OF NUTRACEUTICAL MARKET, 2011-2020
Driver Level of Impact

Span of Years 2011-2015 2016-2020
Increase in aging population High High
Shift towards self-medication High Medium
Technology driving higher efficacy Medium High
Rising healthcare costs High High
INCREASINGLY AGING POPULATIONS
More than 1 billion people globally will be over the age of 60 by 2020, and this group is
likely to experience one or more chronic age-related diseases and seek some form of
treatment through nutraceutical products. Developed nations such as the U.S. and
Germany have more than 70% of older people as compared to other countries like India,
with a more youth-based population. The elderly population is shifting their preference
from pharmaceutical medicines to nutraceutical products to provide nutritional as well as
health benefits for greater enjoyment of their lengthening lives.
RISING HEALTHCARE COSTS
Increases in global healthcare costs have led more individuals to focus on preventative
care, self-diagnosis and self-medication. The medical industry is doing ongoing research in
nutraceuticals to provide more benefits to individuals that seek those benefits. Both the
medical industry and the clinical industry are doing extensive research to determine the
nutritional benefits from nutraceuticals with more emphasis on curing diseases.
SHIFT TOWARD SELF-MEDICATION
Today people are more aware of and knowledgeable about their health and the side
effects caused from the intake of pharmaceutical medicines; therefore, there is a clear
shift of preferences from medicines to natural foods and products with ingredients from

nature. People prefer products that contain ingredients from natural sources that help in
curing diseases as well as provide nutritional benefits.
TECHNOLOGY DRIVING HIGHER EFFICACY
The advances technology continues to offer new means of extraction and enrichment.
These advances can also improve delivery of specific bioactive ingredients to the body.
The development of cholesterol-lowering plant sterols and stanols are used in various food
products. Manufacture of special soya protein for bread and the inclusion of omega-3 fatty
acids in various products to lower the risk of heart disease are other key areas of
technological development. These advances in technology are improving the efficacy and
performance of functional products.
CHALLENGES IN THE NUTRACEUTICAL MARKET
HIGH NUTRACEUTICAL PRODUCT PRICES
Several companies are turning to product innovation as greater competition places

increased pressure on margins. Higher fuel costs have increased the prices of essential
ingredients like wheat and eggs. With increased prices of ingredients, the prices of
nutraceutical products are also increasing rapidly.
Nutraceutical products can command higher prices in the market than pharmaceutical
medicines do. This price gap is causing people to shift from nutraceuticals to medicines if
there are no side effects from medicines and they help in providing cures and health
benefits over a long period.
LACK OF AWARENESS ABOUT NUTRACEUTICALS
Nutraceuticals have benefited people on a large scale. However, most people are still
unaware of the benefits they can derive from nutraceutical products. So consumers with a
preference for nutraceuticals in the form of a combination of medicines in addition to a
nutritional health diet is low in comparison to who choose the perceived health benefits
from pharmaceuticals.
Nutraceutical products provide nutritional benefits as well as help in curing diseases. But
these features of nutraceuticals must be communicated to end users, as people have less
awareness of the fact that nutraceutical can help in curing diseases with no side effects.
People rely less on nutraceuticals due to the fact that information and proper knowledge is
not delivered that could counterbalance their hesitation to the pay the high cost of these
products.

OPPORTUNITIES FOR NUTRACEUTICAL COMPANIES
OPPORTUNITIES FOR ENTERING THE NUTRACEUTICALS MARKET
High growth rates and striking margins have fueled interest from big pharma and food
manufactures. Prominent companies such as Pfizer and Bristol are entering the
nutraceutical market and finding very encouraging growth opportunities. The domestic
players are also making more effort to sustain themselves in the market with more
aggressive and effective pricing.
Niche opportunities also exist for new entrants to effectively coexist with larger
incumbents. All stakeholders, including ingredient suppliers, wholesalers, retailers, FBS
product manufacturers, advertisers and technology as well as R&D labs are constantly
evaluating new ways to enter and grow in this market. The FBS market has higher growth
and operating margins than the overall food and beverage market; therefore, FBS is
increasingly attractive. Main strategies for capitalizing on this market include new product
introduction, mergers and acquisitions, innovative branding and research and
development.
Many value-added processors and formulators (e.g., Agricore) are looking to move down
the value chain by turning ingredients into final products. Niche players can effectively
compete by developing and patenting proprietary processes and technologies. Private
labels will continue to place increased demand on branded products as consumers spend
more wisely after the global economic downturn.
FEWER CONTRACT MANUFACTURERS
Contract manufacturing for nutraceutical products is still in a nascent stage as there are
fewer manufacturers in the market. The contract manufacturing outsourcing (CMO) of
nutraceutical products helps in improving the product manufacturing and delivery time
because it cuts lead time.
FOCUSED ON NEW PRODUCT DEVELOPMENT
The nutraceutical product market is emerging slowly, with large numbers of competitors in
the local as well as the global market. The global players are forcing local players to
manufacture new products as the market is growing rapidly. This encourages good
manufacturing practices for nutraceuticals and increases market share in terms of quality
and introduction of new nutraceutical products.
MARKET STRATEGIES
The growth strategies adopted by companies in the nutraceuticals market from 2011 to
2015. The three major strategies identified are:
1. New product development.

2. Mergers and acquisitions.

3. Partnerships, collaborations, expansion and joint ventures
A high growth rate and striking margins have fuelled interest from leading manufacturers
of pharmaceuticals and food companies willing to enter the nutraceutical market through
various strategic acquisitions, partnerships, joint ventures and collaborations in growing
markets of Asia-Pacific and Latin America.
Tata Chemicals entered into the probiotics market in 2014 and started its first
nutraceutical plant in Chennai, India. The company is looking to produce high-purity
carbohydrate oligosaccharides, which will be helpful in improving wellness and nutrition in
the food industry and farming productivity. Further, it will also help to improve an
individual’s ability to absorb nutrients into the body.
STRATEGY BY TYPE
In the overall nutraceuticals market, a preferred strategy is new product launches,

whereby most market players are launching new nutraceutical products in different parts
of the world. A significant number of agreements, joint ventures and collaborations have
occurred between companies to share expertise and increase market penetration by
reaching underserved areas. Similarly, nutraceutical companies are also focusing on
expansion, mergers and acquisitions, and investments in the European, Asian and North
American markets.
FIGURE 4
GLOBAL NUTRACEUTICALS MARKET GROWTH STRATEGIES, 2011-2015

(%)

LEGEND
(%)
Strategy Percent
New product launch 45.8
Mergers and acquisitions 22.9
Partnerships, collaborations, joint ventures, 31.3
expansion and agreements
Total 100.0
The high number of product launches (22) shows that industry players are keen to capture
underserved nutraceutical markets by providing more options to consumers. Other
developments such as agreements, collaborations, and mergers and acquisitions were
implemented in moderate numbers in 2015. In terms of strategies, most nutraceutical
companies are focusing on new product launches (45.8%) followed by partnerships,
collaborations, joint ventures, expansion and agreements (31.3%) and mergers and
acquisitions (22.9%) from 2011 to 2015.
GROWTH STRATEGIES BY COMPANY
Nordic Naturals (U.S.), Equateq Ltd. (U.K.), Danisco A/S (Denmark) and Martek Bioscience
Corp. (U.S.) are the most active companies in the nutraceuticals market during the
analysis period (2011 to 2015).
FIGURE 5
GLOBAL NUTRACEUTICALS GROWTH STRATEGY ACTIVITY BY COMPANY,

2011-2015
(%)

LEGEND
(%)
Company Percentage
Nordic Naturals 33.3
BASF SE 10.4
Cargill Inc. 10.4
Danisco A/S 8.3
Cosucra Groupe 8.3
Other 29.3
Total 100.0
The figure above shows major market players accounting for a 70.7% of share in overall
developments in the nutraceutical industry. Nordic Naturals is the most active company in
the nutraceutical market, accounting for 33.3% of total developments from 2011 to 2015,
followed by BASF SE (10.4%), Cargill Inc. (10.4%), Danisco A/S (8.3%) and Cosucra Groupe
(8.3%). Other players are active and together have contributed 29.3% of developments in
the nutraceutical industry.
New Product Development
Some of the major companies that have introduced nutraceutical products are shown in
the below table.
TABLE 94
NEW NUTRACEUTICALS PRODUCT LAUNCHES, 2011-2015
Date Company Development

2015 Nordic Naturals Nordic Naturals introduced Omega Curcumin, a simple solution
(U.S.) for cellular stress. This product contains combining omega-3s,
curcumin and antioxidants.
2015 Pharma Marine Pharma Marine launched the sustainably sourced supplement
(Norway) CodMarine Oil for the first time in North America. The omega-3
sources in the oil product are fully traceable to sustainable and
well-managed Marine Stewardship Council (MSC) certified
fisheries.
2015 Nordic Naturals Nordic Naturals introduced Postnatal Omega-3, which provides
(U.S.) the omega-3 nutritional support women require after
childbirth—both for themselves and for their babies. This
product also contains a potent dose of the omega-3 EPA to
support positive mood after childbirth and optimal fat
metabolism.

2015 Nordic Naturals Nordic Naturals introduced new "Nordic Probiotic" sport. This
(U.S.) product offers natural support for gastrointestinal (GI) health,
combining probiotics and prebiotics to promote the growth of
friendly bacteria and maintain GI balance.
2015 Danisco A/S Danisco launched "HOWARU" Cardio probiotics.This product
(Denmark) con-tains contains Lactobacillus AB-Life, a patented probiotic
formulation documented to have a positive effect on
maintaining healthy cholesterol levels.
2015 Nordic Naturals Nordic Naturals introduced "Ultimate Omega." This product
(U.S.) contains 70% purified omega-3 fatty acids, providing an
exceptionally high concentration of EPA and DHA in one
delicious serving. It is formu-lated to support healthy aging,
improve mood, and healthy glucose levels, and supports other
organs such as the liver and prostate.
2015 BASF(Germany) BASF introduced an omega-3 fatty acids product called
"Pronova Pure." This product offers a highly concentrated
omega-3 fatty acid with an outstanding purity profile for usage
in dietary ingredients.
2014 Nordic Naturals The company launched Postnatal Omega3, which has been
(U.S.) named the "Official Postnatal Omega-3" of the American
Pregnancy Association, and utilizes Nordic Naturals' exclusive,
new, ultra-concentrated omega-3 oil.
2014 Nordic Naturals Nordic Naturals introduced multi-vitamin and mineral
(U.S.) supplementa-tion in the form of chewable “gummies.” These
daily gummies provide significant amounts of vitamins A, B, C
and D, plus the minerals iodine, magnesium, zinc and calcium.
2013 Danisco A/S Danisco probiotics include a range of specific probiotic strains
(Denmark) marketed under the HOWARU brand. HOWARU premium
probiotics are health-enhancing bacteria that today are widely
used in dairy, dietary supplements and nutritional products.
2013 Nordic Naturals Nordic Naturals introduced Allergen-Free, 100% Vegetarian
(U.S.) Probiotic.
2013 Nordic Naturals Nordic Naturals launched innovative EPA Elite Targeted Support
(U.S.) in one of the most powerful EPA-only concentrates available
without a prescription.
2013 Nordic Naturals Nordic Naturals introduced Nordic CoQ10 Ubiquinol Active
(U.S.) Antioxidant Form of CoQ10, which supports cardiovascular
health and energy production.
2013 Nordic Naturals Nordic Naturals introduced Vitamin C Gummies for Kids and
(U.S.) Adults
2013 Danisco A/S Danisco Animal Nutrition has unveiled Axtra PHY, the very
(Denmark) latest technological advance in phytase enzyme solutions.
Launching at the International Production and Processing Expo,
Atlanta, in January 2015, Axtra PHY is the result of an extensive
development program, including animal studies conducted
under a wide range of conditions. The patented phytase,
isolated from Buttiauxella, has unrivaled performance and
economic benefits.
2012 Cargill Inc. (U.S.) The company announced introduction of its Oliggo-Fiber inulin
in liquid form.

2011 Beneo-Orafti S.A. The company announced new products that include Fibralac
(Belgium) Milk for adults from Costa Rica, Wickbold “Estar Bem” breads
and Doces de leite (milk jam), both from Brazil. These products
are expected to generate increased revenues for prebiotic
ingredients used in them.
2011 Nordic Naturals Nordic Naturals launched premium products at China Expo
(U.S.) 2011, where the company was also looking for prospective
partners for the distribution to launch its products in the
Chinese market.
2011 Nordic Naturals NSF International gave its dietary supplement Good
(U.S.) Manufacturing Practices (GMP) Certification to Nordic Naturals
after completion of its new eco-friendly headquarters.
2011 Nordic Naturals Nordic Naturals launched an unflavored supplement in the U.S.
(U.S.) It is DHA with Vitamin D3, a liquid omega-3 supplement
especially for babies.
2011 Nordic Naturals Nordic Naturals launched the Daily Omega that includes
(U.S.) one-per-day omega-3 solutions in three forms, which are Daily
Omega with vitamin D3 lemon-flavored soft gel, Daily Omega
strawberry-flavored soft gel and Daily Omega Kid chewable
strawberry-flavored soft gel.
Mergers and Acquisitions
Some nutraceutical companies that have merged and acquired other companies to
strengthen their nutraceutical business are shown in the table below.
TABLE 95
MERGERS AND ACQUISITIONS, 2011-2015
Date Company Detail

2015 Glanbia, Plc Glanbia plc announced to acquire a leading range of protein
(Ireland) and enriched bars thinkThin LLC (“thinkThin”) for a cash
thinkThin LLC consideration of $217 million. This acquistion will increase
(U.S.) Glanbia Performance Nutrition’s (“GPN”) presence in the bar
category and provide exposure to the rapidly expanding
nutrition bar segment, which is currently valued at $2.8 billion in
U.S. retail.
2014 Omega Protein Omega Protein, a nutritional product company, announced
Corp. (U.S.) and acquisition of Bioriginal Food & Science Corp., for $70.5 million
Bioriginal Food & to expand its depth in human nutrition
Science Corp.
(Canada)
2014 Marine Marine Ingredients, a leading manufacturer of quality marine
Ingredients based ingredients and customized products, announced to
(Germany) and acquire the manufacturing facility for natural fish oils, medium
BASF (Norway) concentrated omega-3s, and customized bottled fish oil in
Brattvåg (Norway), from BASF.

2012 Cargill Inc. (U.S.) In the Netherlands, Royal DSM announced that it has
and DSM successfully completed the acquisition of Cargill’s cultures and
enzymes business. The acquisition, announced in October 2012,
will enable DSM to become a global tier-one dairy ingredients
supplier.
2012 BASF SE BASF SE made a bid to acquire Pronova BioPharma ASA, which
(Germany) and was the pioneer in high concentrates of omega 3 fatty acids.
Pronova Pronova Corp. is the world’s second-largest manufacturer of
BioPharma ASA omega-3 ingredients. This acquisition will enable BASF SE to
consolidate its market share in the global omega-3 ingredients
market.
2012 BASF SE BASF SE announced the acquisition of the German
(Germany) and pharmaceutical company Equateq Ltd., a major manufacturer of
Equateq Ltd omega-3 fatty acids, to improve its global omega-3 production
(U.K.) capacities.
2012 BASF SE BASF SE completed the acquisition of Equateq to fortify its
(Germany) and omega-3 acids business.
Equateq Ltd.
(U.K.)
2011 Martek Bioscience Martek signed a definitive agreement with Altech to sell a
Corp. (U.S.) and notable portion of its assets at its Winchester, Ky.,
Altech manufacturing facility. The agreement does not permit
production of omega-3s and omega-6s polyunsaturated fatty
acids at this site. This deal is in the line with Martek’s
restructuring plans for its Winchester, Ky., production site in an
effort to reconfigure its operations, enhance capacity utilization
and reduce manufacturing costs and operating
expenses. This deal calls for Alltech to pay Martek a total of
roughly $14 million over the upcoming four years.
2011 Martek DSM acquired Martek for the cost consideration of $1.1 billion.
Bioscience Corp. This acquisition will serve as a platform for DSM to enter into the
(U.S.) and DSM omega-3 and omega-6 markets through Martek’s portfolio of
microbial DHA and ARA. Through this acquisition DSM will garner
new opportunities in the infant nutrition business as well as food,
beverages and dietary supplements. Using its global market
reach, technology base and application skills, DSM can channel
and boost the growth of Martek’s portfolio into other
geographies, applications and market segments beyond
Martek’s existing strong U.S.-based position in infant formula
ingredients and its growing position in food, beverage and
dietary supplement applications worldwide. In addition, Martek’s
algal and other
microbial-based biotechnology platforms and its robust
biotechnology pipeline that backup DSM’s portfolio are expected
to create new nutritional and nonnutritional growth opportunities
in, for example, biochemicals and biofuels.
2011 Danisco A/S DuPont’s acquisition of Danisco would boost the probiotic market
(Denmark) and and would lead to more acquisitions.
DuPont

2011 Omega Protein Omega Protein Corp. concluded the acquisition of the Cyvex
Corp. (U.S.) and Nutrition Inc., leading to a strengthening of its non-marine based
Cyvex Nutrition product line as well as ensuring an extended omega-3
Inc. (U.S.) distribution network to Omega Protein it return for its
OmegaPure refined menhaden fish oil.
Partnerships, Collaborations, Expansion, Joint Ventures and Agreements
Some companies entered into partnerships, collaborations, joint ventures or agreements

to increase their nutraceutical business. These are shown in the table below.
TABLE 96
PARTNERSHIPS, COLLABORATIONS, EXPANSION, JOINT VENTURES AND

AGREEMENTS, 2011-2015
Date Company Detail

2015 Compass Minerals Compass Minerals has signed a definitive agreement to
(U.S.) and purchase a 35.0% stake in Produquimica Industria e Comercio
Produquimica S.A. (Produquimica) for $120.7 million, one of Brazil’s leading
Industria e Comercio manufacturers and distributors of specialty plant nutrients.
S.A. (Brazil) Produquimica has a long history in Brazil and strong prospects
for continued growth and margin expansion. Moreover, it has
wide range of specialty plant nutrients, application
technologies and extensive distribution network.
2015 Marcos Baghdatis Marcos announced a one-year sponsor partnership with Nordic
(U.S.) and Nordic Naturals, a leading supplier of omega-3 fish oils worldwide.
Naturals (U.S.) This partnership expected to increase Marcos' product sales in
the region help in order to meet personalized nutritional
needs.
2015 Verdesian Life Verdesian Life Sciences is introduced a new formulation of a
Sciences (U.K.) plant nutrition product "Primacy ALPHA." It is a phosphite-free
product and delivers the benefits of plant nutrition, health and
yield responses without any PO3 residue
2015 Cosucra Groupe Cosucra announced a $32.7 million investment in the
Warcoing S.A. construction of a second production unit at its Warcoing site
(Belgium) (Belgium) to increase its Pea protein turnover from $87.million
today to $163.5 million in 2020.
2014 Beneo-Orafti S.A. Beneo Inc. and HORN, headquartered in Southern California,
(Belgium) and announced a new partnership. Effective Feb. 18, 2014, HORN,
Horn (U.S.) one of North America’s premier distributors of specialty
ingredients, was selected as Beneo’s Western U.S. regional
distributor.

2013 Cargill Inc. (U.S.) Cargill’s Animal Nutrition business and Purac, a subsidiary of
and Purac AB CSM, are to collaborate in the development and
commercialization of bio-based animal feed solutions. Under
the collaboration, Purac will focus on technology development
and production of Aloapur, while Cargill Animal Nutrition’s
Provimi business will focus on application development and
commercialization of the product.
2013 Nordic Naturals Nordic Naturals and Lipid Technologies are partnering to offer
(U.S.) and Lipid practitioners an exclusive omega-3 blood spot-test
Technologies opportunity
for their patients.
2013 Nordic Naturals Nordic Naturals expands Canadian presence with new
(U.S.) and Trainers distribution partner, Trainers Choice, to head up mass market
Choice distribution for Canada.
2012 Cosucra Groupe Cosucra has entered into a partnership with REDA Food
Warcoing S.A. Ingredients for distribution of ingredients in the Gulf region
(Belgium) (Iran, United Arab Emirates and Saudi Arabia). This is
expected to increase product sales in the region and enable
the
company to tap a potentially large market for prebiotic
ingredients.
2012 Cosucra Groupe The company established a partnership with U.K.-based
Warcoing S.A. company Caldic. This move was aimed at increasing the
(Belgium) and distribution network for its ingredients in the U.K.
Caldic
2012 Cosucra Groupe The company announced increased collaboration with Cargill
Warcoing S.A. that has been an exclusive distributor for Cosucra’s inulin and
(Belgium) and oligofructose powders under the Oliggo-Fiber brand in North
Cargill Inc. (U.S.) America since 2001. This is expected to strengthen the
Cosucra’s sales in North America.
2011 Dannon (France) Groupe Danone’s Research Centre teamed up with Pasteur
and Pasteur Institute in order to improve research in the field of probiotics.
Institute (France) Groupe Danone and Japan’s Yakult Honsha Co have entered a
joint venture in India in order to develop a probiotic market in
India. They have entered into an agreement to form a
strategic
alliance in order to strengthen their position in the global
probiotic market.
2011 BASF SE and Cargill BASF SE and Cargill Inc. entered into a joint venture whereby
Inc. they would jointly develop a rapeseed oil containing omega-3
fatty acids. This will help BASF SE to meet growing demand
for
omega-3 fatty acids.

2011 Beneo-Orafti S.A. NutraCea, a global leader in the production and marketing of
(Belgium) and value-added products derived from rice bran, and
NutraCea Beneo-Remy,
a world leader in functional food ingredients derived from rice,
announced an exclusive, co-branded sales and marketing
agreement. Under the terms of the distribution and
cooperation agreement entered into on September 29, 2011,
NutraCea will produce stabilized rice bran (SRB) for exclusive
distribution by Beneo-Remy under their “RemyLiVe” brand in
over 40 countries in Europe, the Middle East and Africa (EMEA)
as well as in Russia, India, Australia and New Zealand.
2011 Equateq Ltd. (U.K.) Equateq signed a long-term supply agreement with Amarin for
and Amarin the supply of omega oil pharmaceuticals for cardiovascular
indications. Under the terms of this agreement, Amarin has to
purchase a minimum $10 to $20 million of API for use in
AMR101. In addition, Amarin also agreed to pay Equateq $1.5
million in milestone payments and to advance Equateq $5.0
million as a refundable deposit against future API purchases,
with $1.0 million of the milestone payments to be paid as a
part of signing the agreement.

Chapter 10
COMPETITIVE OUTLOOK AND COMPANY
PROFILES
FOD013F
March 2017
Natraj Pandal
Project Analyst
ISBN: 1-62296-448-9
BCC Research
or (+1) 781-489-7301
www.bccresearch.com
CHAPTER 10
COMPETITIVE OUTLOOK AND COMPANY PROFILES
This chapter contains a discussion of many of the important players in the nutraceutical
industry along with their background details, product range and business strategy.
COMPETITIVE OUTLOOK
The nutraceuticals market faces both external and internal competition. External industry
competition is generated by manufacturers of natural, organic and “less evil foods” that
are addressing health benefits similar to those that FBS manufacturers are addressing. As
competitive pressure grows, both FBS competitors and outside threats such as
pharmaceutical companies are increasingly filing petitions against the health claims of FBS
products.
Natural foods and beverages have owned the largest market share of FBSs, with organic
products being second. Functional products are still struggling to overcome these
categories and to gain share. The internal competition is also wide due to FBS market
fragmentation. Functional FBS companies are competing on the basis of taste, health,
convenience, price, safety, efficacy, packaging and brand loyalty. Price has become a
more important factor due to the recent economic conditions.
Correct branding and positioning is still a challenge, and differentiation will become
increasingly difficult as more external competitors begin to assert “functional” claims.
Foods with low or no fats or sugar content (including natural as well as organic foods) are
increasingly being marketed with claims like “natural,” and “pure.”
The global nutraceutical market is of a highly competitive nature and has several local and
international companies coexisting within it. In order to compete in the nutraceuticals
market, companies are launching various new and innovative nutraceutical products in the
market on the basis of ingredients, packaging and serving ability.
Various new nutraceutical products are being introduced into the market due to evident
consumer interest toward new products, new flavors, new formulations and new foods.
There are several large corporations trying to introduce new nutraceutical products every
year; they include major manufacturers Kellogg Co., General Mills Inc. and Procter &
Gamble Hygiene and Health Care Ltd.
These companies are seeking to gain advantage through nutraceuticals and are deferring
to their existing products for support of sales with new marketing approaches.
Furthermore, these companies highlight the benefits of their core products along with their
new products.

COMPANY PROFILES
ARISTA INDUSTRIES
557 Danbury Roads

Wilton, CT 06897
Tel: 203/761-1009, Fax: 203/761-4980
Website: www.aristaseafood.com
Overview
Founded in 1930, Arista Industries is a privately held company on the eastern seaboard of
the U.S. The company deals in production, import and supply of seafood products. The
company’s omega-3 fatty acids production is a subdivision of its specialty oils and butter
segment. Arista Industries also caters to industry segments such as marine oils, vegetable
oils and seafood and serves clients in the cosmetic, pharmaceutical, foodservice and
wholesale and retail seafood industries in the U.S. and internationally. The company has
more than 300 employees throughout the world in 2015.
Financials
Arista Industries generated revenue of more than $16.9 million for the financial year
ended 2015.
Products and Services
Arista Industries’ products include omega-3 fatty acids, omega-6 fatty acids, borage oil,
DHA (Docosahexaenoic Acid), GLA (Gamma Linoleic Acid), EPA (Eicosapentaenoic Acid),
marine oils and krill oil.
Strategy
Arista Industries is constantly innovating in an effort to improve the customer experience

by being committed to implementing sustainable practices across the supply chain from
aquaculture and fisheries management to logistics and distribution practices. Arista
believes that promoting sustainable products and practices is the most effective way to
ensure a bright future for the company and industry.

BASF SE
Carl-Bosch-Strasse 38
Ludwigshafen, 67056
Germany
Tel: 49-621-600
Fax: 49-621-604-2525
Website: www.basf.com
Overview
Established in 1865, BASF SE is headquartered in Ludwigshafen, Germany. BASF SE is one

of the world’s largest chemical companies. The company operates in six business
segments including chemicals, plastics, functional solutions, performance products,
agricultural solutions, oil and gas. Omega-3 fatty acids are developed and manufactured
under the BASF SE’s nutrition and health subsegment of the performance products
segment.
BASF operates globally through subsidiaries in more than 80 countries with 338 production
facilities. The company operates primarily in Europe and has an active presence in North
America, the Asia-Pacific region, South America, Africa and Middle East countries; it
employs about 112,435 people as of June 2015.
Financials
BASF SE reported nutrition and health subsegment revenues of approximately $2.2 billion
in 2015, decrease of 1.6% over 2014 revenues.
BASF SE offers omega-3 acid under its health and nutrition business segment. The
company sales of the omega-3 acid are under the brand name Dry n-3. BASF SE’s
omega-3 fatty acids are used for fortification of baby foods and other foods such as fish oil
powder.
Strategy
BASF SE is focusing on joint ventures and acquisitions in order to strengthen its omega-3
production in Europe and North America. The company has future plans to gain the market
share in the omega-3 fatty acids market by acquisitions of leading pharma companies.

BENEO-ORAFTI S.A.
Aandorenstraat 1
Tienen, 3300
Belgium
Tel: 32-1-680-1301
Fax: 32-1-680-1308
Website: www.beneo.com
Overview
Founded in 1990, Beneo-Orafti S.A. (Beneo) is headquartered in Tienen, Belgium. The

company deals in the production and sale of food ingredients derived from chicory. Beneo
offers natural inulin and oligofructose food ingredients. The company has a major revenue
base in Italy, Spain, Switzerland, Czech Republic, Singapore, Taiwan, Malaysia, the U.S.,
Brazil, Costa Rica, Argentina and other countries.
Financials
Beneo reported annual sales of about $261 million for the financial year 2015.
Beneo offers functional dietary fibers that help to improve digestive health, support weight
management and enhance calcium absorption for bone health. The company’s key
nutraceutical products are shown in the table below.
TABLE 97
BENEO'S NUTRACEUTICAL PRODUCTS
Brand Description
Orafti Inulin This is an ideal fiber that also supplies a creamy texture and a
smooth mouthfeel in low-fat yogurts.
RemyPro A concentrated rice protein source with a biological value that is
higher than most other plant nutrient sources.
BeneoPro W The brand name for vital wheat gluten by Beneo.
Beneo inulin and A source of nutrition for young pets.
oligofructose
BeneoCarb S This is unique low-glycemic sugar syrup made from pure beet
sugar. It has a sweet honey-like taste and can be used to improve the
organoleptical profile of animal food.

Strategy
Beneo is focusing on the manufacturing of prebiotic ingredients and extending its product
portfolio with new product launches, especially in the food segment. The company also
plans to expand its operations into different regions to increase its market share and
competitive edge. A Knowledge Program is the most notable strategy of Beneo—designed
to communicate the health benefits of inulin and oligofructose to food manufacturers and
consumers in order to increase consumer awareness and thus their sales.
CARGILL INC.
P.O. Box 9300

Minneapolis, MN 55440
Tel: 1-800-227-4455
Fax: 952/742-7393
Website: www.cargill.com
Overview
Founded in 1865, Cargill Inc. (Cargill) is headquartered in Minneapolis, Minn., in the U.S.
Cargill is privately held and known worldwide as an international producer and marketer of
food, agricultural, financial and industrial products and services. The company produces
synthetic-based fluids and lubricants under its industrial, or bioindustrial segment.
The various types of products that Cargill manufactures are biodegradable base oils
suitable for chain and bar, high-temperature processing fluids, rolling oils and process oils,
machine lubricants, spray and de-dusting oils, and low-viscosity base oils suitable for use
as rust-prevention fluids. The company operates more than 70 countries and employed
more than 150,000 people in 2015.
Financials
Cargill recorded revenues of approximately $120.4 billion 2015, decrease of 11.0% over
2014.
Cargill offers a broad range of probiotic products under its functional food and beverages
business segments.

TABLE 98
CARGILL'S PROBIOTIC PRODUCTS
Brand Description
CoroWise Naturally sourced cholesterol reducer (plant sterols)
Oliggo-Fiber Inulin
Regenasure Glucosamine
Leci-PS Phosphatidylserine
Arthred Hydrolysed collagen
Leci-Choline Phosphatidylcholine-enriched soy lecithin
Cargill also offers feed nutrition products under its animal nutrition and feed products
business segment.
TABLE 99
CARGILL FEED NUTRITION PRODUCTS
Brand Description
Nutrena High-quality nutrition that meets the needs of animals at every life stage.
LNB LNB products include vitamin and mineral premixes, milk replacers and
specialty products such as acidifiers, water-soluble vitamin blends and young
animal feeds.
Provimi Offering the broadest array of products and services in premixes and specialties
for animal nutrition.
Strategy
Cargill’s global presence is noteworthy and it looks to strengthening its market position
with newer health feed additive products and streamlining its production lines. The
company also looks at M&A’s as a way of increasing its impact on the market. Cargill is
aiming to achieve greater penetration of emerging markets and increasing probiotic
production capacities with its strong R&D capabilities.
COSUCRA GROUPE WARCOING S.A.
1 Rue de la Sucrerie
7740 Warcoing
Belgium
Tel: 32-69-446-600
Website: www.cosucra.com

Overview
Founded in 1852, Cosucra Groupe Warcoing S.A. (Cosucra) is headquartered in Warcoing,

Belgium. The firm originally dealt with the extraction of sugar from beets for sale in France,
Belgium and the Netherlands. The company started its first inulin product in 1986 and
introduced about six prebiotic brands into the market in 1990. Cosucra is primarily a
prebiotic ingredient manufacturer producing natural food ingredients from chicory and
peas. The company’s products include fibruline, pisane and swelite. Cosucra serves food
and beverage, specific nutrition, meat and savory, and animal feed markets; it currently
supplies prebiotic ingredients to over 400 food manufacturers around the world. The
company employed more than 250 employees in 2015.
Financials
Cosucra reported annual sales of approximately $200 million in 2015.
Cosucra’s nutraceutical products are shown in the following table.
TABLE 100
COSUCRA: NUTRACEUTICAL PRODUCTS
Brand Description
Fibruline Fibruline (inulin) and Fibrulose (oligofructose) are soluble fibers obtained from
chicory root. They are tasteless, odorless, soluble and easy to process.
Pisane With no labeling constraints, this non-GMO and gluten-free ingredient is
extracted in a natural process from the yellow pea.
Swelite With no labeling constraints, this non-GMO and gluten-free ingredient is
extracted in a natural process from the yellow pea.
Strategy
Cosucra is expanding its sales platform by expanding its range of products and entering
emerging markets. The company aims at larger production and distribution of ingredients
to increase its global market share in the prebiotic ingredients industry. Cosucra’s
development strategy is to increase and streamline its distribution lines by strengthening
relations with existing distributors in various regions and with new partnerships and
collaborations.

CRODA INTERNATIONAL PLC
Cowick Hall, Snaith, Goole

East Yorkshire, DN14 9AA
U.K.
Tel: 44-140-586-0551
Fax: 44-140-586 1767
Website: www.croda.com
Overview
Established in 1925, Croda International Plc (Croda) is headquartered in Yorkshire, U.K.

The company’s activities involve the consumer care business segment: About 56.3%
includes personal care, life sciences and crop care as well as the performance segment;
43.7% industrial chemicals. The company’s healthcare business, which operates under the
consumer care segment, supplies a range of ingredients including excipients, ultrapure
medical grade lanolins and omega-3 lipid concentrates to pharmaceutical, dermatological,
animal health, nutraceutical and functional food markets.
Croda operates in over 36 countries in four geographic areas: Europe, North America, Latin
America and Asia. The company also has technical centers and manufacturing facilities
across the U.K., France, Germany, the Netherlands, Italy, Spain, the U.S., Brazil, India,
Singapore, South Korea, Indonesia and Japan. Croda employed more than 4,230 people in
2015.
Financials
Croda reported revenues of around $1.3 billion in 2015, an increase of 3.4% over the
2014 revenues.
Croda’s healthcare segment manufactures superior quality and purified nutritional

products containing omega-3 in ethyl ester and triglyceride form. Croda’s high-purity
Incromega lipid concentrates provide high levels of EPA, DHA and DPA to meet specific
consumer needs.
TABLE 101
CRODA'S NUTRACEUTICAL PRODUCT INCROMEGA
EPA DHA Total Omega-3

Product (%) (%) (%) Chemical Form
Incromega E7010 70 min 13 max 90 min Ethyl Ester
Incromega EPA 700E 70 min 10 max 85 min Ethyl Ester
Incromega TG6015 58 min 10 min 80 min Triglyceride


Incromega EPA 500TG 55 min 6 min 75 min Triglyceride
Incromega E5020 50 min 20 min 70 min Ethyl Ester
Incromega TG3322 SR 33 min 22 min 60 min Triglyceride
Strategy
Croda is using a strategy of joint ventures and new product launches to enhance its
omega-3 fatty acids sales. The company is also focusing on region-wide expansion
techniques aimed to broaden the scope of omega-3 around the world in a phased manner,
thus enhancing product sales and eventual geographic expansions.
To achieve products with superior quality and purity of pharmaceutical and nutraceutical
industries, Croda developed a proprietary flash chromatographic technique called Super
Refining. This technique physically removes impurities from pharmaceutical excipients and
nutritional oils while their fundamental structure remains intact. In the manufacturing of
nutritional products, the company employs a multiple purification process called Super
Refining with PureMax technology for superior standards in quality testing of highly
concentrated omega-3 fatty acids.
DANISCO A/S
Langebrogade 1
Copenhagen, 1001
Denmark
Tel: 45-32-662-000
Fax: 45-32-662-175
Website: www.danisco.com
Overview
Founded in 1989, Danisco A/S (Danisco) is headquartered in Copenhagen, Denmark.

Danisco is a leading food ingredient enzyme- and bio-based solutions company. The
company is engaged in the development, production and sale of food ingredients and
enzymes for the bakery, dairy, beverage and animal feed segments. Danisco was acquired
by DuPont in 2011 for more than $6.0 billion. Danisco’s product portfolio includes
antimicrobials, antioxidants, fibers, emulsifiers, food enzymes, probiotics, medium chain
triglycerides, proboscis and other products. The company operates more than 80 locations
in 40 countries and employed over 7,000 people in 2015.

Financials
Danisco reported annual revenue of around $2.4 billion in 2012. DuPont reported annual
revenue of around $25.3 billion in 2015.
Danisco offers a wide range of food ingredients including antioxidants, phytosterols,

probiotics, soy protein and vitamins.
TABLE 102
DANISCO FOOD INGREDIENTS
Brand Description
Guardian Chelox, Guardian and Grindox Antioxidants
Howaru and Florafit Probiotics
Alpha, Centex, Nurish, Procon, Profine, Proplus, Response, Supro, Supro Ex, Soy proteins
etc.
ActivK Vitamins
PinVita Phytosterols
Strategy
Danisco has set up a sustainability strategy for transformation. The company is focusing
on bio-based ingredient solutions to enhance its food ingredient products in the health and
nutrition market. Danisco’s mission is to deliver innovative, sustainable solutions that
increase the efficiency and safety of the food production chain in an environmentally
responsible manner.
GROUPE DANONE S.A.
15, rue du Helder

75 439 Paris Cedex 09
France
Tel: 33-144-352-075
Fax: 33-142-256-716
Website: www.danone.com
Overview
Founded in 1919, Groupe Danone S.A. (Danone) has its headquarters in Paris, France.
Danone is a food processing and commercializing company. Danone was formerly known
as Groupe Danone. The company along with its subsidiaries engages in the production and

sale of a range of beverages, fresh dairy products, cereal- and nutrition-based baby food,
medical nutrition food, packaged food articles and various other related products. Danone
sells all of these products under the brands Danone, Activia, Essensis, Evian, Volvic, Aqua,
Gallia, Nutricia, Cow and Gate, Fortimel, FortiCare and Infatrini. Geographically, the
company operates in North America, Latin America, Western Europe, Central Europe,
Asia-Pacific, Africa and the Middle East. Danone has 158 manufacturing units and 20
research and development centers around the world. The company employed more than
99,780 people worldwide in 2015.
Financials
Danone reported revenue of approximately $24.7 billion in 2015, an increase of 6.0% over
2014.
Danone offers a wide range of probiotic products under the brand name of Activia. The
company’s key nutraceutical products are shown in the table below.
TABLE 103
DANONE'S NUTRACEUTICAL PRODUCTS
Brand Description
Activia Activia is a delicious and nutritious probiotic yogurt that helps to improve
digestive comfort.
Oikos Oikos is a low-fat, high-protein Greek yogurt with a thick and creamy texture
that is perfect for enjoying as-is or for cooking.
DanActive A delicious daily drinkable probiotic yogurt for the whole family with L. Casei
Danone DN-114 001 cultures.
Silhouette Nourish your body and mind with Silhouette’s line of yogurts—fat-free and
with no added sugar. Discover new high-protein Silhouette GREEK at 50
calories.
Danone In addition to being low in fat, the new Danone Creamy yogurt is made with
Creamy simple and good ingredients. It is made with fresh milk, real fruit, no gelatin,
no preservatives and no artificial flavors or colors. The ingredients and the
smooth texture make it an ideal everyday yogurt.
Danino Danino yogurt is made with real fruit puree that is bursting with flavor. It’s
the perfect treat for snack time or dessert.
Strategy
Danone is focusing on core business of high-growth and high-margin like dairy products
and beverages. The company has expanded its nutraceutical business across Asia, Latin
America, Africa and the Middle East by various strategic partnerships and acquisitions.

Danone acquired Clover S.A. in South Africa and the Tessala in Algeria.
MARTEK BIOSCIENCES CORP.
6480 Dobbin Rd.

Columbia, MD 21045
Tel: 410/740-0081
Fax: 410/740-2985
Website: www.martek.com
Overview
Established in 1985, Martek Biosciences Corp. (Martek) is headquartered in Columbia, Md.

The company is primarily engaged in the development and manufacture ofnutritional
products for good health based on microbial sources. Martek carries outinnovation,
development, manufacturing and sales of nutritional products. The companydeveloped a
number of products including their flagship product, life’sDHA, as well asdietary
supplements and animal feeds. Martek also developed other nutritional ingredients,an
omega-6 fatty acid, DHA and ARA by using proprietary technology. The companyprimarily
operates in the U.S. but has also expanded its roots to China and the U.K. More than
99.0% of the company’s infant formula sales in the U.S. market and other products are
sales in more than 75 countries around the world. In February 2011, Martek acquired
Royal DSM NV (Netherlands) for $1.1 billion. The company employed more than 225
people worldwide in 2015.
Financials
This is a privately held company and no financial information is available in the public
domain.
Martek develops, manufactures and sells naturally produced products derived from micro
algae, fungi and other microbes. The company’s nutraceutical products are shown in the
following table.

TABLE 104
MARTEK'S NUTRACEUTICAL PRODUCTS
Product Description
life’sDHA Considered the best source of DHA and omega-3, used for nutritional purposes
for children, adults, sports nutrition and for animals. DHA (docosahexaenoic acid)
is the only omega-3 that supports brain, eye and heart health throughout all
stages of life. After five years on the market, infant formula fortified with
life’sDHA accounts for 99% of all infant formula sales in the U.S. Recent food
and beverage launches from Minute Maid Pomegranate Blueberry Juice to
Horizon Organic Milk Plus life’sDHA are exceeding sales expectations. The
following foods and supplements contain life’sDHA: Horizon, Cofco Cooking Oil,
Spring Valley, Francesco, Rinaldi and Crisco.
Services Contract manufacturing services are based on DHA, Omega-3. The company’s
technology platform involves microbial biology, algal genomics, fermentation
and downstream processing. This technology platform has led the company’s
development of products, including, an omega-3 fatty acid for brain, heart and
eye health throughout life for use in infant formula, pregnancy and nursing
products, foods and beverages, dietary supplements and animal feeds.
Strategy
Martek is focusing on an expansion strategy, especially into the Chinese market. The
company has engaged into an agreement with Feihe Dairy and COFCO to expand its
penetration in Chinese market. Further, Martek also sold certain assets to streamline its
operations as a part of its strategy to significantly outset price reductions resulting from
their infant formula contract extensions through the execution of production cost savings,
product innovation initiatives and growing their non-infant formula business.
NORDIC NATURALS
111 Jennings Dr.

Watsonville, CA 95076
Tel: 800/662-2544
Fax: 831/724-6600
Website: www.nordicnaturals.com
Overview
Established in 1995, Nordic Naturals is headquartered in Watsonville, Calif. Nordic Naturals

provides fish oil products—mostly with 95% concentration in natural triglyceride form. The
company conducts clinical studies every year to launch new products and is a trusted
brand for many medical professionals and research institutes. Nordic Naturals markets its
products through health food stores, retail outlets and through distributors in the U.S. and
35 countries around the globe including Canada, Brazil, Columbia, U.K., Belgium, Denmark,
Kuwait, UAE, India, China, Singapore, Indonesia, Japan and South Korea. The company

sells around 150 different fish oil products in a variety of flavors, concentrations and
delivery forms. Nordic Naturals had approximately 375 employees throughout the world in
2015.
Financials
Nordic Naturals generated revenue of approximately $25 million in financial year 2015.
Nordic Naturals’ products are for different categories that depend on the presence of
omega-3, which is different for different ages, different functions and different sources.
Products include children’s multivitamins, omega-3 concentrates, omega-3
non-concentrates, daily omegas and pet products. The company’s omega-3 products are
shown in the following table.
TABLE 105
NORDIC NATURALS' OMEGA-3 PRODUCTS
Product Description
Products 1. Ultimate Omega Junior, Children’s DHA, Children’s DHA, Omega-3.6.9 Junior,
for Ultimate Omega 500, Baby’s DHA and Omega-3 Effervescent.
children 2. Children’s multivitamin Children’s Gummies.
3. Children’s gummies: Nordic Omega-3 Gummies, Nordic Omega-3 Gummy
Worms and Nordic Omega-3 Fishes.
Products 1. 100% arctic cod liver oil: Arctic Cod Liver Oil, Arctic Cod Liver Oil Soft Gels,
by Arctic-D Cod Liver Oil.
category 2. Kenai wild Alaskan salmon oil: Kenai Wild Alaskan Salmon Oil Soft Gels and
Kenai Wild Alaskan Salmon Oil Liquid.
3. Omega-3 concentrates: Ultimate Omega, Ultimate Omega Liquid Ultimate
Omega-D3, Ultimate Omega 500, Ultimate Omega in Fish Gelatin, Ultimate
Omega Sport, DHA 1000, DHA, Prenatal DHA, EPA, EPA Xtra and Ultimate
Omega Junior.
4. Omega-3 non-concentrates: Omega-3, Omega-3 Liquid, Omega-3D,
Omega-3D Liquid, Omega-3 in Fish Gelatin, Arctic Cod Liver Oil Soft Gels, Arctic
Cod Liver Oil, Arctic-D Cod Liver Oil
5. Omega-3.6.9 combinations- Complete Omega-3.6.9, Complete Omega-3.6.9
Liquid, Complete Omega-3.6.9-D and Omega Woman.
6. Omega-3 + nutrients- Omega Blood Sugar, Omega LDL , Omega Probiotic,
Ultimate Omega +CoQ10, Ultimate DHA Eye, Omega Joint, Omega Joint,
Omega Joint Xtra
7. Vitamin D3 formulas- Vitamin D3, Ultimate Omega-D3, Omega-3D,
Omega-3D Liquid, Arctic-D Cod Liver Oil, Complete Omega-3.6.9-D,
Omega-3.6.9-D Junior, Nordic Berries

Pet Omega-3 Pet, Omega-3 Pet, Cats and Small Breed Dogs, Omega-3 Pet, Medium
products to Large Breed Dogs, Omega-3 Pet Large to Very Large Breed Dogs & Multi-Dog
Households, Pet Cod Liver Oil
Strategy
Nordic Naturals is focusing on continuously improving the quality of its fish oils in light of
the importance of omega-3s to good health. The company is working on purity, freshness
and structures that maintain the overall quality of fish oil. Nordic Naturals is extending its
business with new product launches in the fish oil market.
OCEAN NUTRITION CANADA LTD.
101 Research Dr.

Dartmouth, NS B2Y 4T6
Canada
Tel: 902-480-3200
Fax: 902-480-3199
Website: www.ocean-nutrition.com
Overview
Established in 1997, Ocean Nutrition Canada Ltd. (ONC) is headquartered in Dartmouth,

Nova Scotia, Canada. The company operates as a wholly owned subsidiary of DSM, the
world’s largest integrated shellfish harvester and processor. ONC is a leader in fish-oil
derived omega-3 fatty acids for dietary supplements. The company is primarily engaged in
the researching, manufacturing, distributing and marketing dietary supplements and food
ingredients from fish oil to improve human health.
ONC’s products include omega-3 fish oils and oil concentrates for the dietary supplement
market; Levenorm, a fish protein hydrolysate that supports healthy blood pressure level in
prehypertensive people; and omega-3 powders, which are used in various food products
such as baked goods, milk, yogurt, juice, nutrition bars and confectionary products. These
products are available in different ranges depending on the presence of omega-3. The
company offers dietary supplements and healthy foods to the multi-national companies
throughout North America, Europe, Asia and Australia. ONC has a strategic agreement
with Wilmar International Ltd., an agribusiness group headquartered in Singapore. ONC
operates primarily in the Canada and also has an active presence in the U.S., Australia,
Europe, the U.K., Ireland, Mexico and China. ONC employed more than 400 people as of
2015.
Financials
ONC revenue was not given in DSM’s annual report for the financial year ended 2015.

The company is a supplier of a variety of pure and palatable omega-3 fish oils formulated
for bakery products, pharmaceutical products, nutraceutical products and supplementary
products etc. ONC deals in omega-3 bakery products, Big Shotz multivitamin and mineral
juices, kettle corn and chocolate containing omega-3s.
Strategy
Being the world’s largest producer of Omega-3 EPA/DHA from fish oil, ONC is positioned to
deliver unique solutions that provide companies with a competitive edge, which includes
unmatched cost advantage and the highest-quality omega-3 EPA/DHA ingredients
available for both dietary supplements (DS) and healthy food ingredients (HFI).
ONC has built three high-tech processing plants which can deliver a reliable supply of fish
oils and fish oil powders. ONC’s excellence and innovation in serving customers in
research and development, manufacturing, marketing and distribution of omega-3
ingredients is the major element of its strategy, ensuring sustainable growth and position
as an industry leader.
OMEGA PROTEIN CORP.
2105 City W. Blvd, Suite 500

Houston, TX 77042-2838
Tel: 800-345-8805
Fax: 713-940-6166
Website: www.omegaproteininc.com
Overview
Established in 1878, Omega Protein Corp. (OPC) is headquartered in Texas. In 1994, it was
developed as Zapata Protein, which was renamed Omega Protein Corp. in 2002. The
company is principally engaged in the processing of fish oil, fish meal and fish soluble
used in animal feed, human food products and dietary supplements. OPC produces,
markets and distributes fish meal and fish oil products, most of which contain omega-3,
primarily in the U.S.
The major competitors of the OPC are ADM Co., American Seafoods Group LLC and Cargill
Inc. The company owns and operates four menhaden processing facilities—two plants in
Louisiana, one plant in Mississippi and one in Virginia. OPC also operates a health and
science center in Reedville, Virginia, which has capacity for processing 100-metric tons per
day of fish oil for the company’s food, industrial and feed grade oils. OPC has operations in
North America, Europe, Asia, and South and Central America. The company employed
around 1,150 people in 2015.

Financials
Omega Protein Corp. generated revenue of approximately $359.3 million in financial year
2015.
Omega Protein Corp. sells three general types of products, namely fish meal, fish oil and
fish soluble. Key brands include Fish Meal, Special Select SeaLac Fish Oil, SeaCide
OmegaPure Fish Soluble and Neptune OmegaGrow, OmegaEquis and OmegaGrow Plus.
The company’s nutrition products are shown in the following table.
TABLE 106
OMEGA PROTEIN'S NUTRITION PRODUCTS
Product Description
Animal The company has developed a complete line of high-quality protein feed
nutrition ingredients from nature’s best source of protein and omega-3 fatty acids, the
menhaden fish. OPC produces three types of fishmeal—FAQ, Special Select
and SeaLac—for the nutritional needs of all animal species. The company also
manufactures Neptune Aqua Grade Liquid Protein and Virginia Prime Refined
Oil for livestock and pet applications. Omega Protein is produced with fish oil
naturally rich in omega-3 fatty acids EPA and DHA, which help improve
immune response, reproductive function and performance.
Human Nutraceutical ingredients: Omega Protein offers some of the most innovative
nutrition ingredients in the marketplace under the Cyvex Nutrition brand. Every Cyvex
Nutrition ingredient is guaranteed by the exclusive NutriPrint quality
assurance system for safety and efficacy.
Food Ingredients: Omega-3 fatty acids from fish are essential to brain
development and a healthy body. Flavorless, odorless and the perfect balance
of EPA and DHA, OmegaPure is the preferred source of omega-3 rich fish oil
with a number of available delivery systems. This functional food ingredient
was the first fish oil to have direct GRAS approval by the FDA for human
consumption.
Plant OmegaGrow and OmegaGrow Plus were developed to meet the specific needs
nutrition of farmers seeking a natural way to effectively fortify crops and increase
yields. When used as fertilizer, these fish-based nutrients enhance plant
growth and support beneficial microbial populations in the soil.
These products are designed for foliar applications on virtually any
crop—vegetables, fruits and field crops, greenhouses and nurseries—for
integrated pest management programs.
Strategy
High quality and purity of nutritional products with the critical importance of the omega-3
fatty acids warrant painstaking control every step of the production process to ensure

product integrity, consistent quality and complete traceability. In order to sustain its
leading position in the omega-3 market, the company has created the OmegaPure
CTechnology and Innovation Center (OPTIC) for research and development of new and
innovative ways to integrate omega-3 fatty acids in food and beverage applications.
PHARMA MARINE USA LLC
2317 Moore Ave.

Fullerton, CA 92833
Tel: 714/871-1998
Website: www.pharmamarine.com
Overview
Established in 2007, Pharma Marine USA LLC (Pharma Marine) is headquartered in

Southern California. Pharma Marine was established by Leif Kjeti and then joined Asgeir
Saebo. The company started as a provider of bioactive components for raw materials. In
search of raw materials from both Asia and South America, they expanded with a new
factory in Norway in 2009. Pharma Marine has a new state-of-the-art production in Norway.
The company holds around 40% of the world’s high-grade omega-3 output. Pharma Marine
employed more than 60 people in 2015.
Financials
This is a privately held company and no financial information is available in the public
domain.
Pharma Marine is a supplier of the range of DHA (docosahexaenoic acid) concentrates

using only the trimmings from the food production of Calamari as raw material. The
company’s calamari products are shown in the following table.
TABLE 107
PHARMA MARINE'S CALAMARI PRODUCTS
EPA DHA EPA + DHA

Product Form (min. mg/g) (min.mg/g) (min.mg/g)
Calamarine 90/180 TG TG (Tryglyceried) Only 90 180 270
Calamarine 165/335 EE (Ethyl Ester) or TG 165 335 500
Calamarine 140/360 EE or TG 140 360 500
Calamarine 50/500 EE Only 50 500 500

Strategy
Pharma Marine is focusing on its DHA ingredient business to increase its market share and
competitive edge. The company developed Calamarine, which is imbued with unique
characteristics that provide customers with an opportunity to differentiate themselves in
the increasingly commoditized omega-3 market.
Pharma Marine is continuously developing and bringing to market a range of eco-friendly

DHA concentrates. The company is poised to play an important role in the global omega-3
market. In order to sustain its leading position in this market, it has also developed an
in-house state-of-the-art research laboratory, where several market-changing, patent
protected innovations are being developed and offered to the market.
ZYMES LLC
777 Terrace Ave.

Hasbrouck Heights, NJ 07604
Tel: 201/727-1520
Fax: 201/727-1571
Website: www.zymes.com
Overview
Founded in 2005, Zymes LLC (Zymes) is headquartered in New Jersey. Zymes is

essentially a bioscience company principally engaged in the development and
manufacturing of innovative products and solutions using science, technology and nature
to improve the quality of life. The company deals in water-soluble omega-3, omega-3
beverages and omega-3 powder. Zymes primarily operates in the U.S. The company also
operates an affiliated company, Zymes Omega Solutions Inc., which is engaged in creating
and marketing omega-3 fortified consumer products that promote health and wellness.
Zymes also holds the worldwide exclusive rights for the use of its proprietary PTS
technology for omega-3 acids for food, beverage and dietary supplements. The company
employed more than 30 people in 2015.
Financials
Zymes generated revenue of approximately $2.0 million in the financial year 2015.
Zymes has successfully solublized omega 3s (EPA/DHA from both fish oil and algae) by the
use of Zymes’ Ubisol-Aqua solubilizing technology. The company’s omega-3 products are
shown in the following table.

TABLE 108
ZYMES' OMEGA-3 PRODUCTS
Product/
Services Description
Zymes water Zymes water-soluble omega-3 offers the solubility and stability of
soluble omega-3 fatty acids for use in food and beverage applications. Current
omega-3 omega-3 products have limited shelf life, ranging from two weeks to six
months, during which most require refrigeration. Processing limitations
allow for only limited types of products for the delivery of omega-3s. No
company prior to Zymes has been
able to stabilize omega-3s and deliver them in clear beverages.
Zymes omega-3 Zymes water-soluble omega-3 is the only available source for clear
beverages beverage products. Zymes Ubisol-Aqua Technology (the lead component
of which is PTS) combined with proprietary patented formulations and
trade secrets, delivers the solution for clear, shelf-stable omega-3s in
finished products.
Zymes omega-3 Zymes has successfully created a powder form of its proprietary
powders omega-3 formulations. This stable powder can be added directly to water,
resulting in a clear solution. The powder can also be used as an
ingredient in a variety of products including granola bars, cereals and
powdered stick packs. Beyond the consumer benefits in the omega-3
powder form, there are significant processing and logistical benefits
afforded in the use of a powder form in the manufacturing of omega-3
fortified consumer food and beverages.
End-product Food and beverage manufacturers can now offer Zymes’ omega-3
formulations formulations in the following categories: Clear beverages, gelatin
desserts, powder stick packs, liquid concentrates, fountain beverages,
cereal, cookies, food requiring high-temperature baking, ice cream,
coffee creamers and beverage sweetener.
Strategy
Zymes is looking forward to bringing to market exciting new products to increase its
market share and competitive advantage over other players in omega-3 market. The
company holds substantial intellectual property on technology for, among other things,
enhanced drug delivery systems. Zymes strives to develop and offer innovative solutions
to market through its patented science and technology, enabling new products to enhance
the well-being of people.

Chapter 11
APPENDIX
FOD013F
March 2017
Natraj Pandal
Project Analyst
ISBN: 1-62296-448-9
BCC Research
or (+1) 781-489-7301
www.bccresearch.com
CHAPTER 11
APPENDIX
LIST OF ACRONYMS
ANAISA National Association of Food Supplements

Industry
AQSIQ Administration of Quality Supervision
Inspection and Quarantine
CAGR Compound annual growth rate
CHCA China Health Care Association
EC European Commission
EFSA European Food Safety Authority
FAO Food and Agriculture Organization
FBS Food, beverage, and supplement
FDA U.S. Food and Drug Administration
FOSHU Foods for Specific Health Use
FSSAI Food Safety and Standards Act of India
GRAS Generally recognized as safe
IADSA International Alliance of Dietary/Food
Supplement Associations
MOH Ministry of Health
NHCR Nutrition and Health Claims Regulation
SFDA China’s State Food and Drug Administration
USCHPA U.S.-China Health Products Association
WHO World Health Organization

Nutraceuticals - Global Markets

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Nutraceuticals - Global Markets

Uploaded by

Copyright:

Available Formats

NUTRACEUTICALS: GLOBAL MARKETS

ABOUT BCC RESEARCH

Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com

This publication provides informative material of a professional nature. It does not

©Copyright 2017 by BCC Research, Wellesley, MA 02481 USA

Copyright © BCC Research, Wellesley MA USA, Website: www.bccresearch.com

CHAPTER 1 INTRODUCTION .......................................................................................... 2

SUMMARY TABLE GLOBAL NUTRACEUTICAL MARKET, BY PRODUCT, THROUGH ........... 6

SUMMARY FIGURE GLOBAL NUTRACEUTICAL MARKET, BY PRODUCT, 2015-2021 ....... 6